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ABSTRACT 
The study of retroviruses has been of pivotal significance to the field of biomedical 
science, where it has provided fundamental insights into the processes underlying both 
viral and non-viral carcinogenesis. Ovine pulmonary adenocarcinoma (OP A), a contagious 
lung cancer of sheep and goats, has emerged over the past three decades as an invaluable 
model of human epithelial cancers. It is one ofthe very few animal models 
whereas most other animal models of human 
cancers pertain to the haematopoietic system. OP A represents a unique, naturally 
occurring, inducible, outbred animal model of peripheral lung carcinomas, and is caused 
by a betaretrovirus - jaagsiekte sheep retrovirus (JSRV) - that is receiving increasing 
attention in the fields of retrovirology and lung cancer research. 
JSRV exists in two highly homologous, yet molecularly distinct forms. The first is an 
exogenous form of the virus that is transmitted horizontally from one animal to another. 
This form is infectious and the direct cause of OP A. The other is an endogenous form, 15 
to 20 proviral copies of which reside benignly in the genome of sheep and are transmitted 
vertically from one generation to the next. At the time this study commenced, no 
knowledge existed regarding the underlying pathogenic mechanism by which JSRV causes 
OPA. Even though the nucleotide sequence of exogenous JSRV had been elucidated seven 
years earlier, only limited sequence information was available on endogenous JSRVs. With 
a view towards identifying genetic regions or elements within exogenous JSRV that could 
potentially be implicated in its pathogenic function, this study began with the cloning of 
the first three full-length endogenous JSRV loci ever isolated from sheep. The DNA 
sequences of these full-length endogenous JSRV loci were determined and 
xxv 
comprehensively analysed. Comparison with exogenous JSRV isolates revealed that the 
two forms ofthe virus are highly homologous, yet can be consistently distinguished in 
three short regions within the coding genes. Two of these reside in the gag gene, and one at 
the end of the env gene. These regions were named the variable regions (VRs) of sheep 
betaretroviruses. 
The JSRV VR3 in env was linked by our collaborators to the virus's ability to transform 
cells in tissue culture. The effects and biological significance ofVRI and VR2 in gag are 
subtler and more difficult to determine. After identifying these regions, it became the 
objective of this study to develop relevant molecular tools that could be used to discern the 
significance of these variable regions in vivo, and to characterise these tools in vitro to 
assess their suitability for in vivo studies. The development of these tools entailed the 
design of a novel strategy that was implemented to precisely substitute the endogenous 
VRI and VR2 (individually and in combination) into an infectious molecular clone of 
exogenous JSRV. These chimeric constructs were shown to support retroviral particle 
release into the supernatant of transiently transfected cells in tissue culture. These particles 
were confirmed by independent experiments to have arisen specifically from transfection 
with the chimeric clones. Finally, the particles were shown to be capable of infecting 
cultured cells and of productively integrating their genomes into those of their host cells, 
rendering these particles fully competent retroviruses that can be used in the context of in 
vivo studies to determine the biological significance ofVRI and VR2. 
This study has made a significant contribution to the further development of the OP A / 
JSRV model system of human epithelial lung cancers. It has also led to the design of a 
molecular substitution strategy that can be adapted to introduce any genetic region into a 
xxvi 
cloned DNA construct, regardless ofthe degree - or lack of interrelation - of the two DNA 




AND LITERATURE REVIEW 
1.1 THE STUDY OF RETROVIRUSES 
The discovery and study of retroviruses has been of far-reaching significance in the fields 
of biology and medicine (Vogt, 1997a). The signet ofthese viruses lies in their replicative 
strategy and the associated RNA-dependent DNA polymerase enzyme, reverse 
transcriptase. The discovery of this enzyme (Baltimore, 1970; Temin & Mizutani, 1970) 
had tremendous scientific impact by necessitating a revision of the hitherto accepted 
central dogma of the flow of genetic information from DNA to RNA to protein. Since its 
discovery, it has become an indispensable tool for the operation of virtually all molecular 
biology and biotechnology laboratories. 
The study of retroviral oncogenesis led to the discovery of viral oncogenes and their 
cellular origin in the form of proto-oncogenes (Fan, 1994; Rosenberg & Jolicoeur, 1997; 
Vogt, 1997a). All retrovirally transduced oncogenes were found to be of normal cellular 
origin, and the common mechanisms involved in retrovirally induced neoplasms extend to 
tumours lacking a retroviral aetiology - many of the genes that were initially identified as 
retroviral oncogenes in animal cancer models are now known to be activated in certain 
types of human cancers (Barbacid, 1987; Bos, 1989; Fan, 1994; Hynes & Stem, 1994; 
Sawyers, 1992). Even important pathways involved in normal cellular growth and 
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differentiation were elucidated and continue to be illuminated by studies of retroviral 
systems (Rosenberg & Jolicoeur, 1997). 
In addition to their roles in promoting our understanding of normal and aberrant cellular 
growth processes and providing us with an invaluable tool in molecular biology, 
retroviruses hold immense therapeutic potential in the form of transfer vectors for genetic 
material in gene therapy. The use ofretroviral constructs is being clinically pursued or 
experimentally investigated for gene therapy targeting various tissues and organs, e.g. 
muscle (Fassati & Bresolin, 2000), liver (Kalpana, 1999), the central nervous system (Suhr 
& Gage, 1999), the haematopoietic system (Cornetta & Fan, 1997) and even stem cells 
(Havenga et ai., 1997), mostly for the treatment of cancers, but also for numerous 
congenital and acquired diseases. The development and efficacy of such therapeutic 
approaches relies on a continually more detailed understanding of retroviruses, their 
induced pathogenesis and their life cycles, as well as the identification of novel, and the 
characterisation of hitherto relatively unknown, retroviruses. 
1.2 THE DISEASE: JAAGSIEKTE / OVINE PULMONARY 
ADENOCARCINOMA 
"Jaagsiekte", which translates directly to "chasing sickness", is the Afrikaans name 
originally given to a contagious lung cancer of sheep, since affected animals appeared as 
though they had been chased. Previously the disease was also referred to as sheep 
pUlmonary adenomatosis or ovine pulmonary carcinoma. As of June 2001 , the various 
research groups working with it agreed on the standardised use of "ovine pUlmonary 
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adenocarcinoma" (OP A) to describe this disease (Fan, 2003). "Ovine" refers to sheep; 
"pulmonary" relates to the lungs; the prefix "adeno-" means "gland"; and carcinomas are 
malignant tumours originating in epithelial tissues. OP A was further classified as a 
bronchioloalveolar carcinoma (BAC) (Nobel & Perk, 1978) in accordance with the 
previously accepted World Health Organisation classification criteria for tumours of 
domestic animals (Stunzi et ai., 1974). 
OP A is a well-differentiated multifocal tumour that originates from the transformation of 
epithelial alveolar type II (ATII) pneumocytes and the non-ciliated bronchiolar (Clara) 
cells (Nisbet et ai., 1971; Nobel et aI., 1969; Nobel & Perk, 1978; Perk et aI., 1971 b; Perk 
et aI., 1971a). These early reports were recently confirmed when the transformed cell types 
were proportionally enumerated - 82% were found to be ATII cells, 7% Clara cells and 
11 % could not be classified owing to insufficient differentiation (Platt et ai., 2002). 
Metastasis to regional pulmonary lymph nodes occurs in 10 to 50 % of cases, depending on 
the country in which the data originate (DeMartini & York, 1997; Verwoerd, 1996). The 
cause of this variation has not been established, but might be linked either to differences in 
breed susceptibility or to different viral strains (Verwoerd, 1996). The transformed cells do 
not lose their secretory function, and the lung fluid production that is characteristic and 
clinically diagnostic of OP A probably originates from the tumour cells (DeMartini & 
York, 1997). 
OP A is one of the major infectious diseases of sheep. It displays an extremely variable 
incidence and prevalence worldwide, occurring in sheep flocks in many countries of 
Africa, Asia, South America and Europe (DeMartini & York, 1997; Hecht et ai., 1996a; 
Sharp & DeMartini, 2003). In some of these, including South Africa, prevalence is as high 
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as 20 % in certain flocks and is thus of considerable economic importance, whereas it is 
infrequently diagnosed in the United States and Canada. OP A was successfully eradicated 
in Iceland by means of a radical slaughter strategy (Sharp & DeMartini, 2003; York & 
Querat, 2003), and has never been reported in Australasia and the Falkland Islands (Ortin 
et at., 1998), even though the large population of Merino sheep in Australia originated 
from South Africa 0' erwoerd, 1996). The most recent region to report OP A for the first 
time is Patagonia, Argentina, which should have been protected against the introduction of 
the disease by the animal health barrier that restricts the introduction of live animals or 
their products into that area (Uzal et at., 2004). The source of OPA infection in Patagonia 
remains unknown. 
Clinical symptoms of OP A manifest once the tumour mass becomes large enough to 
hamper normal lung function; affected animals develop progressive respiratory distress and 
usually die within a few weeks ofthe onset of clinical signs (De las Heras et aI., 2003a). 
The natural incubation period of OP A has been estimated at approximately five to six 
months, with two- to four-year-old sheep being most commonly affected (DeMartini et at., 
1988; DeMartini & York, 1997; Sharp & DeMartini, 2003). Experimentally, however, 
OPA can be induced within three to four weeks (and even as little as ten days) in newborn 
lambs, upon intratracheal inoculation with concentrated lung fluid collected from OP A-
affected sheep (Sharp et aI., 1983). A later study demonstrated that OPA can be induced by 
inoculation of lambs of ages up to six months, and that the incubation period is longer for 
lambs inoculated at a higher age (Salvatori et aI., 2004). 
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1.3 JAAGSIEKTE SHEEP RETROVIRUS 
Jaagsiekte sheep retrovirus (JSRV) is currently the only virus known to induce a naturally 
occurring lung cancer (Palmarini et al., 2004). JSRV resembles type D and type B 
oncoviruses in terms of its morphology and genetic organisation (York et al., 1991; York 
et al., 1992), and is phylogenetically closely related to mouse mammary tumour virus 
(MMTV) and to a group of human endogenous retroviruses (HERVs) that utilise a lysine 
(K) tRNA recognition sequence as their primer binding site (PrBS) for second strand 
synthesis during reverse transcription, hence the designation "HERV-K". Its closest 
exogenous relative is enzootic nasal tumour virus (ENTV), which causes a nasal 
adenocarcinoma arising from the transformation of cells in the respiratory and olfactory 
mucosal glands of sheep and goats (De las Heras et al., 2003b). JSRV exists in two closely 
related, but molecularly distinct forms. The first is an infectious exogenous retrovirus 
(henceforth referred to in this manuscript as JSRV), which is transmitted horizontally from 
one animal to another and is the aetiological agent of OP A (Palmarini et aI., 1999a). The 
second is a group of endogenous retroviralloci that resemble JSRV at the nucleotide level 
(York et al., 1992), but are transmitted vertically through the germ line of animals in the 
fashion of Mendelian genes. These endogenous sequences are henceforth referred to as 
enJSRVs in this manuscript. enJSRVs are widely distributed in ungulates, with 15 to 20 
copies of closely related sequences being found in the genomes of all domestic sheep and 
goats (Hecht et al., 1996b). OPA is associated absolutely with its aetiological agent JSRV 
(Palmarini et aI., 1996a), whereas enJSRVs by themselves are not associated with disease. 
No sheep population has been identified that lacks enJSRVs, and the possible role of these 
sequences in disease, as well as their importance to the host organism, has yet to be 
elucidated. 
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1.3.1 JSRV is the aetiological agent of OPA 
Historically, herpesviruses and lentiviruses were considered likely candidates as the 
aetiological agents of OP A. However, the gradually accumulated evidence implicating a 
retrovirus (specifically JSRV) became increasingly more convincing. It is only briefly 
summarised here, as it has been extensively reviewed (DeMartini & York, 1997; Hecht et 
ai., 1996a; Palmarini et aI., 1997; Verwoerd, 1996; York & Querat, 2003), and is now 
largely of historical interest: 
• Transmissibility studies showed that the disease could be reproduced by inoculation 
with cell-free extracts of tumour homogenates or concentrated lung fluid. 
• Inocula exhibited a reverse transcriptase (R T) activity with a magnesium ion 
preference, and the RT level in the inocula was inversely proportional to the 
incubation period in experimental transmission studies. 
• Serological studies showed that both lung fluid and tumour homogenate contained 
proteins that cross-reacted with antisera to capsids and nucleocapsids of type D and 
type B retroviruses. 
• Retrovirus-like particles were observed by electron microscopy in lung tumours and 
lung fluid of affected sheep. 
• The full genome of a retrovirus (JSRV-SA) isolated from the lungs of an OPA-
affected sheep was cloned and sequenced (York et aI., 1991; York et ai., 1992), and 
it exhibited a genomic organisation typical of type D and B retroviruses. 
• JSRV was found to be consistently, specifically and absolutely associated with OPA 
(Palmarini et ai., 1996a). 
- 6 -
The above evidence, however, did not prove that infection with JSRV is sufficient to 
induce OPA by itself. The possibility existed that JSRV was acting in the capacity of a 
helper virus, complementing a hitherto undiscovered acutely transforming retrovirus. 
Further definition of the role played by JSRV in OP A was hampered by the lack of an in 
vitro culture system for the virus. The precise nature of association of JSRV with OPA 
was not known until Palmarini et al. (1999a) constructed an infectious molecular clone 
derived from an integrated proviral JSRV sequence (called JSRV21) isolated from a 
spontaneous case of OPA. The JSRV 21 genome was placed under the transcriptional 
control ofthe human cytomegalovirus (CMV) immediate early promoter. The promoter 
was positioned in such a way that the resulting RNA transcript would be very similar to 
wild-type JSRV RNA, giving rise to the plasmid pCMV2JS21 . pCMV2JS21 was transfected 
into the highly transfectable human 293T cell line, from which substantial amounts of 
JSRV21 virus were released into the culture supernatant. Concentrated stocks of JSRV2J, 
obtained from transfected 293T cells, were used for intratracheal inoculation of newborn 
lambs. Two of them became infected with OP A (confirmed at the histological, 
immunological and molecular level), thus proving conclusively, for the first time, that 
JSRV is both necessary and sufficient to induce OPA. 
1.3.2 Characterisation of JSRV 
Arguably, the first cornerstone in the foundation of JSRV molecular biology research was 
the elucidation of the complete genomic nucleotide sequence of JSRV (York et aI., 1991; 
York et al., 1992). The sequence was obtained by assembling the sequences of individual 
cDNAs derived from the purified RNA of a South African isolate, JSRV-SA. The 
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JSRV-SA genome was found to be 7462 nucleotides (nt) in length, measured from the 5' R 
("repeat") to the 3' R region. Analysis of the JSRV -SA sequence revealed that it contains a 
primer binding site (PrBS) complementary to the 3' end of a tRNA Lys 1,2 immediately 
downstream of the U5 region, just like HERV-K. JSRV-SA exhibited a genomic 
organisation typical of type D and type B retroviruses, having overlapping open reading 
frames (ORFs) encoding the structural genes gag,pro,pol and env, with a separate pro 
5' 3' 
Figure 1.1 Schematic representation of the genomic organisation and open reading frames 
of JSRV. The black boxes on the 5' and 3' ends represent the R-U5 and U3-R regions, 
respectively, flanking the retroviral RNA genome. Upon integration, they would form the 5' and 3' 
long terminal repeats of the provirus, each consisting of identical U3-R-U5 sequences. Adapted 
from York et a/. (1992). 
reading frame (Fig. 1.1). Retroviral mRNAs are translated into three polyproteins - Gag, 
Gag-Pro-Pol and Env - which are post-translationally cleaved into mature proteins by the 
retroviral protease enzyme encoded by the pro gene. The pol gene encodes the reverse 
transcriptase (RT) and integrase (IN) enzymes, while the envelope (Env) protein consists 
ofa surface (SU) and a transmembrane (TM) domain (Swanstrom & Wills, 1997). The 
Gag polyprotein is cleaved minimally into three subunits - MA (matrix protein, which is 
peripherally, not integrally, associated with the host cell membrane) on the amino-terminal 
end; CA (capsid protein, which encapsulates the ribonucleoprotein complex containing the 
genomic RNA); and NC (nucleoQapsid, which binds with high affinity to the genomic 
RNA) on the carboxy-terminal end - although most retroviral Gag proteins contain a 
segment between MA and CA and one after NC that are often cleaved further into smaller 
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peptides or proteins (Vogt, 1997b). In JSRV, these have only recently been defined as 
"pIS" (between MA and CA) and "p4" (Murcia et al., 2007). 
In addition to the canonical retroviral genes, JSRV-SA had an accessory open reading 
frame overlapping pol, the function and significance of which has yet to be determined. 
This reading frame was termed "orfx" and was also found in the only other full-length 
JSRV genomic sequence known at that time - JSRV21 (Palmarini et al., 1999a). The orfx 
region is considered rather unusual. Its predicted polypeptide sequence of 166 amino acids 
(AA) is very hydrophobic and exhibits a codon usage that is significantly different from 
that of the pol gene. It does not appear to impose any constraints on the codon usage of pol, 
however. Based on the above observations, the prospect of orfx being a coding region was 
initially considered unlikely (York et aI., 1992), a view which was substantiated by a 
consistent failure to express cloned versions of the gene in bacterial cells (D.F. York, 
personal communication). Subsequently, three independent publications reported the 
conservation of orfx in all known exogenous JSRV sequences, as well as in a number of 
enJSRVs (Bai et al., 1999; Palmarini et al., 1999a; Rosati et ai., 2000). The studies 
concluded that orfx must be a functional gene and that it was not a chance generation in 
JSRV -SA. There appears to be a weak sequence homology between a 90 amino acid 
stretch of the deduced sequence of orfx and the mammalian adenosine receptor subtype 3 
(Bai et ai., 1999; Rosati et ai., 2000), a G-protein-coupled receptor that regulates diverse 
biological events, including cell growth and differentiation. Structural analysis of the 
putative mRNA transcript of orfx placed it in a category of transcripts that include those 
coding for oncogenic growth factors, transcriptional factors, and regulatory proteins 
predicted to be translated poorly. 
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Rosati et al. (2000) concede that the high degree of conservation of orfx might result from 
the fact that it overlaps pol, which needs to be conserved to maintain biological function. It 
was suggested that orfx encodes a novel, hydrophobic and membrane-bound protein of 
unknown function. Cousens et al. (1999) argued against a potential role of orfx in cellular 
transformation. Their reasoning was based on the assumption that ENTV utilises the same 
oncogenic mechanism as JSRV. ENTV has two stop codons in the region homologous to 
orfx, and therefore does not represent an accessory open reading frame in ENTV (Cousens 
et al., 1999). Dr Massimo Palmarini (personal communication) argued at the time that the 
two stop co dons observed in the "orf-x" region of the published ENTV sequence might 
merely be an artefact of the sequencing strategy employed by Cousens et al. (1999), and 
that a possibility existed of ENTV exhibiting an uninterrupted orfx reading frame. In fact, 
when another isolate of EN TV (from an infected goat instead of a sheep) was sequenced, it 
was found to contain orf-x without any stop codons (Ortin et al., 2003). 
Phylogenetic analysis showed that JSRV is closely related to Mason-Pfizer monkey virus 
(MPMV), the type D retroviral prototype, in the Gag, Pro and Pol protein regions, but that 
the Env proteins of these viruses are not related (York et aI., 1992). Conversely, the Env 
protein encoded by JSRV is homologous in terms of its structural organisation with that of 
MMTV (the type B retroviral prototype) and HERV-K (also a type B retrovirus), whereas 
the gag, pro and pol genes of these viruses are not closely related. JSRV was therefore 
thought to have diverged from the A-B-D evolutionary lineage of retroviruses between the 
divergence of the B prototype MMTV and the D prototype MPMV. JSRV thus represents a 
chimera characterised by a type B morphology (as determined by the spikes on the viral 
envelope, encoded by env) and a predominantly type D genome. Another possible 
explanation of the chimeric nature of JSRV was proposed by Hecht et al. (1996b): JSRV 
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could have arisen as a consequence of homologous recombination between type B and type 
D retroviruses. In terms of classification, both type D and type B retroviruses belong to the 
betaretrovirus genus (Buchen-Osmond, 2004). 
Phylogenetic analyses based on the U3 region (Bai et aI., 1996), as well as orfx and env 
regions (Bai et aI., 1999), of various isolates of JSRV indicate that there are two exogenous 
genotypes of JSRV, the older of the two being endemic to Africa, and the more recent 
being prevalent in the USA and UK. Furthermore, the African JSRV genotypes group 
more closely with endogenous JSRV sequences than do the ones from the USA and UK. 
1.3.3 Cellular distribution and expression of JSRV in the host 
The transformed epithelial tumour cells in the alveoli of OP A-affected sheep have been 
identified as the major sites of proviral JSRV translation and virion assembly (Palmarini et 
at., 1995). A high level of viral expression is also observed in the mediastinal lymph nodes 
draining the lungs, and a lower level of expression has been demonstrated in various 
anatomically dispersed lymphoid tissues (e.g. spleen; thymus; bone marrow; mammary 
lymph node) and peripheral blood mononuclear cells (PBMCs) (Gonzalez et at., 2001; 
Palmarini et at., 1996b). More specifically, JSRV was found to infect CD4+, CD8+ and B 
cells, as well as adherent lymphocytes, which exhibited a higher proviral load than the non-
adherent cells (Holland et aI., 1999). Macrophages in the lungs of affected animals contain 
the highest proviral burden amongst the non-lung tissues. This type of dispersed viral 
infection, of both lymphoid and non-lymphoid tissues, is similar to that observed with 
other betaretroviruses (Palmarini et at., 1996b). 
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It has not been determined whether lymphoid infection with JSRV precedes infection of 
the cells where transformation occurs, or if it is a consequence thereof (but see below). 
Proviral JSRV DNA was detected in lymphoid cells of animals seven days post-
inoculation, at which point there were no signs of OP A (Holland et aI., 1999). This 
indicates that lymphoid infection precedes transformation and tumour development. 
Systemic lymphatic dissemination could also precede transformation. Gonzalez et al. 
(2001) showed that JSRV proviral DNA can readily be detected in the peripheral blood 
leukocytes of infected, yet non-symptomatic sheep during the pre-clinical phase, and 
probably prior to transformation of lung epithelial cells, since some sheep showed no 
discernible lung tumours at necropsy. Similarly, during the recent OP A outbreak in 
Patagonia, Uzal et al. (2004) found a positive reaction using an exogenous JSRV-specific 
peR from the lung tissue of a sheep that had not developed any nodules in its lungs at the 
point of its (OP A-unrelated) death. 
Although JSRV evidently infects other cell types, neoplastic transformation is limited to 
those cells in which JSRV is efficiently expressed, viz. the differentiated epithelial cells of 
the lung (Palmarini et al., 1995; Palmarini et al., 2000a; Palmarini & Fan, 2003). This tight 
restriction of expression is considered rather unusual for oncogenic retroviruses 
(Rosenberg & Jolicoeur, 1997). In a recent study JSRV-infected flocks were monitored 
over an extended period of time (Caporale et al., 2005). It was found that JSRV infection 
can occur at any point during a sheep's lifetime (perinatally, in the first few months oflife, 
or in adult sheep), and that the majority of JSRV-infected sheep do not develop clinical 
disease for the duration of their commercial lifespan. The incubation period of naturally 
acquired OPA, as opposed to OPA induced by concentrated JSRV-containing inocula, was 
as much as several years. Furthermore, JSRV was found to be more readily detectable in 
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peripheral blood leucocytes and lymphoid organs during preclinical stages of infection 
than in the lungs. The investigators suggest a model whereby JSRV infects lymphoid cells 
in the first instance. These would serve as a reservoir of infectious virus, which only 
infects type II pneumocytes and/or Clara cells (which have a low replicative index) if these 
are undergoing active mitosis in response to, for instance, other pulmonary infections. 
Whereas the retroviral envelope gene products determine the cell types that can be infected 
via interaction with specific cellular receptors (Hunter, 1997), enhancer sequences within 
the L TRs of retroviruses interact with transcription factors of the infected cells (Fan, 1994; 
Rosenberg & Jolicoeur, 1997). The LTR of JSRV contains enhancer sequences that 
interact with transcription factors specifically expressed in differentiated epithelial cells of 
the lungs, rendering efficient expression of this virus lung-specific (McGee-Estrada et al., 
2002; Palmarini et al., 1995; Palmarini et al., 2000a; Palmarini & Fan, 2003). 
In a recent study contributed to by the author, the LTR enhancer elements of Moloney 
murine leukaemia virus (M-MuLV) were replaced with those of JSRV, yielding a chimeric 
M-MuLV / JSRV LTR (McGee-Estrada et al., 2005). Using luciferase reporter assays, the 
relative activity of this chimeric LTR was shown to be at least five-fold more active in 
MLE-15 cells (a mouse type II pneumocyte cell line) than in mouse fibroblasts (NIH-3T3 
cells) when compared to the wild-type M-MuLV LTR. The JSRV enhancers thus imparted 
lung cell specificity on the chimeric LTR. What proved to be a more relevant and sensitive 
measure of retroviral enhancer activity than the reporter assays, however, was the author's 
contribution to this study. This entailed infectivity studies of M-MuL V viral particles 
under the control of the chimeric M-MuLV / JSRV LTR, compared to wild-type M-MuLV 
particles. The relative infectivity of particles under the control of the chimeric L TR was 
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three to four log values (as opposed to only five-fold) higher in lung epithelial cells than in 
different non-lung cells, compared to wild-type M-MuLV particles (McGee-Estrada et al., 
2005). These experiments clearly demonstrate the high degree of transcriptional specificity 
of the JSRV LTR enhancer elements for the differentiated cells of the lungs, which could 
render JSRV a valuable tool in lung gene therapy. 
1.4 ENDOGENOUS JSRV SEQUENCES 
The genomes of all vertebrates have been colonised by endogenous retroviruses during the 
course of their evolution. They are inherited in much the same fashion as Mendelian genes 
and for the most part, they are non-infectious and non-pathogenic. Both advantageous and 
detrimental roles have been suggested for many endogenous retroviruses, but only rarely 
substantiated experimentally (Boeke & Stoye, 1997; Vogt, 1997a). The existence of 
numerous endogenous sequences related to JSRV in sheep genomes was first reported by 
York et al. (1992). This finding resulted from molecular probing of sheep genomic DNA 
with probes based on the sequence elucidated for JSRV-SA. Probes based on the capsid 
(CA, part of gag) region were used to quantify the endogenous genomic sequences related 
to JSRV; they were found to hybridise to more than 20 bands, both in the tissues ofOPA-
affected and unaffected sheep (Hecht et aI., 1994). 
The above findings were extended by Hecht et al. (1996b) to demonstrate that probes 
based on CA and the envelope surface (SU) region hybridised to between 15 and 20 bands 
in all members of domestic sheep and goats tested. The banding patterns obtained were 
similar for the different genomes tested, indicating that the integration sites are probably 
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similarly conserved. Furthermore, the SU and CA probes hybridised under high stringency 
conditions to samples obtained from six wild Ovis and Capra genera, implying that the 
enJSRV loci thus detected must have become fixed in the genomes of sheep and goats 
prior to the time of their domestication. The gag regions were found to be more conserved 
among sheep and goat enJSRVs than the env regions. Recently, using fluorescence in situ 
hybridisation as well as sheep-hamster hybrid cell lines, the chromosomal distribution of 
enJSRVs was studied for the first time (Carlson et al., 2003). enJSRV proviruses were 
found to generally be randomly distributed among sheep and goat chromosomes, with the 
exception of two loci on different chromosomes that contained multiple enJSRV copies, 
probably in the configuration of tandem repeats. Only two enJSRV chromosomal positions 
were shared by sheep and goats, indicating that the majority of endogenisation events 
occurred after speciation of sheep and goats. 
Palmarini et al. (1996a) reported the consistent presence of a Seal restriction endonuclease 
(RE) site in the gag region of exogenous JSRVs that was absent in enJSRVs. These 
findings allowed them to design a hemi-nested (hn) PCR protocol that could distinguish 
between endogenous and exogenous JSRV transcripts on the basis of the differential Seal 
restriction site in gag. The results of these tests showed that transcripts of endogenous 
JSRV origin are expressed in various sheep tissues, and that the exogenous form of JSRV 
is exclusively associated with OPA. More recently, enJSRV expression was found to be 
most abundant in the reproductive system of ewes, and to be upregulated by progesterone 
(Palmarini et al., 2001a; Spencer et al., 1999). Furthermore, enJSRVs are broadly 
expressed in the ovine foetus, including tissues involved in the deVelopment of the immune 
system (Sanna et al. , 2002). Palmarini et al. (1996a) also found the U3 region in the LTRs 
of enJSRV proviral sequences to contain insertions of 30 and 16 base pairs (bp) relative to 
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JSRV. This observation led to a far more sensitive bn-PCR, based on the unique 
differences between the U3 regions of endogenous and exogenous sequences (Palmarini et 
aI., 1996b), facilitating better detection of exogenous JSRV in a background of enJSRV 
sequences. 
Using PCR primers based on the sequence of JSRV, Bai et al, (1996) amplified a number 
of nearly full-length enJSRV fragments from sheep genomes. Based on restriction 
endonuclease (RE) profiles, they identified six different types of enJSRV loci (Fig. 1.2). 
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Figure 1.2 Comparison of restriction profiles of JSRV and enJSRVs (Bai et al., 1996). 
Restriction profiles of enJSRVs are aligned with those of JSRV. Sites present only in JSRV or 
enJSRVs are highlighted with asterisks. Those sites used to distinguish the four subgroups (loci 1 
to 4) are indicated by full enzyme names, EeoRI and Pstl. Dashed lines indicate the gross locations 
of deletions. Capital letters represent restriction sites: B, 8amHI; E, EeoRI; H, Hindlll; K, Kpnl; N, 
Ndel; P, Pstl; S, Seal; X, Xhol. [Figure derived and legend adapted from Bai et al. (1996).] 
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observed in the other loci. A PstI site present in the gag region of locus 2, but absent in 
locus 1, distinguished subgroup 1 and subgroup 2 within Group I. For similar reasons, 
Group II (comprising locus 3 and locus 4) was divided into subgroups 3 and 4. Groups III 
and IV consisted of loci 5 and 6, respectively, which were characterised by large deletions. 
No restriction maps were published for Groups III and IV. A 220-bp region comprising 
part of gag was sequenced in 15 enJSRV clones from loci 1 to 6; these sequences exhibited 
98% sequence identity amongst each other and an average of 95% identity in the deduced 
AA sequence with the corresponding JSRV region. Sequence comparisons of parts of the 
env transmembrane (TM) regions of enJSRVs showed that a 500-bp stretch on the 5' end 
of this region was 96% identical to JSRV at the nucleotide level. However, a 130-bp region 
of loci 1 to 4 at the 3' end of env exhibited only 62% nucleotide and 30% deduced AA 
identity with the corresponding JSRV region, and was 12 bp shorter. A later study (Bai et 
al., 1999) confirmed these findings, but the significance of the divergence between the 3' 
ends ofTM in endogenous and exogenous JSRV was not discussed. 
1.5 INFECTION WITH JSRV IS IMMUNOLOGICALLY 
SILENT 
York et al. (1992) pointed out that they had expected their finding of numerous 
endogenous JSRV-related sequences in the genome of healthy sheep, based on the 
observation that there was no detectable antibody response to infection with JSRV in sheep 
(DeMartini et al., 1988; Sharp & Herring, 1983). York et al. (1992) speculated that the 
expression of endogenous JSRV antigens, closely related to those of JSRV, in the neonatal 
period during ontogeny would lead to the depletion of JSRV antigen-reactive T and B 
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lymphocyte populations. This would induce a state of immune tolerance with respect to 
JSRV antigens, both of endogenous and exogenous origin, so that no antibody immune 
response is launched upon infection with JSRV. 
The earlier findings regarding the lack of antibody response to JSRV (and ENTV) were 
supposedly improved upon by two reports of the detection of antibodies directed against a 
recombinant major core protein (P27) ofMPMV coupled to glutathione-S-transferase 
(GST) (Kwang et al., 1995; Rosati et al., 1995). These antibody responses were detected in 
sheep with OPA and goats with ENT. The design of the MPMV p27-GST fusion protein 
for the detection of infection with JSRV or ENTV was based on earlier findings that 
MPMV p27 cross-reacts with the capsid antigen of JSRV (Sharp & Herring, 1983) and 
ENTV (De las Heras et al., 1993). Rosati et al. (1995) claimed that neither sera from ENT-
affected nor unaffected goats reacted with the GST moiety alone, although they did not 
show results to substantiate this. Kwang et al. (1995) found the MPMV p27-GST fusion 
protein to react with all OP A-positive control sera but not with any of the negative control 
sera. They developed an ELISA for OP A serodiagnosis and applied it to US and European 
sheep flocks. Based on a number of sheep that tested positive for antigens specific for 
MPMV p27-GST, they concluded that there is a high prevalence of subclinical infection 
with JSRV. 
The above findings were dismissed by Ortin et al. (1998) as having been based on non-
specific reactions. Ortin et al. (1998), using a recombinant JSRV-CA protein coupled to 
GST, also detected positive reactions in the sera ofOPA-affected sheep. However, these 
positive reactions were not limited to infected sheep; they were also detected in non-
affected sheep, as well as sheep from Australia and the Falkland Islands (where OPA has 
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never been reported). Ortin et al. (1998) showed that the reactivity in all sera could be 
completely abolished by absorption with a lysate containing GST, indicating that the 
positive reactions demonstrated by Kwang et al. (1995) and Rosati et al. (1995) were likely 
to be directed against the helminth parasite-derived GST, and not the JSRV or ENTV 
capsid antigens. The positive reactions were thus indicative of infections by parasites 
rather than JSRV or ENTV. These findings therefore confirmed the earlier observations 
regarding the absence of a specific humoral immune response directed against JSRV. 
Further support for this was rendered by way of explanation for this phenomenon: The 
thymus and lympoid tissues associated with the small intestine oflamb foeti were shown to 
express enJSRV transcripts (Spencer et al., 2003). These tissues are partly responsible for 
the development of the immune system in sheep, and expression of enJSRV transcripts 
would lead to their being recognised as "self'. The high degree of homology between 
enJSRVs and JSRV / ENTV would consequently lead to immune tolerance of the latter, as 
already speculated by York et al. (1992). 
Recent studies investigated the non-humoral immune response in the lungs of OP A-
affected animals and found evidence of a strong local infiltration of macrophages during 
OPA development, with concomitant release ofIFN-y (Summers et al., 2005). Also, even 
though infection with JSRV is still considered immunologically silent owing most 
probably to central tolerance as a result of in utero expression of endogenous JSRV 
sequences, humoral immune responses to vaccination with JSRV capsid and nucleocapsid 
proteins were generated when these proteins were administered subcutaneously and 
intramuscularly to sheep with complete Freund's adjuvant (Summers et al., 2006). This 
finding promises the potential deVelopment of a protective vaccine in future. 
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1.6 ONCOGENIC POTENTIAL OF JSRV 
The mechanism of transfonnation leading to OP A has still not been fully elucidated 
(however, see 3.4.2 for a critical appraisal of recent in vitro work to detennine this 
mechanism), but the possible means by which JSRV could cause neoplasia were reviewed 
by Hecht et al. (1996a). Owing to the discovery by Palmarini et al. (1999a) that the JSRV21 
provirus had integrated into part of the sheep genome that did not align with any known 
cellular sequences (including proto-oncogenes), the possibility of insertional mutagenesis 
being the transfonning mechanism was strongly reduced. Even at this stage, however, 
insertional activation has not been eliminated as a possible contributor towards OP A, 
especially in view of the fact that the analysis of70 different JSRV integration sites in 
OP A did identify at least one common integration site near a mitogen-activated protein 
kinase-encoding gene (Cousens et aI., 2004). The remaining integration sites, however, 
displayed an apparently random distribution. Furthennore, since the JSRV21 clone was able 
to induce OPA by itself, in the same time frame as field isolates, JSRV is not a helper virus 
for an acutely transfonning retrovirus. It can therefore be concluded that the genome of 
JSRV itself is most likely to harbour its oncogenic potential. 
This leaves three possible alternatives suggested by Hecht et al. (1 996a). Firstly, even 
though JSRV does not encode any sequences known to be associated with oncogenesis, 
one of its protein products may still induce cellular transfonnation. Secondly, one of the 
viral products may act as a transcription factor to stimulate a cellular oncogene. This type 
of trans-activation is usually associated with a longer time course than the one observed in 
experimentally induced OPA, but JSRV may harbour a more potent activator than those 
found thus far. The third and remaining alternative suggested by Hecht et al. (1996a) is 
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that the binding of the type II pulmonary epithelial cell receptors by their retroviralligands 
could result in signal transduction, thereby stimulating the production of growth factors, 
followed by cell proliferation and subsequent neoplasia. 
1.7 HUMAN BRONCHIOLOALVEOLAR CARCINOMA 
Lung cancer represents the leading cause of cancer mortality worldwide, in both men and 
women (Boring et al., 1994). Bronchioloalveolar carcinoma (BAC, a subtype of 
pulmonary adenocarcinoma) in humans resembles OP A at the ultrastructural and 
histopathological level (Barsky et al., 1994). Like OPA, it originates from the 
transformation of Clara cells and type II pneumocytes (Clayton, 1986; Yesner, 1993; 
Yesner & Carter, 1982), and is equally multifocal in nature (Barsky et al., 1994). OP A has 
long been considered the only outbred animal model of human adenocarcinomas of the 
lung, and ofBAC in particular (Nobel & Perk, 1978; Palmarini & Fan, 2001; Perk & Hod, 
1982). 
BAC differs from other forms of lung cancer in a number of respects. Firstly, a far greater 
proportion of BAC patients are non-smokers than in other types of lung cancer (Barsky et 
al., 1994; De Frutos Arribas et al., 1996; Fujimoto et al., 1999; Read et al., 2004). The 
incidence of cigarette smoking in BAC patients does not appear to differ significantly from 
the population average in several studies, meaning that - depending on the time frame and 
geographic location of the studies - at least 30% and as many as 65% ofBAC patients are 
non-smokers. Secondly, there is a proportionally higher incidence ofBAC in women than 
in other types oflung cancer (Barsky et ai., 1994; Fujimoto et al., 1999; Read et al., 2004). 
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During a retrospective study of 1527 cases ofBAC conducted by Barsky et al. (1994) at 
the UCLA School of Medicine, covering the 35-year period from 1955 to 1990, a male-to-
female ratio of around unity was recorded. The overall male-to-female ratio of lung cancer 
in 1990 was 3:1. Thirdly, Barsky et al. (1994) found that the mean age of patients with 
BAC was lower than that of non-BAC pulmonary adenocarcinoma patients. 
The proportional incidence of BAC relative to other forms oflung cancer is frequently 
reported as having risen sharply over the past four decades (Auerbach & Garfinkel, 1991; 
Barkley & Green, 1996; Barsky et ai., 1994; Ikeda et al., 1991), and it appears to account 
for most of the observed increase in pulmonary adenocarcinomas (of which BAC is a 
subtype). For instance, whereas in 1955 BAC represented less than 5% oftotallung 
cancers as reported in the study by Barsky et al. (1994), it accounted for 24% in 1990, 
making it the most frequently diagnosed form oflung cancer. Similar findings were 
reported in Japan (Ikeda et ai., 1991). However, BAC is also still frequently cited as 
accounting for approximately 3% of lung cancer diagnoses, as was the case several 
decades ago. There are recent reports to substantiate this claimed incidence. Fujimoto et al. 
(1999) as well as Read et al. (2004) report that BAC rates have remained fairly constant, 
accounting for about 3 % of total pulmonary malignancies. It should be noted that these 
reports do not necessarily contradict the findings of those groups which have found 
significant increases in the incidence ofBAC in their study cohorts. The apparent 
discrepancy can be taken to mean that the incidence of BAC has increased in some 
geographical clusters across the world, whereas it has remained unchanged elsewhere. 
Barsky et al. (1994) refer to the similarities between OP A and BAC, and suggest that a 
possible viral aetiology for BAC be considered, based on the multifocality of the disease, 
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since viral-induced neoplasms tend to be multifocal and multi clonal. The findings of a 
dramatic increase in the incidence ofBAC (at least in some centres), a younger age 
distribution (being indicative of a risk factor different from those in other lung tumours), a 
sex ratio close to unity and the rather weak link to cigarette smoking substantiate their 
hypothesis ofBAC possibly being a virus-initiated or -promoted disease entity. Barkley & 
Green (1996) cite a further nine references that have postulated a viral aetiology for BAC. 
They support the suggestion that BAC is possibly a virally mediated neoplasm. The 
apparent geographical clustering of high / increasing incidence ofBAC would also be in 
keeping with an infectious aetiology of at least a subset ofBACs. 
The similarities between OP A and BAC tempt one to speculate about a possible 
involvement of a hitherto unknown JSRV-related retrovirus in the aetiology ofBAC. 
Indeed, studies have been undertaken with the aim of investigating such a link, yet their 
findings are inconsistent. A published preliminary abstract of a conference presentation 
(O'Connell et ai., 1998) indicated that a well-characterised rabbit polyclonal antiserum to 
the JSRV major capsid protein (CA) (Palmarini et ai., 1995) was able to detect 
immunoreactive antigens in the type II pneumocytes and Clara cells of just over half of 
BAC sections tested, and in a lower percentage of peripheral adenocarcinomas. O'Connell 
et al. (1998) also reported that JSRV-CA positivity in BAC had increased over the past 
three decades. Following this preliminary report was a pUblication, by the same 
investigators, in which the sample numbers tested had been substantially increased to 249 
human lung tumours, as well as numerous non-lung adenocarcinomas, non-tumour lung 
lesions, and normal tissues (De las Heras et ai., 2000). Of the BACs, 30% were positive for 
JSRV-related CA, as were 26% of lung adenocarcinomas, whereas other samples tested 
were negative. 
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These results indicated the possible involvement of a JSRV -related retroviral entity in at 
least some human pulmonary adenocarcinomas. Two subsequent reports (Hiatt & 
Highsmith, 2002; Yousem et ai., 2001) attempted to refute these findings by showing that 
the BAC sections in their studies (numbering only 26 and 24, respectively) were negative 
for JSRV DNA (by PCR) and RNA (by RT-PCR), using undisclosed primer sequences for 
amplification. Since the publication of these reports, the author has maintained that such 
studies would have been considerably more meaningful on BAC samples that tested 
positive for JSRV-CA than on immunologically uncharacterised samples, as was the case 
in the studies by Y ousem et al. (2001) and Hiatt & Highsmith (2002). Furthermore, the 
author disagrees with the claim by Y ousem et al. (2001), that their molecular assessment 
represents a superior means of evaluating the presence of JSRV. Whereas this statement 
might be true when pertaining to JSRV sequences specifically, PCR and RT-PCR would be 
less suitable for the detection of JSRV-related viruses than immunological assays. This is 
aptly demonstrated by the ability to detect JSRV using antibodies directed against the 
capsid protein ofMPMV or MMTV (Sharp & Herring, 1983). The nucleotide homology of 
these viruses would not have sufficed for mutual detection by PCR or R T -PCR. This line 
of reasoning, maintained by the author since the report by Y ousem et al. (2001), has 
recently been supported by a review that relates human BAC to OP A (Momex et al., 
2003). 
1.8 RATIONALE OF STUDY 
Carcinomas (cancers arising in epithelial tissues) are relatively rare in animals compared to 
humans and most animal models of human cancers pertain to those of the haematopoietic 
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system (Cremer & Gruber, 1992; Hecht et ai., 1996a; Rosenberg & Jolicoeur, 1997). OPA 
is amongst the only naturally occurring, outbred animal models of carcinoma, and 
represents a unique cancer model system of differentiated epithelial cells of the lung. Since 
the cause of OP A - jaagsiekte sheep retrovirus - has been established, and the endpoint of 
disease has been well characterised, this model system provides the opportunity of 
dissecting the multi-step cellular and molecular processes that lead from infection to 
tumour development. In this way, the OP A model is superior to the spontaneously 
occurring feline bronchioloalveolar carcinoma (Grossman et ai., 2002), since it can be 
readily induced via infection with JSRV. Even though a retroviral aetiology for human 
BAC has not been firmly established, its operative mechanism of transformation - even if 
triggered differently - is likely to share some pathways with OPA (Grossman et aI., 2002; 
Rosenberg, 2001). The identification of shared pathways would provide potential targets 
for both intervention and, ultimately, measures for the prevention of BAC, pulmonary 
adenocarcinomas, and other epithelial cancers. 
Dissecting the mechanism of pathogenesis employed by JSRV necessitates the detailed 
molecular and cellular characterisation of this virus. No information on the mechanism of 
JSRV pathogenesis was available at the commencement of this study; in fact, the infectious 
molecular clone JSRV21 (Palmarini et ai., 1999a) was not even available. This made the 
selection of regions within JSRV to study for their potential roles in pathogenesis very 
difficult. The aim of the first part of this study was to identify genetic regions or elements 
that could be used to distinguish exogenous from endogenous JSRVs. Only limited PCR-
derived nucleotide sequence data had been obtained from the non-pathogenic endogenous 
JSRVs. It was decided that the first step towards the identification of regions to focus on 
should be a comprehensive comparison between endogenous non-pathogenic and 
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exogenous pathogenic isolates of JSRV. It was hypothesised that the nucleotide sequence 
comparison of several full-length endogenous JSRV genomes (as opposed to mere PCR 
fragments) with exogenous JSRV would reveal characteristics at the genetic level that are 
consistently different in exogenous vs. endogenous JSRVs and could therefore be 
potentially implicated in the pathogenesis of exogenous JSRV. Chapter 2 of this thesis 
describes the characterisation of three endogenous JSRV clones and the identification of 
so-called variable regions that consistently distinguish exogenous pathogenic from 
endogenous non-pathogenic JSRVs. 
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CHAPTER 2 
CLONING, SEQUENCING AND ANALYSIS OF 
FULL-LENGTH ENDOGENOUS LOCI RELATED TO 
JAAGSIEKTE SHEEP RETROVIRUS 
2.1 INTRODUCTION 
The author's work that is described in this manuscript was preceded by two series of 
experiments, which were instrumental in paving the way towards the design of the current 
study. For this reason, parts ofthese two series of experiments will be described briefly, 
focussing on those aspects that impacted on the author's subsequent research. 
2.1.1 Full genome peR approach 
As part of an undergraduate vacation project, the author spent seven weeks in the 
molecular section of the Department of Virology in December 1996 and January 1997, 
seeking to gain some practical research experience and learn techniques relevant to his 
undergraduate degree. During this period, he pursued two goals. The first was to answer 
the important question raised by Dr. D.W. Verwoerd in a guest editorial in the British 
Veterinary Journal, namely whether or not sheep from Australia (where OPA does not 
occur) also harbour JSRV-related endogenous proviruses (Verwoerd, 1996). The second 
goal was to peR amplify the largest possible enJSRV fragment from sheep genomic DNA. 
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The author was provided with muscle tissue of three different Australian sheep, from 
which he isolated high molecular weight genomic DNA following a FastPrep SPIN 
(BIO 101 Systems) protocol. Using a primer pair designed in-house for the peR 
amplification of the p26 / capsid region of the JSRV gag gene, the target was successfully 
detected in all Australian sheep DNA samples, as well as in the positive controls. This 
demonstrated, for the first time, the existence of endogenous proviruses related to JSRV in 
Australian sheep. This result was expected in view of the fact that even some wild relatives 
of sheep and goats had been shown, though only by molecular hybridisation, to harbour 
endogenous JSRV-related sequences (Hecht et aI., 1 996b), but the question had not 
previously been formally addressed. 
Long-range peR using the Expand High Fidelity peR System (Boehringer Mannheim) 
was employed according to the manufacturer's recommendations in an endeavour to 
amplify large enJSRV products. The primers used for this were all based on the exogenous 
JSRV-SA sequence (York et aI., 1992). Attempts to amplify near full-length enJSRV 
sequences using primers JB 1 and JB2 (Bai et al., 1996) failed, presumably because they 
could anneal in the same LTR, and such short amplification would have out-competed the 
possible amplification of full-length sequences. The replacement of primer JB-l with P-I 
(Palmarini et al., 1996b) did not lead to successful amplification either, presumably for the 
same reasons. 
It was subsequently decided to target only approximately half the enJSRV genome in each 
reaction. To this end, primer pairs P-I + OrfX-2 and OrfX-l + JB-2 were used for the 5' 
and the 3' halves, respectively. [See Appendix III for annealing position of primers 
referred to in this thesis.] Following optimisation of peR conditions, the 3' half(- 4 kb) of 
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an endogenous JSRV locus was successfully amplified and cloned into a pMOS-Blue 
T -vector (Amersham). At a later point, the 5' half of an enJSRV locus was also amplified 
(although not by the author), and both clones were sequenced. However, this approach 
could give no indication whether the 5' and the 3' halves that had been amplified were 
each derived from the same enJSRV locus. 
2.1.2 Screening of sheep genomic library 
Dr. Denis York dedicated time during his sabbatical leave at the end of 1997 and the 
beginning of 1998 to the endeavour of isolating truly full-length endogenous JSRV loci. 
This work was conducted in the laboratories of the Cancer Research Institute at the 
University of California, Irvine (henceforth abbreviated to CRIlUCI), where our 
collaborators were concurrently engaged in the isolation of a full-length exogenous 
provirus of infectiously integrated JSRV (Palmarini et al., 1999a). To this end, they had 
already constructed a lambda phage genomic DNA library (using Lambda DASH II Vector 
and Gigapack III Gold Packaging Extracts from Stratagene) from the lung tumour ofa 
sheep with naturally acquired OPA. The construction of this library had been based on the 
digestion of DNA from the sheep lung tumour with the RE enzyme XbaI, which, according 
to the only available exogenous JSRV sequence at the time (York et aI., 1992), was 
believed not to cut within JSRV DNA. 
The above phage library of approximately 7.5 x 105 plaque-forming units (Pfu) was 
divided into 15 sub-libraries, each of which was independently amplified by re-infection of 
Escherichia coli XLI-Blue MRA cells (Stratagene). DNA was extracted from aliquots of 
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each of the sub-libraries and screened for the presence of exogenous JSRV using the 
exogenous-specific hemi-nested U3 peR ofPalmarini et al. (1996b). Those sub-libraries 
negative for exogenous JSRV were further screened for the presence of enJSRVs, 
employing the following steps: 
• Sub-libraries were plated on to bacterial agar plates. 
• Three plaque lifts were performed from each plate, by use of nylon membranes. 
• The phages were lysed on the nylon membranes and the membranes were baked to 
fix the DNA they contained on to the membranes. 
• Replica DNA-containing nylon membranes were hybridised with 32P-Iabelled JSRV 
gag-specific or env-specific probes. 
• Those primary plaques that were positive for both probes potentially contained full-
length JSRV sequences (since gag and env are on opposite sides of the retroviral 
genome) and were consequently picked and re-plated on bacterial lawns. 
• Resulting plaques were screened with gag and enJSRV LTR probes. 
• The positive plaques were amplified for DNA extraction, and the DNA once again 
tested for the absence of exogenous JSRV using the exogenous-specific hemi-nested 
U3 peR ofPalmarini et al. (1996b). 
• Further testing involved the peR amplification of a portion of gag that would 
contain the exogenous-specific Seal site, and Seal digestion of these peR products 
indicated that this site was absent. 
On the basis of the above screening process, three recombinant phages containing distinct 
enJSRV loci were identified. These were used for large-scale phage preparations, phage 
purification and DNA extraction. The DNA was digested withXbaI and -12 kb bands 
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positive for JSRV gag and env by Southern blotting were excised from gels and ligated 
into a pBluescript plasmid vector (Stratagene). This gave rise to the plasmid clones 
penJS5F16, penJS56Al and penJS59Al, which were brought back to the Department of 
Virology to be used by the author for his research project. 
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2.2 MATERIALS AND METHODS 
2.2.1 Description of general laboratory practice employed 
• All bacterial cultures were grown at 37°C unless otherwise stipulated. 
• Aseptic technique was used during all bacterial work. 
• All solutions prepared were autoclaved unless otherwise specified. 
• Water used, unless otherwise stipulated, was double-distilled, deionised, autoclaved 
water. This is abbreviated to ddjH20 for the remainder ofthe manuscript. 
• The names of suppliers and manufacturers used in this manuscript are those that were 
applicable at the time of purchase of any product named, even if the company names 
changed at a later point. For instance, Expand PCR systems were purchased first 
from Boehringer Mannheim and later from Roche. 
2.2.2 Preparation of chemically competent Escherichia coli cells 
Chemically competent E. coli cells were prepared according to an adaptation of the method 
taught in the Department of Genetics, (formerly) University of Natal, Pietermaritzburg, in 
the years 1995 to 1997. The procedure is based on established methods (Sambrook et ai., 
1989) and was modified only to suit our laboratory conditions. 
1. A single colony of E. coli was inoculated into 5 ml Luria-Bertani (LB) medium and 
grown overnight with vigorous shaking (-250 rpm). 
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2. Two millilitres of the overnight culture were inoculated into 200 ml LB medium in 
a 1 I flask. Prior to addition of the overnight culture, 1 ml LB was withdrawn as a 
blank for the spectrophotometer (Beckman DU600). 
3. The 200 ml culture was grown with vigorous shaking and 1 ml fractions withdrawn 
for spectrophotometric analysis until the A590 reached 0.375 (not greater than 0.4). 
4. The culture was dispensed into 4 x 50 ml pre-chilled sterile centrifuge tubes. The 
cells were left on ice for 10 min to cool and were kept cold for the remainder of the 
procedure. 
5. The cells were pelleted at 3,000 rpm for 5 min at 4°C. 
6. The supernatant was poured off and each cell pellet was resuspended in 10 ml of 
cold CaCh solution on ice. 
7. The cells were pelleted at 2,500 rpm for 5 min at 4°C and the supernatant 
discarded. 
8. * Each cell pellet was once again resuspended in 10 ml of cold CaCh solution on ice. 
The resuspended cells were pooled and kept on ice for 30 min. 
9. The cells were pelleted at 2,500 rpm for 5 min at 4°C and the supernatant 
discarded. 
10. The pellet was resuspended in 8 ml ice-cold CaCh solution containing 15% 
glycerol. 
11. The cells were dispensed into labelled pre-chilled sterile microcentrifuge tubes in 
250 JlI aliquots. 
12. The cells were frozen immediately in a dry ice / ethanol bath and stored at -700C. 
* The author introduced the pooling of the cells in this step, both for convenience and to 
assure even cell concentrations in subsequent steps. 
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Steps 11 and 12 above were later modified by the author as follows: 
• The aluminium block that accommodates 1.5 and 2.0 ml microcentrifuge tubes was 
removed from a laboratory heating device. 
• Inside a cooler box, this block was packed in crushed dry ice. 
• Sterile micro centrifuge tubes were labelled and placed into the holes ofthe 
aluminium block. 
• The cells were aliquotted into the microcentrifuge tubes in the aluminium block and 
subsequently stored at -70°C. 
The above modification has several advantages: 
a. The procedure takes less time, because aliquotting of the full 8 ml can be 
completed without the need to take batches of aliquotted cells to a -70°C freezer, 
nor do microcentrifuge tubes have to be inserted into a dry ice / ethanol bath. 
b. The cells are frozen as soon as they are pipetted into the microcentrifuge tubes, 
thus optimising their competence. 
c. The labels do not come off, as they are apt to do in the dry ice / ethanol bath. 
Solutions required: 
LB medium (1 1) 
109 tryptone 
5 g yeast extract 
10 gNaCl 
Dissolved in 800 ml distilled water, then made up to 1 I with distilled water and dispensed 




10 mM Tris buffer, pH 8 
CaCh solution containing 15% glycerol 
As above, except that glycerol was added to a final concentration of 15% before the final 
volume was adjusted. Addition of glycerol permits long-term storage of competent cells at 
-70°C. 
2.2.3 Transformation of competent E. coli cells 
A general procedure for the transformation of chemically competent E. coli cells is given 
below. This was adapted, in terms of heat shock times and temperatures, depending on the 
host strain used. When competent cells were purchased (as opposed to being made 
competent in-house), the suppliers' protocols were followed. 
1. Competent cells were thawed on ice and divided into 100 J.lI aliquots in sterile 
microcentrifuge tubes. 
2. Depending on the type of transformation, either half a ligation mixture (typically 
10 J.lI) or 100 pg to lOng of plasmid DNA (depending on the host strain used) was 
added to the competent cells and mixed by finger tapping. To assess transformation 
efficiency, an uncut plasmid vector (2 ng) was frequently used as a positive control. 
3. This competent cell / DNA mixture was left on ice for 30 min. 
4. The cells were heat shocked in a 42°C water bath, for 45 sec (strain JM105) or 2 
min (strains DH5a and GM2163). 
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5. One millilitre ofpre-wanned (37°C) SOC (Stratagene; for DH5a and GM2163) or 
LB medium (for JM105) not containing any selective antibiotic was added, and 
cells were left to incubate at 37°C for one hour. 
6. Aliquots of transformation culture were plated on agar plates containing one or 
more antibiotics appropriate for the selection of plasmids used for the 
transformation. In the case of transformation with ligation mixtures, a 90 J..LI aliquot 
was usually plated on one agar plate. The remaining cells were pelleted and 
resuspended in -100 J..LI of medium, and plated on a second agar plate. Where 
colour selection was used, agar plates also contained 80 J..Lg/ml X-gal and 0.1 mM 
IPTG. 
7. When the plates were dry, they were inverted and left in a 37°C incubator 
overnight. 
2.2.4 Plasmid isolations 
2.2.4.1 MaxiPrep 
All large-scale plasmid preparations were performed using either the CONCERT High 
Purity Plasmid MaxiPrep Purification Kit (Gibco-BRL, Life Technologies) or the Plasmid 
Maxi Kit (Qiagen), according to the manufacturers' protocols. The former kit was 
discontinued and last used by the author in 2001. The use of the Qiagen kit was more 
convenient owing to the availability in the department of the so-called QIArack, in which 
the QIAGEN-tips 500 could be placed during the column binding, washing and elution 
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steps. The Gibco-BRL kits, on the other hand, yielded more consistent results in terms of 
DNA yield and purity from saturated 100 ml cultures and had fewer faulty columns. 
2.2.4.2 MiniPrep 
The QIAprep Spin MiniPrep Kit (Qiagen) was used for small-scale preparation of high-
purity plasmid DNA, essentially according to the manufacturer's instructions pertaining to 
the use of a microcentrifuge. It was optimised for purification of high-copy number 
plasmid DNA, which was expanded by overnight broth culture of transformed E. coli 
strains, comprising 1-5 ml LB medium. Prior to the procedure being performed, the 
following manufacturer's guidelines were employed: 
RNase A solution was added to buffer Pl . 
Buffer PE required the addition of 96-1 00% ethanol. 
Buffers P2 and N3 were checked for salt precipitation. If salt crystals were evident, they 
were dissolved by incubation at 37°C. 
All centrifugation steps were carried out at maximum speed (;::: 10,000 x g) in a table top 
microcentrifuge. 
Procedure: 
• Bacterial cells (in pellet form) were resuspended in a 250 III volume of buffer PI. 
The resulting homogeneous suspension of cells was transferred to a 1.5 ml 
micro centrifuge tube. 
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• A 250,....1 volume of buffer P2 was added to the cell suspension. The tube was gently 
inverted 4-6 times to mix the contents. Vortexing was not recommended as the force 
would cause genomic DNA shearing to occur. The lysis was continued for up to five 
minutes, by inverting the tube until the solution became visibly viscous. 
• Buffer N3 was added to the lysate at a volume of 350 ,....1. The contents were gently 
but thoroughly mixed to prevent salt precipitation. 
• The solution was centrifuged at maximum speed for ten minutes. 
• The supernatant was collected and transferred to a QIAprep column attached to a 
collection tube. 
• The QIAprep column containing the lysate was centrifuged for one minute at 
maximum speed. The supernatant was discarded. 
• The plasmid DNA attached to the QIAprep spin column was washed with 500 ,....1 
buffer PB and centrifuged for one minute at maximum speed since mostly E. coli JM 
strains were used. 
• The filter tube was disconnected and the flow-through supernatant was discarded. 
• A further wash was carried out using buffer PE at a volume of750 ,....1. The tube was 
centrifuged for one minute at maximum speed. 
• The supernatant was disposed of and the filter tube was re-connected to the 
collection tube. The tube was centrifuged for a further minute to collect residual 
wash buffer at the bottom of the collection tube. This was an important additional 
step as the wash buffer contained ethanol, which would have inhibited downstream 
reactions if not completely removed. 
• At this point, the collection tube was discarded and the QIAprep column was placed 
into a sterile 1.5 ml microcentrifuge tube. A 50 ,....1 volume of buffer EB (10 mM Tris-
CI, pH 8.5) was added to the filter tube. The tube contents were allowed to stand at 
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room temperature for one minute to facilitate the elution process, before being 
subjected to centrifugation for one minute at maximum speed. 
2.2.5 DNA quantitation 
The DNA utilised as template in each peR assay or sequencing reaction was quantitated 
using a Beckman DU 530 Spectrophotometer by measuring the absorbance of the purified 
DNA at 260 nm. The DNA concentration was calculated by the spectrophotometer using 
the following parameters: cell path length (mm) of 10 and double-stranded DNA 
absorption factor of 50. The DNA concentration was determined from the absorbance 
value at 260 nm. The instrument was fitted with a sipper accessory that drew the fluid into 
a chamber of a path length equivalent to that of a quartz cuvette. 
Procedure: 
• AI: 1 00 dilution of each sample was made and placed into a micro-centrifuge tube. 
• It was vortexed thoroUghly. 
• An 800 ,....1 volume of distilled water, which served as the blank, was taken up by the 
sipper (all DNA samples were reconstituted in ddjH20). 
• The absorbance at 260 nm was displayed as 0.00. 
• Each absorbance at 260 nm of each sample was measured using the same procedure. 
There was no washing of the sipper between samples. 
• The ratio (A26o / A28o) was obtained for each DNA sample to detect protein 
contamination and determine sample purity. 
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• After all samples had been spectrophotometric ally read, the sipper was washed with 
distilled water. 
2.2.6 Polymerase chain reaction 
The general PCR conditions for reactions performed throughout the study are described 
(Tables 2.1 and 2.2). Deviations are explicitly indicated, where applicable. 
Table 2.1 Constituents of polymerase chain reactions employed. 
Reagent Volume (~l) Final concentration 
lOx reaction buffer containing 15 mM 
5 Ix 
Mg2CI 
Forward primer (10 pmol/~l) 1 0.2~M 
Reverse primer (1 0 pmol/~l) 1 0.2 ~M 
dNTP mix (10 mM each) 1 200 ~M of each 
dNTP 
dd jH20 variable -
DNA (1 pg-100 ng) variable -
Thermostable DNA polymerase (Taq) variable 
2.5 - 5.0 
U/reaction 
Final volume 50 
Where optimisation was required, the fmal Mg2CI concentration was varied from 
2.0 to 6.0 mM. 
DNA template varied from 1 pg plasmid DNA to 100 ng genomic DNA. 
If a hot start step was included, the manufacturer's instructions were followed 
relating to the initial denaturation time period. This varied from 2 minutes to 15 
minutes. The use of TaKaRa Ex Taq DNA polymerase (Takara Bio Inc.) required a 
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"cool start" procedure, where tubes were added to the thermocycler block preheated 
to 94°C. 
Table 2.2 Cycling conditions applied to polymerase chain reactions. 
Time Temperature (OC) Number of cycles 
Hot start 2 - 15 minutes 94 or 95 1 
Initial denaturation 5 minutes 94 or 95 1 
Denaturation 30 seconds 94 or 95 
Annealing 30 seconds 55 25-35 
Elongation 1 minute / kb 72 
Final elongation 7 minutes 72 I 
Hold 00 15 -
2.2.7 Automated DNA sequencing 
Automated DNA sequencing was performed on two ABI PRISM 310 Genetic Analyzers 
(perkin Elmer), one in the Department of Chemical Pathology, Faculty of Medicine, 
(former) University of Natal and the other at the South African Sugar Association 
Experimental Station, Mount Edgecombe. At the CRlIUCI, an ABI PRISM 377 DNA 
Sequencer (perkin-Elmer) was used. The author did not operate any of these automated 
DNA sequencers, but he did prepare the samples to be loaded on the sequencers. For 
sample preparation, two commercially available kits were initially used, viz. the Thermo 
Sequenase Dye Terminator Cycle Sequencing Premix Kit (Amersham Biosciences) and the 
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ABI PRISM BigDye Terminator Cycle Sequencing Ready Reaction Kit (PE Applied 
Biosystems). Each of the suppliers offered a choice of sample preparation and clean-up 
procedures, one of each of which was adapted for use in the Molecular Section of the 
Department of Virology. Unless otherwise stipulated, all dye-termination sequencing 
reactions were performed in a GeneAmp PCR System 2400 (Perkin Elmer). 
2.2.7.1 Sample preparation using the Thermo Sequenase kit 
Composition of sequencing reaction: 






96°C 1 min 
96°C 30 sec 
45"C 15 sec 
60°C 4 min 
4°C 00 
5 pmol minimum 
200 -250 ng 
variable 
x 25 cycles 
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Clean-up: 
1. When cycling was complete, each 20 III sequencing reaction was transferred to a 
1.5 ml microcentrifuge tube, and the extent of volumetric loss (owing to 
evaporation from ineffectively sealed PCR tubes), when it occurred, was noted. 
2. A volume of 7 III of 7.5 M ammonium acetate was added to each tube. 
3. The tube contents were brought to a final ethanol concentration of 70% by the 
addition of2.5 volumes (68 Ill) of cold (-20·C) 100% ethanol, and mixed 
thoroughly using a vortex mixer. 
4. Tubes were centrifuged in a-microcentrifuge at maximum speed (13,000 rpm; 
~ 15,000 x g using an 18-position rotor) for 15 min. The directional position of 
tubes was noted. 
5. Supernatants were carefully aspirated using a 100 III pipette, and a different pipette 
tip for each sample. Residual droplets on the walls of the tubes were absorbed with 
finely rolled tissue paper. 
6. The DNA pellets were washed with 300 III 70% ethanol and centrifuged for 5 min. 
7. The supernatants were removed as above and the pellets were air dried. 
8. Each pellet was dissolved in 4 III of Formam ide Loading Dye and vortexed 
vigorously for 10-20 sec to ensure complete resuspension. The tubes were 
centrifuged briefly to collect the sample at the bottom of the tubes. 
9. Samples were heated to 70·C for 2- 5 min to denature, and then placed on ice until 
being loaded on the automated sequencer. 
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2.2.7.2 Sample preparation using the FS Terminator and BigDye kits 
The same procedures were followed in the application of the FS Terminator and BigDye 
kits, except where indicated. 
Composition of sequencing reaction: 







Samples were mixed well and spun briefly prior to cycle sequencing. 
Cycling conditions: 
96°C 10 sec 
50°C 5 sec x 25 cycles 
60°C 4 min 
4°C 00 
Clean-up: 
1. The contents of each tube were spun down in a microcentrifuge and transferred into 
1.5 ml microcentrifuge tubes, taking note of any volumetric losses. 
2. The following were added to each tube, to give a final ethanol concentration of 
60± 3%: 
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16 III of ddjH20 
64 III of non-denatured 95% ethanol 
3. Tubes were closed, vortexed briefly, and left at room temperature for 15 to 20 
minutes to precipitate the extension products. (For FS Terminator kit, the samples 
were placed on ice for 10 minutes). 
4. The tubes were placed in a microcentrifuge and their orientations marked. 
5. The tubes were centrifuged for 20 minutes at maximum speed (13,000 rpm; 
~15,000 x g using an I8-position rotor). 
6. Supernatants were carefully aspirated using a 100 III pipette, and a different pipette 
tip for each sample. Residual droplets on the walls of the tubes were absorbed with 
finely rolled tissue paper to ensure complete removal of unincorporated dye 
terminators present in the supernatants. This step was required to be performed 
immediately after centrifugation in step 5 finished. When this was not possible (e.g. 
when batches of more than six sequencing reactions were processed concurrently), 
tubes were centrifuged for a further two minutes, and the supernatants removed 
immediately thereafter. 
7. The pellets were washed by the addition of 250 III 70% ethanol, followed by brief 
vortexing and centrifugation for ten minutes at maximum speed, in the same 
orientation as in steps 4 and 5 above. (For FS Terminator, pellets were merely 
washed in 250 III 70% ethanol. Ethanol was carefully aspirated so as not to disturb 
the pellet. No centrifugation step was included. A Kimwipe was used to remove all 
residual ethanol traces from the sides of the tubes. The pellets were dried in a 
vacuum centrifuge). 
8. The supernatants were aspirated as in step 6 above. 
9. Optionally, the washing step was repeated. 
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10. The tubes were placed with the lids open in a heat block at 90°C for 1 minute to dry 
the samples. 
11. Each sample pellet was resuspended in 20 III (later 15 Ill) Template Suppression 
Reagent (TSR). 
12. Samples were vortexed and spun down. 
13. Samples were heated at 95°C for 2 minutes to denature, and then kept on ice. 
2.2.8 DNA sequence manipulations 
Model 310 
Vo"ion 2.1.1 
Claus S-16'1 0 
Claus S-16 
Lane 10 
Sillnal G:901 A:599 T:530 C:4BO 
Dr POP6(BO Sel-My Primor} 
POP6-BOdR 
Poln,. 669 10 7125 Ba .. 1: 669 
Page 1 of 2 
Tue, Apr 21, 1998 8:05 
Mon, Apr 20, 1998 22:15 
S leln : 9.94 SomlAda tlve 
ceC A Te-O l T O ..... ' .. QQ AQ C ol O Q C,l Q .... O (i ." 00000 a t 0 <:<:l('O .... 4 .. c", oa 0 ""C( CC AOO O C<:C " O eee", ... "".QQO 00 • 
1(1 40 to 10 10 10 100 1 
Figure 2.1 Example of an electrofluorescent profile printout, as used in this study. The 
corresponding text file containing the sequence was truncated at position 480, where base calls 
could still be made with confidence, Each sequence was manually edited base by base. 
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Sequencing outputs were provided in the form of electrofluorescent profile printouts (Fig. 
2.1) and corresponding plain text files of the nucleotide sequences for every sample. Prior 
to any form of analysis, each printout was manually edited one base at a time to verify, and 
where applicable, correct the base-calling of the software associated with the sequencers. 
Any changes were recorded in the corresponding text files , which had been opened in 
DNAsis for Windows, Version 2.1 (Hitachi Software Engineering Co., Tokyo) (Fig. 2.2). 
10 20 30 40 50 60 
trrrcCCA1TC AG'lTl'GlATA TAGGAGCAIn' Gl"ITI.C.lGAG AGAATGGGTG GATGC'l'GTCC 
70 80 90 100 110 120 
TCGATA1TCG GGGAAATCAG GTGlTCCTCC AGGTGCCQG TCCCATAAAl GGG'IWI'ATI' 
130 140 150 160 170 180 
GGCATTGnG ATGTI'ATACA CCGATGCAlT TCmcTCGl CATAAAGTCC AI.GGAGm'C 
1'0 200 210 220 230 240 
TA1TCCTATG CCGATGCTI'A AlTGl11'GfC lC"UCGGl ATGTCCAGGG In'CCGG'lTCC 
250 260 270 210 2tO 300 
Gl'CACGIn'AC GATCTCIIIC COOl I 111 IC A'I"CAA'l'GCCT GMlTAGTCA CTCGlGGlTA 
310 320 330 340 350 360 
GGlTATATCA AGC"l'GACACC TGTATACAAT GUGA'nIC'I'& 'I'UlTrGlTAA A'UDCCAT 
3'70 310 3tO 410 420 
AGGGTA'n'Gl In'AIn'AlGAC CATAlAGGlG AT'I"I'GC'I1'&C 1'GA.GGlGU' 'l'GTGU.TATC 
430 440 4$0 .., 410 480 
TGJ:i .IICCT CCTUUGAC Tl"GGATCATI' lCA1'A11rcM; GTCCTGmC nTA1ICCCAT 
..., 500 510 sao $40 
810 820 830 
DAD'I'IIDIf ...... • • •• • ••••••••• . . . . . . . . .. . ........ . . ........ . 
850 860 900 
Figure 2.2 DNAsis sequence illustration in text format. The same sequence as in Figure 2.1 is 
shown, prior to truncation or editing. Any residues found to be different from the sequencer 
software-generated base calling were changed in this type of file . 
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Auto Connection 
Target Sequences: I 2l..J..t.quenc,(S 
Rlllaci or not releaeelJdlllng l 
eonnad!onl or lellCtld .equene .. : 
109'1'~.1'T_ 
OVerlap MInImum Size (1-100): c::1ill-
Minimum Matching Percentage (1-100): []Q]1II 
H!Ip I 
1 
~ ReIIa.e Connection 
001 I Caneln 
~~~- - - -~- --- - -- -- ----1 
3 1952-5.S!Q 
4 52 5.S0 
5 .l71488R. SEQ 
6 .l61488R. SEQ 
'1 AHaI' .SO 
8 .AS'1S4J'. SEO 
9 uscr SQ 
10 .ll'155R SO 
11 119'15SR.SlQ 
Running Status 
c AI* Conne 
Figure 2.3 Generation of sequence contigs in DNAsis. Edited sequences were selected for 
grouping into contigs (top panel) and the sequence overlap conditions were set. The software read 
all selected sequences in both directions and, where applicable, assembled them into contigs of 
semi-overlapping sequences. These could be displayed graphically (bottom panel) such that their 
directions and relative positions were shown. 
- 48-
The "Contig Manager" function of the DNAsis software was then used to progressively 
align all edited sequences. It reads each sequence in both directions and aligns any regions 
of overlap in accordance with the overlap parameters stipulated by the user (Fig 2.3, top 
panel). Sets of partially overlapping sequences are assembled into groups referred to as 
"contigs", which the software can then represent in different forms (Fig. 2.3, bottom panel; 
Fig. 2.4). 
10 20 30 40 50 
> 1 - ....... •• =1111181 50 > -4 .... -.. ,.. ..• ,.. M'tI 46 !&9'1SSR.SEQ < -66 · ......... .. .. . . . ... .......... · ......... ...•...... -11 
U'15SR.SEQ < -135 · ......... .. ..... ... .......... · ......... ....•.•... -N 
< -226 · ......... · ......... . ......... · ......... . ......... -11'1 
> -463 ... .. . . ... · ......... .. . .. .. ... · ......... ..•....... -414 
> -46' .....•.... ••.•..•..• . ......... •.•......• ..•••..•.. -420 
~1l488R. SEQ < -533 •.......•. .......•.. .......... . ......... . ....•.... -414 
-5'3 .......... · ......... .......... · ......... ..•.•.••.. -544 
~'134F.S!Q > -11' .......... .......... ......••.. .. .... ... . . .....•... -610 
~1488R.SEQ < -10'13 •......... ......•... ......•••• · ......... . ..•...... -1024 ----------- - iiTiiCTtGi-~ iiiiiCiiCi ecc;.iCiCCi TimiiiCi Ccmsensus 1 50 
A 10 eo " 100 52-3. SEQ > 51 II, 100 
~52-3.SEQ > 47 tI= H 
!&975SR.SEQ < -16 ..••••.... ••••••• 34 
U155It.SEQ < -IS ••........ ••....•... . ......•.. •......... ...•..•.•. -$I 
52-5. SEQ < -116 ..•..•.•.• .••...•... ........•• . .......... . .•.....•. -U7 
&9S42r.SEQ ) -413 .•.......• ........•. .......•.. .........• . ....•••.. --US42r.SEQ ) -41' .•••...... ...•...... ....•..••. .•........ . .•..•••.. 370 
~'11488R.SEQ < -483 .......... .......... .......... . ......... .......... ....,.. 
&952-5. SEQ < -543 .......... •......... . ......... · ......... •.•.•••... ;..;.e.t 
~134F.S!Q ) -60 ........•• ..•••..•.. .•....••.. . ......... ...•...... 
~1488R..Q < ........ . ........... 
--------- -Consensus 
Figure 2.4 DNAsis alignment view of sequences in a contig. Each sequence in a contig is 
displayed in the direction corresponding to the primers used for amplification, and aligned with 
other sequences in the regions of overlap. Discrepancies were resolved by reference to the 
electrofluorescent profile printouts. 
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2.2.9 peR and sequencing primer design 
Additional sequencing primers, based on enJSRV sequences obtained, were designed with 
the aid of OLIGO 4.1 Primer Analysis Software (National Biosciences, Inc.). OLIGO 4.1 
was a DOS-based programme. The instructions from the Help menu were followed to 
optimise primer design. 
PCR primers based on conserved JSRV and enJSRV regions identified as part of this study 
were designed according to the positions of the conserved regions in nucleic acid sequence 
alignments generated in this study. OLIGO 4.1 was employed to determine the optimal 
length of the PCR primers such that primer pairs had compatible annealing temperatures. 
[See Appendix II for sequences ofPCR primers designed specifically for this study.] 
2.2.10 Phylogenetic analyses 
Sequences were collected in various versions of BioEdit software (Hall, 1999). The latest 
versions were used, as they became available. Individual sets of sequences to be aligned 
were saved in F ASTA format and opened in the DOS-based Clustal W (Thompson et ai., 
1994), and later the Windows-based Clustal X (Thompson et ai., 1997) software. The 
sequences were aligned using this software, and the alignments saved as F ASTA files, to 
be viewed and manually edited in BioEdit. Edited alignments were imported into the latest 
available versions of GeneDoc (Nicholas & Nicholas, 1997), and trimmed on either end 
such that all sequence stretches analysed were of the same length. The trimmed alignments 
were exported in PHYLIP format to be analysed in the latest available versions of the 
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Phylogeny Inference Package (PHYLIP) (Felsenstein, 1989). The PHYLIP files containing 
the alignments were opened in the latest versions of Molecular Evolutionary Genetics 
Analysis (MEGA) software (Kumar et al., 1994; Kumar et al., 2001; Kumar et al., 2004) 
to obtain the base frequencies and the transition/transversion mutation ratios for each 
alignment analysed. These are required for later analyses in PHYLIP. Estimates of branch 
lengths of neighbour-joining trees were calculated using the "Dnadist" and "Neighbor" 
programmes within PHYLIP. Consensus trees were generated by use of 1,000 bootstrap 
sampling replications in "Seqboot", followed by analysis using "Dnadist", "Neighbor" and 
"Consense". The resulting output files were saved with file extensions ".tre", to be opened, 
viewed and manipulated for illustration and publication purposes in the latest available 
versions of Tree View (page, 1996). 
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2.3 RESULTS 
2.3.1 Sequencing of full-length endogenous JSRV loci 
The author was provided with three aliquots of plasmid clones of endogenous JSRV loci, 
as described in Section 2.2, as well as two sets of JSRV primer aliquots. Sufficient 
quantities of plasmid DNA of sufficiently high purity for use in sequencing reactions were 
generated for each of the clones by transformation ofDH5a competent cells (Clontech), 
expansion of transformed clones by culture in LB medium, and plasmid DNA isolation, 
using a Plasmid Maxi Kit (Qiagen). The primer aliquots were gifts from Dr. Massimo 
Palmarini and were based on the sequence of JSRV -SA (York et al., 1992). The primers 
had been synthesised before Dr. Palmarini had embarked on his post-doctoral research at 
the CRIlUCI, and he was unable at the time to provide the sequences of any of these 
primers. The names of most of the primers also did not provide information regarding their 
positions in the JSRV genome. Set 2 was simply numbered 1 through 21. In Set 1, some 
primers had been assigned names that could subsequently be seen to relate to their 
positions within the JSRV genome; others related to positions within specific genes; 
whereas the rest had names that did not relate in any obvious way to any part of the JSRV 
genome. No clear distinction could be made a priori between these three categories within 
Set 1, however, and the directions (i.e. forward or reverse) of many of the primers in Set 1 
were also unknown. The directions and positions of primers in Set 2 were all unknown. 
Since the two sets of primers essentially constituted random JSRV-specific primers, the 
author employed a "shot-gun sequencing" approach. This entailed setting up sequencing 
reactions in batches of six or eight, with each reaction using a different primer. Initially the 
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FS Terminator kit from PE Applied Biosystems (properly known as "ABI PRISM Dye 
Terminator Cycle Sequencing Core Kit With AmpliTaq DNA Polymerase, FS") was used 
to set up sequencing reactions. Within three months, Thermo Sequenase (Amersham 
Biosciences) as well as BigDye (PE Applied Biosystems) chemistries were introduced into 
the project (see Fig. 2.5). 
Of the 43 primers available, over half yielded positive results in terms of DNA sequence 
outputs, and the obtained sequence fragments were aligned with the aid of DNA sis for 
Windows, Version 2.1. This gave rise to a number of overlapping groups of sequences, 
called contigs, which represented more than 75 % of the endogenous genome. Once all the 
sequence data that could be obtained from the use of the JSRV-SA-based primers had been 
generated, eight new sequencing primers were designed (based on the accrued sequence 
information ofenJS5F16) using Oligo 4.1 software. The resulting sequences allowed the 
merger of the separate contigs, as well as the elucidation of the 5' and 3' L TR sequences. 
In all, 64 successful sequencing reactions were required to complete the sequence of the 
first full-length endogenous JSRV locus (Table 2.3), and a further 23 for the 5' and 3' 
flanking regions. Every part of the genome was covered by at least one forward and one 
reverse reaction, or by three reactions in the same direction, using at least two different 
primers. In the event where there was even a single nucleotide discrepancy between a 
forward and a reverse sequence, or amongst three sequences in the same direction, the 
sequences were repeated, or new primers were designed in order to address such 
ambiguities. This was done to ensure that artefacts that can arise from the sequencing 
reactions were not misinterpreted as true sequence data. One such problem area is shown 
in Figure 2.5; it was resolved by use of Thermo Sequenase chemistry in place of the FS 
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Figure 2.5 Resolution of sequencing ambiguities by use of alternative sequencing 
chemistries and design of new primers. A. A problematic area is highlighted in the DNAsis 
sequence alignment and editing window. The four sequences displaying the liN" had all been 
obtained by use of the FS Terminator kit. The sequence shown as "!41215F.SEQ" was generated 
using Thermo Sequenase, as was the reverse sequence "A61488R'.SEQ". B. The two top panels 
show the ambiguous region, as obtained by use of a forward primer and the FS Terminator kit. The 
lower panels show the same region, using Thermo Sequenase. The lower left panel represents a 
reverse sequence of the same area. 
- 54 -
Comparison of the enJS5F16 sequence with that of JSRV-SA revealed, amongst numerous 
minor mutations, that enJS5F 16 is marked by two large deletions of 154 and 872 bp in pol, 
the second of which causes a 5' truncation in orfx (Fig. 2.6; Table 2.4). In order to 
determine if this was a distinguishing feature of endogenous JSRV loci, the pol region of 
enJS59Al was sequenced (the choice of relevant primers could, by this stage, be 
determined from the sequence data generated for enJS5FI6). It was shown to be of the 
same length as the pol region from JSRV-SA, even though the open reading frame was 
interrupted by a stop codon. However, it did represent an uninterrupted open reading frame 
in orfx. 
Table 2.3 Number of sequencing reactions required and number of primers used 
to elucidate the complete nucleotide sequence of clones enJS5F16, 
enJS59Al and enJS56Al. 
The sequencing of enJS59Al continued, followed by enJS56Al , employing a far more 
structured strategy than the "shot-gun sequencing" approach used for enJS5F16. This was 
facilitated by the knowledge that had been gained of the various primer positions. The 
sequencing of enJS59Al and enJS56Al also necessitated the design of new primers (Table 
2.3), either because stocks ofthe JSRV-SA-specific primer aliquots had been depleted, or 
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Figure 2.6 The genomic structure of exogenous and endogenous JSRV-related retroviruses 
of sheep. The gag open reading frame has been fixed in the same reading frame for all sequences 
shown. Premature stop codons are indicated by vertical white bars. Sequences after premature 
stop codons are indicated by diagonal lines. Stretches of different peptide translation resulting from 
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frameshift mutations are indicated by white dotting. The positions of variable regions of JSRV 
sequences are indicated in JSRV21 by asterisks. The nucleotide lengths (from the 5' R to the 3' R) 
of the sequences are indicated at the bottom right. 
because the existing primers did not yield satisfactory results in terms of sequence quality, 
presumably owing to mismatches with the endogenous sequences. 
2.3.2 Sequence analysis of full-length endogenous JSRV loci 
The sequences of the three full-length endogenous JSRV loci were scanned and analysed, 
both visually and computationally. The full proviral lengths of enJS5F16, enJS56Al and 
enJS59Al are 6916, 7940 and 6696 bp, respectively. In Table 2.4, the lengths from R to R, 
which would delineate the repeated 5' - and 3' -termini of exogenous retroviral RNA 
genomes (Fig. 1.1), are indicated for ease of comparison with JSRV s. ENTV was included 
in the comparisons, owing to its very close relationship with JSRV, both in terms of 
nucleotide sequence and pathogenic function (Cousens et al., 1999). Several noteworthy 
findings are described in the sections below. 
2.3.2.1 Insertion sites and flanking regions 
The question of whether or not enJSRVs share common integration sites was addressed by 
sequencing outwards of the endogenous JSRV genomes beyond the L TRs. The sheep 
genomic sequences at which each of the insertions occurred, were determined (Fig. 2.7), 
and it was noted that they were different for all three loci. The lack of homology between 
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the integration sites indicates that these viruses were most probably inserted randomly into 
the genomic DNA of their host cells at the time they became fixed in the sheep genome . 
.. . . .. CTCCTCTGT C-\ enJS5F16 \ - CTGT CCAT ........ . 
.. . .... . AATTTAGC-\ enJS59Al \-TTAGCCCAGGC ..... . 
... . . . AATGTATGGG- \ enJS56Al \-GGGCTCATAAC ..... . 
Figure 2.7 The sites at which each of the three endogenous loci became fixed in the sheep 
genome by integration are different. 
The entire 5' and 3' flanking regions ofpenJS5F16, and parts of the flanking regions of 
penJS59Al were sequenced. These flanking regions had arisen from the cloning strategy 
used to isolate the endogenous loci, viz. RE digestion of sheep genomic DNA with Xba!. 
The flanking regions therefore constituted those parts of the sheep genome upstream and 
downstream of the endogenous proviral loci, up to an XbaI site. Sequencing of these 
regions was performed by determining the DNA sequence just outside the loci and 
designing primers based on those (outward sequencing). Concurrently, primers based on 
the cloning vector were used to sequence "into" the cloned region from each end. In both 
instances, new primers were progressively designed and utilised, until the entire flanking 
region included in penJS5F16 had been assembled. The sequence of the flanking region 
was interrogated by means of a BLAST search, but no meaningful homology could be 
identified. However, some information on the vector used for cloning could be elucidated. 
[It was not clear which version of pBluescript (Stratagene) had been used during the 
cloning procedure.] The six possibilities could be narrowed down to only two: pBluescript 
II SK(+) or pBluescript II SK(-). 
- 58 -
2.3.2.2 Long terminal repeats 
All three endogenous proviral loci had an upstream and a downstream L TR, the hallmark 
of complete proviruses. The U5 regions were highly conserved among all sequences, with 
the exception of two single base pair deletions in JSRV-SA and ENTV, and a single base 
pair insertion in enJS59Al. The 13-bp repeat regions (R) of all three clones were identical 
to those of exogenous JSRVs. The U3 regions ofenJS5F16 and enJS56Al are 98 % 
homologous to one another, and 91 % homologous to the U3 region of enJS59Al over 
89 % of its length. However, the latter region is marked by a stretch of numerous deletions 
and mutations relative to the other two endogenous U3 regions, thereby lowering its 
overall homology to these substantially. The reported finding by (palmarini et al. , 1996a) 
and (Bai et al., 1996) that exogenous U3 regions are 47 bp shorter than endogenous ones 
could be confirmed when comparing JSRV21 and JSRV-SA with enJS5F16 and enJS56Al. 
However, no distinct insertions of 30 and 16 bp in the endogenous U3 regions, relative to 
the exogenous ones, could be identified. No combination of theoretical nucleotide 
omissions in the enJSRV U3 regions will lead to homology with the corresponding 
sequences in JSRV s. At least, the homology that can be achieved this way is far lower than 
that which is observed between regions in the U3 that are naturally conserved amongst the 
JSRVs. Rather, there appear to be regions of homology, interspersed with regions that lack 
homology, and the total lengths of the non-homologous stretches of the endogenous 
sequences are longer, thereby accounting for the 47-bp difference. 
An interesting observation regarding the endogenous LTRs is that, whereas the 5' and 3' 
LTRs ofenJS5F16 are identical to one another, those ofenJS56Al and enJS59Al display 










Genomic sequence and feature comparisons of the endogenous JSRV proviral loci enJS5F16, enJS56A1 and enJS59A1 with JSRVs 
and ENTV, indicating regions homologous to exogenous coding regions. 
R toR I US Positions and lengths of coding regions, and lengths of deduced polypeptide sequences (I) U3 
proviral 
length 
(bp) (bp) gag pro pol "oif-x " env (bp) 
7462 113 263 -2101 1993 - 2862 3108-5441 4606 - 5106 5350 -7197 272 (1839 bp 1612 AA] [870 bp 1289 AA] [2334 bp 1777 AA] [501 bp 1 166 AA] (1848 bp / 615 AA] 
3106 - 5451 
7455 115 264 -2099 1991 - 2860 [2346 bp 1781 AA] 4604 - 5104 5348 - 7195 272 [1836 bp 1611 AA] [870 bp 1289 AA] stop codon 12 bp downstream relative [501 bp I 166 AA] [1848 bp 1615 AA] 
to JSRV-SA owing to point mutation 
4602 - 5102 
5346 -7199 
[1854 bp 1617 AA] 256 - 2097 1989 -2858 3104 - 5437 [501 bp] 7434 113 termination point further 250 [1842 bp 1613 AA] [870 bp 1289 AA] [2334 bp 1777 AA] two stop codons :. downstream compared with JSRV 
noORF 
sequences :. longer ORF 
264-2114 3121-4428 3911 - 4093 4337 - 6172 
6484 1 [1851 bp 1616 AA] 2006 -2875 [1308 bp 1435 AA] 
[183 bp] [1836bp / 611 AA] 
115 5'-truncation 200 bp at 3' end ofTM(J) have very 319 6916 Two regions in MA(2) lacking [870 bp 1289 AA] two large in-frame deletions, of 154 & 
homology with JSRVs and ENTV 872 bp 
owing to deletion low homology to JSRVs and 
in pol ENTV 
3121 - 5464 
264-2114 [2344 bp] 4619 - 5119 5361 -7196 
7508 1 [1851 bp / 616AA] 2006 - 2875 deletion of ' AT' at 5322, leading to [501 bp] [1836 bp 1611 AA] 115 frameshift; stop codons at 5419 & stop codon at 5081 200 bp at 3' end ofTM(3) have very 319 7940 Two regions in MA (2) lacking [870 bp 1289 AA] 
homology with JSRVs and ENTV 5440; final (theoretical) stop codon 12 owing to point low homology to JSRVs and 
bp downstream relative to JSRV-SA mutation ENTV 
owing to point mutation 
262 -2113 3120 - 5465 5362 - 5986 
[1852 bp] [2346 bp] [625 bp] 
6281 1 single bp insertion at position 482, 2005 -2874 point mutation leading to TGA stop 4618 - 5118 
stop codon in position 5398 owing 
116 leading to frameshift mutation; first codon in position 3770; final to point mutation; large deletion of 6696 [870 bp 1289 AA] [501 bp 1 166 AA] stop codon at position 520; two (theoretical) stop codon 12 bp down- 1223 b~ thereafter; 200 bp at 3' end 
regions in MA(2) lacking homology stream relative to JSRV-SA owing to ofTM() have very low homology 
with JSRVs and ENTV point mutation to JSRVs and ENTV 301 




sequence duplications at the 5' and 3' ends of the genome during reverse transcription, 
they are always identical at the time of integration. Differences between the 5' and 3' 
L TRs of endogenous retroviruses are therefore indicative of the time that has passed since 
their insertions (Mager & Freeman, 1995), and it can be deduced that enJS5F 16 represents 
the most recent integration into the sheep genome, whereas enJS59Al represents the most 
ancient one, out of the three loci studied here. 
2.3.2.3 The 5' untranslated region (5' UTR) 
The tRNALYSI,2 primer binding site immediately downstream ofU5 is conserved for all the 
JSRV sequences, as well as ENTV, indicating that all of these viruses utilise the same class 
oftRNA molecule to prime second strand synthesis during reverse transcription. The 35-bp 
region immediately upstream of the gag ATG start codon was found to be identical in all 
JSRV sequences, as well as ENTV (Fig. 2.8). (ENTV-2 has two single nucleotide 
differences in this stretch compared to ENTV and JSRVs.) This represents the longest 
sequence of absolute nucleotide sequence homology in a non-coding region of known 
JSRV sequences, an observation that had not previously been reported. Although the 
significance ofthis highly conserved region was not investigated, given its position 
immediately upstream of the gag ATG start codon, it probably relates to the translation of 
the Gag and Gag-Pro-Pol polyproteins by the host cell translation machinery. Like cellular 
mRNAs, the translation of JSRV mRNA would necessitate the recruitment of the small and 
large ribosomal subunits, via the cellular eukaryotic translation initiation factors, to the 
start codon. This might be achieved via an alternative mechanism to the canonical 
translation initiation of cellular mRNAs, which would most likely impose specific mRNA 
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secondary structure constraints on this region, thus accounting for its high degree of 
sequence conservation. 
2.3.2.4 The gag gene 
The gag regions of enJS5F16 and enJS56Al represent full open reading frames with an 
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Figure 2.8 Nucleotide sequence alignment of the 5' untranslated regions of sheep 
betaretroviruses: exogenous JSRV21 , JSRV-SA, and ENTV and the endogenous enJS5F16, 
enJS59A 1, and enJS56A 1 proviruses. The primer binding site (PrBS) is underlined and the 
beginning of the gag open reading frame is indicated by an arrow above the ATG start codon. Dots 
refer to sequences identical to the top sequence, while dashes indicate lack of sequence. 
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comparison of the same regions in JSRV-SA and JSRV21. When comparing these 
endogenous and exogenous sequences, their predicted AA homology is around 93 %. The 
discrepancy is attributable almost entirely to two regions of 75 and 117 base pairs between 
the predicted matrix (MA) and capsid (CA) parts of gag [i.e. in p15 (Murcia et ai., 2007)] 
that are conserved in all three endogenous loci. These regions yield no meaningful amino 
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Figure 2.9 Alignment of a selection of the deduced gag amino acid sequences of sheep 
betaretroviruses. The single base pair insertion in enJS59A 1 gag was corrected to create its 
deduced amino acid sequence and facilitate its inclusion in this alignment. VR1 and VR2 are 
indicated by shaded areas. Note that the proline residues in VR1 of the exogenous sequences are 
absent in the endogenous proviruses. The beginning of the putative CA region is indicated. 
Endogenous sequences CapMA2 and CapMA5 were obtained by PCR amplification from goat 
DNA. 
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75-bp region also exhibits polymorphism between JSRV and ENTV in that there is only 
50% identity at the amino acid level compared to the 95.8% identity for the entire Gag 
polyprotein. This region was termed VRI (variable region 1) for the betaretroviruses of 
sheep (Fig. 2.9). VRI is 12 bp shorter in JSRVs than in enJSRVs, and it encodes a stretch 
of seven consecutive proline residues in exogenous JSRVs, five of which are conserved in 
ENTV. This proline-rich region is not encoded by any of the three enJSRVs. This finding 
had not been reported previously and appears to represent a highly conserved difference 
between endogenous and exogenous JSRV sequences, at both the nucleotide and the amino 
acid level. 
Approximately 150 base pairs downstream ofVRI is another region of polymorphism 
between endogenous and exogenous JSRV sequences, which was termed VR2. It is also 
relatively proline rich for both endogenous and exogenous viruses. It is interesting that 
ENTV shows a closer relationship to the endogenous loci in VR2 than to the exogenous 
JSRVs. 
The gag gene of enJS59Al is marked by a frame shift mutation with a termination codon 
brought about by a single base pair insertion, and thus does not encode a full open reading 
frame. Even when correcting for this frameshift, its predicted amino sequence is less 
similar to the other two enJSRV loci (less than 93 %) than they are to one another. It is also 
less similar to the exogenous JSRV s than the other two loci, confirming that it seems to 
represent a more ancient insertion into the sheep genome. 
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2.3.2.5 The pro gene 
The pro gene is the only one that represents an uninterrupted open reading frame of the 
same length in endogenous and exogenous lSRVs and ENTV. All comparisons yield 
amino acid sequence identities ranging from 95.2 % to 99.7 %. In their 5' halves, all 
lSRV-related sequences examined encode the five conserved motifs found in all dUTP 
pyrophosphatase (dUTPase) enzymes (Fig. 2.10), as already noted by York et al. (1992) 
Motif 
1 2 3 4 5 
E. coli AGLDL .... RSGLGHK .... GLIDSDYQG .... GERIAQMI .... RGEGGFGHSG 
human AGYDL .... RSGLAAK .... GVIDEDYRG .... GDRIAQLI .... RGSGGFGSTG 
tomato AGYDL .... RSGWALK .... GVIDADYRG .... GDRIAQLI .... RGSGGFGSTG 
yeast AGYDI .... RSGLAVK .... GVVDRDYTG . . .. GDRVAQLI .... RGAGGFGSTG 
HSV-l AGYDI .... RSSLNAR GLIDSGYRG GAKVAQLV .... RGTRGFGSTG 
MPMV AGLDL .... RSSITMK .... GVIDNDYTG .... GNRIAQLI .... RGQGSFGSSD 
MMTV AGLDL .... RSSNYKK .... GVIDSDFQG .... GERIAQLL .... RGSEGFGSTS 
HERV-K10 AAVDL .... RSSLNLK .... SVVDSDYKG .... RDRIAQLL .... KRIGGLVSTD 
HERV-K cons. AAVDL .... RSSLNLK .... GVVDSDYKG .... GDRIAQLL .... KRIGGFGSTD 
EN TV AGLDL .... RSSASLK .... GVIDSDYTG .... GgRIAQLL .... RQDKGFGSSD 
JSRV-SA AGLDL .... RSS~LK .... GVIDSDYTG .... GgRIAQLL .... RgDKGFGSSD 
enJS5F16 AGLDL .... RSSASLK .... GVIDSDYTG .... GgRIAQLL .... RQDKGFGSSD 
enJS56Al AGLDL .... RSSASLK .... GVIDSDYTG .... GgRIAQLL .... RQDKGFGSSD 
enJS59Al AGLDL .... RSSASLK .... GVIDSDYTG .... GgRIAQLL .... RQDKGFGSSD 
Figure 2.10 Amino acid motifs conserved amongst all known dUTPase enzymes. JSRV-like 
viruses have identical motifs. Bold underlined letters indicate residues unique to JSRV-like 
sequences. HERV-K cons. , consensus sequence of HERV-K dUTPases (Harris et al., 1997); HSV-
1, herpes simplex virus 1. Table modified from (Harris et al., 1997) (1997) by addition of MPMV, 
HERV-K consensus and JSRV-related sequences. 
pertaining to JSRV-SA. Even though there are numerous differences in the nucleotide 
sequences encoding these motifs, the mutations are silent and do not manifest at the amino 
acid level. This stringent conservation may indicate a functional enzyme, even in the 
endogenous sequences. Three of the five motifs show residues which are unique to the 
lSRV-like sequences relative to the other sequences used for the comparison in Figure 
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2.10. This may have implications on the functionality of the encoded enzyme, but a larger 
number of dUTPases would be required for comparison to establish if these residues are 
indeed unique to JSRV. 
2.3.2.6 The pol gene 
The pol gene is marked by major defects in enJS5F16 and enJS59Al: in enJS5Fl6 there 
are two large in-frame deletions of 154 and 872 bp, while a point mutation in enJS59Al 
creates a stop codon (position 4071 of the provirus sequence) in the reverse transcriptase 
domain (Fig. 2.6; Table 2.4). Translation of an enJS59Al transcript (assuming that this 
locus is transcribed) would thus be aborted after having processed only 28 % of pol. 
enJS56Al harbours a 2-bp deletion with respect to exogenous JSRVs at the 3' end of the 
pol gene (corresponding to the end ofthe integrase [IN] domain) that would yield a 
polypeptide 14 amino acids shorter compared to the native JSRV IN, with the last 33 
amino acids having no similarity due to the frameshift. At the nucleotide level of pol, 
homology between JSRV-SA and the two more recently integrated loci is in excess of98% 
(disregarding the deletions in enJS5FI6). Homology with enJS59Al is 93%. By 
comparison, the homology between JSRV-SA and JSRV21 pol genes is 96.3%. This coding 
region, which includes orf-X, is thus highly conserved at the nucleotide level. 
Another observation relates to the 3' termination signals of pol translation (albeit 
theoretical in the case of the three endogenous loci) in the JSRV-related sequences (Fig. 
2.11). It can be seen that ENTV, ENTV-2, JSRV-SA and enJS5F16 share the same 
termination signal, whereas the pol regions of JSRV21 , JSRV-JS7, enJS56Al and 
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enJS59A1 end four codons further downstream. All but the ENTV sequence share the 
downstream stop codon, even though it would not be used in those sequences that are 
already terminated earlier. 
ENTV GAC ATT GAA TGA GAC CAC GAA TGG ACT ACC 
ENTV-2 GAC ACT GAG TGA GCC TAC GAG TGA GCT ACC 
JSRV-SA GAC CCT GAG TGA GCC CAC GAG TGA GCT GCC 
JSRV21 GAC GCT GAG CGA GCC CAC GAG TGA GCT GCC 
JSRV-JS7 GAC GCT GAG CGA GCC CAC GAG TGA GCT GCC 
enJS5F16 GAC ACT GAG TGA GCC CAC GAG TGA GCT GCC 
enJS56Al GAC ACT GAG CGA GCC CAC AAG TGA GCT GCC 
enJS59Al GAC ACT GAG CGA GCC CAC GAG TGA GCT GCC 
Figure 2.11 Termination sequences of pol in sheep betaretroviruses. Stop codons are marked 
in bold letters. 
2.3.2.7 Open reading frame "x" 
The orf-x region (the alternate reading frame inpol) is uninterrupted in enJS59Al. In 
enJS5F16, orf-x is marked by a major truncation as a consequence of the deletion inpol 
(Fig 2.6), while in enJS56A1 there is a stop codon 39 bp before the usual stop codon in 
exogenous JSRV orf-x. 
2.3.2.8 The env gene 
The majority of env (1223 bp of 1836 bp) is deleted in enJS59A1 (Fig 2.6). In addition, it 
is marked by an early stop codon only 36 bp downstream of the AUG start codon. In 
enJS5F16 and enJS56Al, however, env is a full open reading frame with 98% amino acid 
identity when comparing the two sequences, and ~92% identity when comparing either of 
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them to JSRV-SA or JSRV21 env. The last 67 amino acids of env (in the transmembrane 
domain) represent another region of high divergence (only ~58% amino acid identity) 
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Figure 2.12 Alignment of deduced env amino acid sequences in the transmembrane region 
of sheep beta retroviruses and JSRV-related endogenous sequences. VR3 is highlighted by 
shading. The beginning of the cytoplasmic tail domain is indicated. 
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variability exists between exogenous JSRV and ENTV sequences in this area as well. [See 
Appendix I for GenBank accession numbers relevant to this thesis.] It is even highly 
variable between JSRV type I (African) and JSRV type II (UK and USA) isolates 
compared to other parts of the genome, and was termed variable region 3 (VR3) of sheep 
betaretroviruses. 
2.3.2.9 Restriction profile analysis of the three endogenous JSRV loci 
An attempt was made to classify the three full-length enJSRV sequences according to 
restriction profiles, analysing them with the same eleven restriction endonuclease 
recognition sites used by Bai et al.(1996) in their classification of enJSRVs into six 
different loci (cf Section 1.4, and Figure 1.2 therein): 
enJS56A 1: The restriction profile of this sequence corresponds to locus 1, including 
the distinguishing EcoRI site of the Group I sequences, with the exception of a Pst! site 
which it shares with JSRV-SA. None of the loci described by Bai et al. (1996) share this 
site with JSRV-SA. 
enJS5F16: This sequence has the same restriction profile as enJS56Al (including 
the JSRV-SA-derived PstI site). In addition, it has another PstI site which, according to 
Bai et al. (1996), was the distinguishing feature of locus 4 enJSRV s. This sequence, 
however, also exhibits the EcoRI site purportedly characteristic only of Group I sequences. 
enJS59A1: This sequence lacks the EcoRI site that identifies Group I loci. It is 
missing four different recognition sites that are conserved amongst all JSRV sequences in 
the system used by Bai et al. (1996), both endogenous and exogenous. These missing sites 
- 69-
are not attributable to deletions in this clone, but to point mutations. In addition, this 
sequence has a Pstl site and anXhol site that are not included in any of the sequences used 
by Bai et al. (1996) in the establishment of their classification system. 
Owing to the fact that some of the above findings, relating to the three endogenous clones, 
were not in keeping with the classification system ofBai et ai. (1996), the exogenous 
JSRV21 sequence (Palmarini et ai., 1999a) was analysed according to the same criteria: 
JSRV2I~ This sequence is missing four different recognition sites, the presence of 
which is expected to identify exogenous JSRVs. It is missing five sites that are meant to be 
conserved amongst all JSRV sequences. Furthermore, it displays a purportedly 
endogenous-specific HindUl site in gag, as well as the same endogenous locus 4-specific 
Pstl site which was found to be present in enJS5F16. 
The only restriction marker that was consistently accurate amongst the sequences analysed 
here, was the differential Seal site in gag, as published by Palmarini et al. (1996a). 
However, since the absence of this site was used as a criterion to select for the three 
endogenous loci, the results of the Seal analysis are meaningless in this context. 
Furthermore, analysis of gag shows that the point mutation which results in the loss of the 
Seal site in the endogenous sequences, is a silent mutation. Either sequence variation 
encodes glutamic acid at the altered codon, implying that the presence or absence of the 
Seal site is of no functional significance. 
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2.3.3 Amplification of JSRV variable regions from goat DNA 
To assess whether the three variable regions that had been identified for sheep 
betaretroviruses were also found in the endogenous betaretroviruses of goats, two sets of 
PCR primers were designed, based on consensus sequences of regions in the enJSRVs that 
were conserved upstream and downstream of the variable regions. VR1 and VR2 were 
amplified as one product using primers 533F and 1157R (numbering based on the 
sequence of JSRV21). The forward primer 6748F anneals in the TM, upstream ofVR3, and 
the reverse primer 35R anneals in part of the repeat region and U5 of the LTR, leading to 
amplification of part ofTM (including VR3) and U3. Genomic DNA was isolated from 
cultured large T -immortalised goat embryo fibroblast (TIGEF) cells to provide template 
DNA for the PCR, and the resulting products were cloned using a TOPO T A Cloning Kit 
(Invitrogen). Two clones from each experiment were sequenced, and the sequences of the 
cloned inserts were incorporated into the alignments that had already been generated 
(Figures 2.14 and 2.15). They resemble the sheep endogenous loci in the three variable 
regions (Figures 2.9 and 2.12). 
2.3.4 Phylogenetic analyses 
All JSRV and JSRV-related nucleotide sequences available in Genbank by the time the 
three full-length endogenous sequences had been obtained, were assembled into a 
comprehensive alignment using the BioEdit programme in conjunction with ClustalW. 
Using selections from within this alignment, phylogenetic trees were generated for all 
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Figure 2.13 Unrooted phylogenetic trees for env and U3 of ovine betaretroviruses, as 
derived by neighbour joining and 1,000 bootstrap sampling replications. Endogenous loci 1-6 
are abbreviated to L 1 - L6 _ The branch lengths are proportional to an estimate of evolutionary 
change. Names of sequences generated in this study are underlined. Figures created by author for 
(Palmarini et al., 2000b)_ 
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or env - U3), using programmes within the PHYLIP package, and TreeView. Three such 
trees were published (palmarini et al., 2000b), two of which are shown in Figure 2.13. In 
all the trees generated, three distinct branches could be discerned: one for endogenous loci, 
one for the exogenous ENTV sequence, and one for exogenous JSRV sequences. This 
trend was expected, and confirmed earlier fmdings based on limited gag sequences 
(Cousens et al., 1996). The exogenous JSRVs could be seen to divide further into type I 
sequences of African origin and type II sequences of US and UK descent, as previously 
described (Bai et al. , 1996). 
Another feature of all the trees, which had not previously been reported, was that 
enJS59A1 branched apart from the other two full-length endogenous loci cloned here. 
Other endogenous sequences previously isolated by PCR cloning consistently grouped 
with either enJS59A1 or with enJS5F16 and enJS56Al. This indicated at least two 
phylogenetic groups, which were termed enJSRV-A and enJSRV-B (Fig. 2.13). Additional 
confirmed enJSRV phylogenetic groups might arise if other complete proviral sequences 
become available. 
The comprehensive alignment of all JSRV-related sequences was continually updated to 
include any new sequence data as they became available on Genbank. This alignment is 
available in electronic format (as a FASTA file) on request from the author. Once again 
drawing on this alignment and by incorporating all sequences that had become available 
since the first set of trees was published (palmarini et al. , 2000b), phylogenetic trees were 
generated for the regions corresponding to the TM-U3 and gag goat DNA-derived PCR 
fragments (Section 2.3.3) (Figures 2.14 and 2.15). These later trees confirmed previous 
results pertaining to separate branches within exogenous JSRVs (JSRV-I and JSRV-II) and 
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Figure 2.14 Unrooted phylogenetic tree for TM-U3 of endogenous and exogenous ovine and 
caprine betaretroviruses, as derived by neighbour joining and 1,000 bootstrap sampling 
replications. The branch lengths are proportional to an estimate of evolutionary change. Names of 
sequences generated in this study are underlined. 
within endogenous JSRVs, and assigned the goat DNA-derived enJSRV fragments to the 
enJSRV-A group together with enJS59Al. Furthermore, they showed a clear phylogenetic 
grouping of ovine vs. caprine ENTV sequences, in keeping with descriptive comparisons 
of these sequences (Ortin et al., 2003). 
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Figure 2.15 Unrooted phylogenetic tree for part of gag of endogenous and exogenous ovine 
and caprine betaretroviruses, as derived by neighbour joining and 1,000 bootstrap sampling 
replications. The branch lengths are proportional to an estimate of evolutionary change. Names of 
sequences generated in this study are underlined. 
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2.4 DISCUSSION 
The overall aims of this part of the study were to fully sequence three full-length clones of 
endogenous, non-pathogenic JSRV, analyse and characterise the sequences obtained, and 
compare them to known exogenous, pathogenic JSRV sequences. Since no knowledge 
existed at the outset of this study that could relate any parts of the JSR V genome to its 
pathogenic potential, the sequence comparisons of the full-length enJSRVs to exogenous 
JSRV were to be carried out with a view towards identifying genes or genetic elements that 
consistently distinguish the non-pathogenic endogenous from the pathogenic exogenous 
isolates of JSRV. Such regions could then be implicated as potential factors involved in 
JSRV -mediated pathogenesis. 
In short, the objectives of this study were met. For the first time, the complete nucleotide 
sequences of proviral endogenous JSRV loci were determined. Owing to the fact that the 
endogenous clones were obtained subsequent to endonuclease digestion of sheep genomic 
DNA, as opposed to being generated in fragments by peR amplification, these sequences 
are a faithful representation of those found within the genetic material of the animals they 
were derived from. Analysis of the sequences revealed that they shared the same genomic 
organisation as exogenous JSRV. All three proviruses contained uninterrupted open 
reading frames for at least one structural gene. In particular, enJS56AI was a virtually full-
length provirus, with open reading frames for gag, pro, most of pol, and env. Sequence 
comparisons with exogenous JSRV showed that three short regions consistently distinguish 
enJSRV s from their exogenous counterparts. Two of these are in gag and one in the 
transmembrane region of env. These were called the three variable regions of 
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betaretroviruses of sheep and goats. Certain aspects of the study are discussed in detail in 
the following sections. 
2.4.1 Sequencing of full-length endogenous JSRV loci 
The elucidation of the three full-length enJSRV sequences presented a number of 
challenges, and took considerably more work and time to complete than an equivalent task 
would do, were it to be attempted now. One obvious reason for this is the progression of 
technology. That aside, the author had had no previous exposure to the field of 
bioinformatics, and relied for the entire duration of the sequencing part of this study on the 
software made available to him for the analysis and manipulation of the sequencing output 
data. This consisted of DNAsis for Windows, Version 2.1 , and a DOS-based version of 
OLIGO for the design of primers. No software was used to visualise electronic versions of 
the electrofluorescent profiles, the use of which facilitates the viewing of sequence details. 
As described under Materials and Methods, the author was only provided with printouts of 
the electrofluorescent profiles, as well as the plain text files corresponding to the base 
calling of the software associated with the sequencer. All forms of sequence editing 
therefore had to be performed manually, which introduces a degree of subjectivity. This 
was compensated for by repeats of all sequences containing ambiguities, and sometimes by 
the design of new primers specifically based on the clones under study. Had software been 
available that allows one to view the raw data generated by the sequencer, the majority of 
the ambiguities could probably have been resolved by the identification of artefacts such as 
pull-up peaks. The author soon became very proficient at the visual editing of sequence 
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printouts, however. Whereas the first clone required nine months to sequence, the second 
sequence was completed in five months, and the third one in four. 
Software limitations were not the only challenge posed to the sequencing aspects of the 
project. As described in section 4.1 under Results, the two sets of sequencing primers 
essentially constituted random primers, so no set strategy could be followed in their use. 
Having determined the positions where these primers anneal as part of sequencing the first 
clone, a more structured approach was applied to the sequencing of the other two clones. 
This, too, contributed to the shorter time frame in which their sequences were able to be 
determined. 
The automated sequencer that the author had access to was committed to other applications 
two days per week, and when it was set up for sequencing, it was fitted with the shorter of 
the two available capillaries (length to detection window of 36 cm), thereby limiting the 
read length of the sequences. On those occasions when this sequencing facility returned 
several batches of unexpectedly failed results, the same samples were sent to another 
facility, which returned usable data. The alternative facility could not be accessed routinely 
owing to the substantially higher cost per reaction and its distance from our laboratory, but 
the usable read lengths per sequence were consistently 50 % to 65 % longer. This was 
attributable primarily to their use of the longer capillaries with a 50 cm length to the 
detection window. Availability of the long capillary throughout the sequencing aspect of 
the study would have reduced the total number of sequencing reactions required for each 
clone. 
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At the commencement of the study, the FS Tenninator kit (PE Applied Biosystems), 
fonnally known as "ABI PRISM Dye Tenninator Cycle Sequencing Core Kit With 
AmpliTaq DNA Polymerase, FS", was used. This was abandoned in favour of the Thenno 
Sequenase Dye Tenninator Cycle Sequencing Premix Kit (Amersham) when the latter was 
introduced to the study. This was done because it yielded higher quality results, and the 
procedure required for cleaning up the sequencing reaction products prior to loading them 
on the automated sequencer was less time-consuming. 
At a later point, PE Applied Biosystems introduced a product that was vastly improved 
with respect to the earlier FS Tenninator kit, called the ABI PRISM BigDye Tenninator 
Cycle Sequencing Ready Reaction Kit With AmpliTaq DNA Polymerase, FS. The BigDye 
kit compared favourably to the Thenno Sequenase kit in tenns of sequence quality, and it 
was superior in tenns of its ability to resolve G residues. It also yielded longer read 
lengths, and used less primer per reaction. Given that our primer stocks were limited to the 
aliquots donated to us by Dr. Palmarini, its use was considered a distinct advantage. Its 
drawbacks lay in the fact that the clean-up procedure was once again more time-
consuming, and the cost per reaction was higher than for the Thenno Sequenase kit. 
In an effort to lower the cost per reaction of the BigDye kit, half the BigDye Ready 
Reaction Mix was replaced with a buffer that was chemically equivalent to that of the 
Ready Reaction Mix, but lacking the polymerase enzyme, deoxyribonucleoside 
triphosphates and dye-labelled dideoxyribonucleoside triphosphate tenninators. 
Comparative titration experiments showed that this dilution of active ingredients did not 
result in any marked deterioration of quality or read length relative to the use of undiluted 
- 79-
BigDye reactions. From this point, the use of Thermo Sequenase was abandoned entirely 
in favour of the BigDye kit. 
2.4.2 Sequence analysis of full-length endogenous JSRV loci 
The completion of the sequence of enJS5F 16 constituted the first -ever sequence 
determination ofa full-length endogenous JSRV. This was followed by the complete 
sequence determination of two further endogenous JSRV loci, which brought the number 
of completely sequenced endogenous betaretroviruses of sheep in line with the number of 
exogenous ones known at that point - JSRV-SA (York et al., 1992), JSRV21 (palmarini et 
al., 1999a) and ENTV (Cousens et al., 1999). The approach that had been taken was 
superior to all previous attempts at elucidating the nucleotide sequences of enJSRVs, 
including the preliminary work carried out by the author for this study, wherein an entire 
enJSRV sequence had essentially been isolated by PCR cloning. However, since this 
approach necessitated the amplification of two fragments in order to assemble an almost 
full-length genome, one could not assume that these fragments were derived from the same 
locus, given that there are 15 to 20 enJSRV loci in the sheep genome. 
The strengths of the approach taken in this study are, in essence, twofold. Firstly, the 
sequences are truly full-length and therefore represent entire genomic sequences. No PCR 
approach can lead to the amplification of proviral loci that would incorporate the entire 
LTRs on either end of the genome. Also, PCR is error-prone, especially when used to 
amplify long products such as full proviruses, even when using proof-reading Taq DNA 
polymerase enzymes (see Part II of this thesis). Such errors are of less significance when 
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the results are to be used for phylogenetic analyses, for instance, but could significantly 
confound any findings of functional studies. 
The second strength of this study lay in the elucidation of three proviral endogenous 
genomic sequences, rather than just a single one. This permitted the meaningful 
comparison of the obtained sequences to define conserved characteristics and show which 
features are unique to individual loci, owing to mutations. It also allowed comprehensive 
comparisons with the exogenous JSRV and ENTV sequences to meet the most important 
objectives of this study - the identification of genetic elements that distinguish the non-
pathogenic endogenous JSRVs from their pathogenic exogenous counterparts. 
It is worth stating the obvious at this point, namely that the elucidation of full nucleotide 
sequences provides considerably more powerful data tools than relying on RE profiles to 
group and characterise sequences. This was aptly demonstrated by attempting to fit the 
three endogenous clones (as well as the exogenous JSRV21 ) into an existing classification 
scheme for enJSRVs that had been developed based on RE profiling. JSRV21 turned out to 
fit the profile of enJSRVs better than some of the endogenous clones did. This is no 
criticism of the previous study; the author appreciates the amount of work required to 
obtain sequence data. It merely reflects that the dividends of such work merit the 
expenditure, both in terms of time and funding. 
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2.4.2.1 orfx 
The first noteworthy finding pertaining to the sequences of the endogenous loci was the 
fact that a large part of pol was deleted in enJS5FI6. Such a deletion would likely render 
this locus entirely defective in terms of its ability to replicate, reverse transcribe or 
integrate independently. An endogenous retrovirus is derived at some point during the 
evolution of its host by integration of a functional retrovirus into the germ lines, causing 
fixation of the provirus. It was therefore not thought that the deletions in pol were likely to 
be characteristic of endogenous JSRVs in general. However, the contemporaneous 5' 
truncation of orfx merited further investigation. Before completing the sequencing of 
enJS5FI6, the part of pol that also contains orfx was sequenced in enJS59AI and found to 
be an uninterrupted open reading frame of the same length as in the exogenous JSRV 
sequences. Orfx was consequently not considered a region that distinguishes endogenous 
from exogenous JSRV s. 
2.4.2.2 A full complement ofORFs in enJS56AI 
When sequencing of the last clone, penJS56Al, was completed, it was noted that it 
encodes open reading frames for all structural JSRV genes. Its integrase domain at the 3' 
terminus of pol is truncated by 14 amino acids owing to a frame shift mutation, but this 
frameshift was not common to the other two loci. Therefore, enJSRVs were not found to 
be distinguished from JSRVs by consistently being defective in one or more genes. Such a 
conclusion would have been difficult to substantiate in any event, since the exogenous 
progenitors of enJSRVs must have been functional in their replicative and infectious 
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capacity, and unless they depended on helper viruses, would have had to encode a full 
complement of genes. The defects seen in the other two loci are, as with other endogenous 
retroviruses, most likely the effect of accumulated changes that occurred after their fixation 
in the sheep genome. 
2.4.2.3 Evolutionary analysis of the enJSRV loci 
Taking into account the four base pair differences between the 5' and 3' L TRs of 
enJS59A1, the two in enJS56A1, and the absolute sequence homology of the LTRs in 
enJS5F16, an estimate of the time of integration of these elements into the sheep germ line 
was made. At the time of integration, the L TRs of each provirus were presumably 
identical, since they would have arisen from sequence duplications at the 5' and 3' ends of 
the genome during reverse transcription. The rate of mutation of L TRs is presumed to 
equate to the general rate of mutation of noncoding sequences and pseudogenes. Thus, a 
molecular clock model was applied to the intragenomic variability of the L TRs to provide 
and estimate of the time elapsed since integration (Dangel et al., 1995; Mager & Freeman, 
1995; Medstrand & Mager, 1998). Calculating from an average value of 4.85 x 10-9 
substitutions per nucleotide site per year relative to pseudogenes (Li et al., 1985), the 
integrations of enJS56A1 and enJS59A1 were estimated to have occurred approximately 
0.9 and 1.8 million years ago, respectively, subject to a wide margin of error. Based on the 
sequence identity of the 5' and 3' L TRs in enJS5F 16, this locus might have integrated less 
than 500,000 years ago. 
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These estimates concur with the conclusions ofa previous study by Hecht et ai. (1996b), 
wherein it was shown that the genomes of sheep (and wild members of the genus Ovis) and 
goats (and wild members of the genus Capra) each contain approximately 20 JSRV-related 
endogenous retroviruses. The RE profiles of these proviral elements differed between the 
two genera, but were similar among members of the same genus. This implies that at least 
the majority of enJSRVs were fixed in the germ line of sheep and goats after their 
speciation, which happened between four and ten million years ago (Irwin et ai., 1991). 
Thus, enJSRVs can be considered modern endogenous retroviruses, which is in keeping 
with their high degree of homology with the currently circulating exogenous retroviruses 
JSRV and ENTV (Boeke & Stoye, 1997). 
This study also broadened the base of knowledge pertaining to the phylogenetic 
relationships amongst the currently known betaretroviruses of sheep and goats. Whereas 
some previous findings could be confirmed by the phylogenetic trees generated, the 
branching of ENTV s into those infecting goats and those infecting sheep, had not been 
graphically represented before, even though these groupings were described. An entirely 
novel finding in this study was the consistent branching of enJSRV s into two groups, akin 
to the division of exogenous JSRVs into type I and type II. 
2.4.2.4 The enJS56AI genome does not support particle formation 
As soon as the entire sequence of enJS56A 1 was completed, the finding that it has open 
reading frames for all confirmed JSRV genes was communicated to our collaborators. 
Using in situ hybridization, they were in the process of showing that enJSRVs are most 
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highly expressed in the luminal epithelial (LE) and glandular epithelial (GE) cells ofthe 
ovine uterus (palmarini et ai. , 2000b). We had already raised the question of whether or 
not some enJSRVs might form particles in vivo, and they were well set up to test the ability 
Plumld Viral 








Figure 2.16 Schematic of the CMV-driven chimeric constructs of JSRV21 and enJS56A1 
created by Palmarini et a/. (2000b)(Palmarini et a/' J 2000b) to narrow down the region 
responsible for the particle formation defect in enJS56A1. The restriction endonuclease 
enzymes employed in the construction of the chimeras are indicated. The determinants of particle 
release were shown to reside in the amino-terminal two thirds of Gag. 
of enJS56Al to support particle formation in vitro, using the same system they had 
developed for JSRV21 particle formation (Palmarini et ai., 1999a). The sequence of 
enJS56A 1 was placed under the same transcriptional promoter system as the infectious 
molecular clone of JSRV21 had been, giving rise to the expression construct 
Pcmv2enJS56Al. This was found not to support particle formation, as assayed by the 
release of mature capsid protein (a product of the gag gene) into the culture supernatant of 
transiently transfected 293T cells. 
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In order to localise the particle fonnation defect ofpCMV2enJS56A1, a set of chimeric 
constructs was created (Palmarini et al., 2000b) as outlined in Figure 2.16. These revealed 
that the only JSRV21-derived region that is required for particle production is the amino-
tenninal two thirds of Gag (pGxPEe, where capital letters denote the genes gag, pol and 
env, and lower case letters denote either endogenous [e] or exogenous [x] origin). The 
remainder of the genome could be enJS56A1-derived without affecting particle production. 
The reciprocal chimera pGePEx was not able to support release of particles into the culture 
supernatant. 
2.4.2.5 Variable regions of ovine betaretroviruses in gag 
The second principal goal of this aspect of the study was met when the variable regions in 
gag were discovered. These regions are highly conserved within the enJSRVs, including 
sequences derived from goat genomic DNAs. They are also conserved amongst the three 
known JSRV sequences JSRV-SA, JSRV21 and JSRV-JS7. However, comparisons ofVR1 
and VR2 between enJSRVs, JSRVs and ENTV reveal a high degree of polymorphism. Of 
particular note is a stretch of seven consecutive proline residues found in VR1 of all JSRV 
sequences that is absent in enJSRV s. 
The strict conservation of some sequence elements amongst both endogenous and 
exogenous JSRVs, such as the 35-bp stretch upstream of the gag start codon, imply that the 
function associated with these regions is common to all JSRV s. Such functions might 
relate to critical interactions with the host cell or to other invariable requirements of the 
viral life cycle. However, sequence elements that are conserved amongst only endogenous 
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or exogenous JSRV s, but differ between these two groups, serve to highlight regions that 
functionally distinguish exogenous from endogenous JSRVs, whether this relates to their 
potential role in pathogenesis, their host cell specificity, or other factors that discriminate 
between these two closely related groups of retroviruses. Since the role of the JSRV pIS 
Gag protein, which includes VRI and VR2, is not known, it was not obvious which 
potential functions of these regions could be investigated. Although the significance of the 
protein(s) between MA and CA was generally poorly understood, these regions had been 
demonstrated to play roles in particle assembly and budding in some retroviruses (V ogt, 
I 997b). 
It was therefore of particular interest that the region identified by the construction of the 
JSRV21 / enJSS6AI chimeric clones as harbouring the endogenous particle release defect 
encompassed both VRI and VR2. The likelihood that either of the variable regions, or their 
combined presence, is responsible for the observed defect seemed very high, in view of the 
high degree of homology between endogenous and exogenous JSRVs in gag outside of the 
variable regions. However, allowance was made for the possibility that some single 
nucleotide difference(s) in the coding region of gag, or in the untranslated leader region of 
gag, determines the particle formation defect. 
2.4.2.6 The variable region of ovine betaretroviruses in env 
Although a high degree of polymorphism observed amongst JSRV-related sequences in the 
carboxy-terminal end of the transmembrane portion of env had been reported previously 
(Bai et al., 1999; Cousens et al. , 1999), it had not been formally established as a feature 
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that distinguishes pathogenic exogenous from non-pathogenic endogenous sequences. It 
was named the variable region 3 (VR3) of ovine betaretroviruses as a result of this study. 
The author considered it more likely that VR3 would have a direct involvement in JSRV 
pathogenesis than either VRI or VR2, since the potential opportunities of envelope protein 
components interacting with cellular signalling pathways are more obvious than those of 
Gag components. Also, a report had just become available that linked a retroviral envelope 
gene to cell proliferation and anchorage-independent growth of some epithelial and 
fibroblast cell lines in vitro (Alian et al., 2000). Since our collaborators at the CRIlUCI had 
the relevant facilities and expertise for the investigation of the possible involvement of 
JSRV Env in transformation, it was decided that they focus on that aspect, while the author 
developed the relevant molecular tools for the functional characterisation ofVRl and VR2. 
2.4.3 Applications of the sequence analyses 
The comprehensive sequence alignment maintained by the author can potentially be put to 
good use in the design of highly specific PCR primers. The author designed a VRl-based 
primer specific for exogenous JSRV sequences that, in combination with a primer that 
would anneal to all known JSRV -related sequences, allows more specific detection of 
exogenous JSRV against a high background of enJSRVs than other methods that rely on a 
single PCR (as opposed to nested or hemi-nested PCR designs) (padayachi, 2005). 
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Another application was in the design ofLTR-based enJSRV-specific primers by the 
author. This was done with a view towards conducting a broad and comprehensive 
phylogenetic study of endogenous JSRV-related loci in wild ungulates (hoofed animals). 
Regrettably, the group that we established a collaboration with to obtain all the samples 
required for the study never provided a single sample. However, the amplification of near 
full-length enJSRVs first from plasmid clones, and then from sheep DNA was successfully 




FUNCTIONAL ANALYSIS OF 
JSRV VARIABLE REGIONS 
3.1 INTRODUCTION 
In addition to providing relevant insights into the evolutionary biology of enJSRVs and the 
degree and nature of their relationship to exogenous JSRV and ENTV isolates, the first 
phase of the study described in this thesis identified three short variable regions in the 
known betaretroviruses of sheep and goats. This represented a milestone in the field, as 
these variable regions were seen to be the defining genetic elements that distinguish 
pathogenic exogenous from non-pathogenic endogenous JSRV sequences. Upon 
publication of these findings (palmarini et al. , 2000b), the task of characterising the three 
variable regions was divided between our laboratory and that of our collaborators at the 
CRIlUCI in accordance with the facilities and expertise available at each institution. 
We did not have the requisite facilities to work on env and VR3, whereas the CRIlUCI did. 
Furthermore, the author was considered by his colleagues to have the skill and patience 
required to design and develop the relevant molecular tools that would enable the 
comparative study of endogenous vs. exogenous VRI and VR2, partly in an attempt to 
follow up on the particle release defect of enJS56Al (Palmarini et al. , 2000b). The in vitro 
study of JSRV env and VR3 required the direct input ofa far greater number of researchers 
than we would have been able to dedicate to the project, even if we had managed to put all 
the relevant facilities in place. 
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The study of JSRV env commenced at the same time as the author's study ofVRl and 
VR2, and there was little a priori indication to suggest that either avenue would provide 
more pertinent insights into JSRV pathogenesis than the other. Since the author' s study 
formed part of a broad, international research endeavour to study the pathogenesis of JSRV 
and to define the applicability of the OP A model for human carcinomas, he was required, 
as part of his work, to critically assess all the developments pertaining to JSRV env and 
VR3. The objectives of this aspect of the study were thus two-tiered. The first was to 
develop molecular tools that could be used, in future, to discern the biological significance 
ofVRl and VR2 in vivo. These tools were required to be designed, constructed, verified, 
and finally assessed in vitro for their applicability to in vivo studies. The second tier of this 
part of the study was to maintain a thorough perspective on the developments in JSRV env 
and VR3 progress in order to put both parts into the context of the overall aims of JSRV 
pathogenesis research. 
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3.2 MATERIALS AND METHODS 
3.2.1 Techniques employed 
Techniques used for this aspect of the study, which were not already described in Chapter 
2, are outlined below. 
3.2.1.1 Restriction endonuclease digestions 
Restriction endonuclease (RE) digestions were performed either at 37°C for two hours, or 
at 16°C overnight in 50 III total reaction volumes, using 4 units of each enzyme. Reactions 
were supplemented with a final concentration of 100 Ilglml Bovine Serum Albumin. DNA 
substrate was added at ~ 100 ng per reaction, of either plasmid DNA or PCR product. The 
following REs were used: 
HpaI (3 - 10 D/IlI; Roche) 
PacI (10 D/IlI; New England Biolabs [NEB]) 
SexAI (4 D/IlI; NEB) 
SmaI (10 D/IlI; Roche) 
XbaI (10 D/IlI; Roche) 
After optimisation all digests, including double-digests using two NEB-sourced enzymes, 
were carried out in 1 x SuREICut Buffer A (Roche). This was due to the fact that NEBuffer 
1 supplied with PacI is not compatible with SexAI activity, and NEBuffer 3 supplied with 
SexAI is incompatible with PacI. All digests worked optimally in SuREICut Buffer A, 
however. 
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3.2.1.2 Purification ofPCR products and agarose gel excised DNA fragments 
The High Pure PCR Product Purification Kit (Roche) was used to remove contaminating 
substances such as unincorporated dNTPs, primers and salts from the PCR products. The 
technique involved addition of the chaotropic salt guanidine thiocyanate, present within the 
binding buffer, to PCR amplified DNA. The DNA binds selectively to special glass fibres 
filled within the High Pure filter tube. 
Procedure: 
• The desired band was excised from an agarose gel using a scalpel blade, under UV 
transillumination. The appropriate eye protection and gloves were used. 
• The piece of agarose containing the DNA band of interest was placed into a 1.5 ml 
microcentrifuge tube. 
• The gel mass was determined by weighing the microcentrifuge tube prior to addition 
of the gel segment and after the gel piece was added to the tube using a coarse 
balance. 
• A volume of 300 III binding buffer was added to a microcentrifuge tube for every 
100 mg of gel segment. 
• The microcentrifuge tube containing the agarose piece was vortexed for 30 seconds 
to resuspend the gel segment in the binding buffer. 
• The gel mixture was heated at 56°C for 10 minutes to liberate the DNA by dissolving 
the agarose. The suspension was vortexed using short bursts every 2-3 minutes 
during the incubation period. 
• After incubation, the DNA was precipitated by addition of 150 III isopropanol per 
100 mg gel segment, into the microcentrifuge tube. 
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• The tube was thoroughly vortexed for 3-5 seconds. 
• A High Pure filter tube was inserted into a collection tube. 
• The mixture was carefully transferred to the upper reservoir of the filter tube. 
• A maximum volume of 700 JlI was added at each time. (If there were more than 
700 JlI, the procedure was completed to the end of the elution step. Thereafter, the 
filter was re-used to bind and elute the second 700 JlI volume to ensure that the 
binding capacity of the filter was not compromised by the addition of excess DNA). 
• Centrifuged for 60 seconds at maximum speed in a table top microcentrifuge at room 
temperature. 
• The filter tube was disconnected and the flow-through was discarded. 
• Re-connected the filter tube to the collection tube. 
• Added 500 JlI wash buffer to the upper reservoir. 
• Centrifuged for 60 seconds at maximum speed. 
• Discarded the flow-through solution and collection tube. 
• Re-connected the filter tube with the same collection tube. 
• Added 200 JlI wash buffer. 
• Centrifuged for one minute at maximum speed. 
• Discarded the flow-through solution and collection tube 
• Centrifuged for 30 seconds at maximum speed to remove residual wash buffer. 
• Discarded the flow-through and collection tube. 
• Re-connected the filter tube to a clean 1.5 ml microcentrifuge tube. 
• Added 50-100 JlI dd jH20 to the upper reservoir of the filter tube depending on the 
expected DNA yield. 
• Centrifuged for one minute at maximum speed to collect eluate. 
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The same kit was used to purify PCR products prior to RE digestion. The following 
procedure was followed: 
• To a 1.S ml microcentrifuge tube containing 100 of DNA, SOOIlI of binding was 
added (binding buffer was adjusted according to the amount of DNA that was 
present). 
• The mixture was thoroughly vortexed for three seconds. 
• A High Pure filter tube was inserted into a collection tube. 
• The mixture was carefully transferred to the upper reservoir of the filter tube. 
• Centrifuged for 60 seconds at maximum speed in a table top microcentrifuge. 
• The filter tube was disconnected and the flow-through was discarded. 
• Re-connected the filter tube to the collection tube. 
• Added SOO III wash buffer to the upper reservoir. 
• Centrifuged for 60 seconds at maximum speed. 
• Discarded the flow-through solution and collection tube. 
• Re-connected the filter tube with the same collection tube. 
• Added 200 III wash buffer. 
• Centrifuged for one minute at maximum speed. 
• Discarded the flow-through solution and collection tube 
• Centrifuged for 30 seconds at maximum speed to remove residual wash buffer. 
• Discarded the flow-through and collection tube. 
• Re-connected the filter tube to a clean 1.S ml microcentrifuge tube. 
• Added SO-l 00 III ddjH20 to the upper reservoir of the filter tube depending on the 
DNA that was initially added. 
• Centrifuged for one minute at maximum speed to collect eluate. 
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3.2.1.3 Sodium acetate I ethanol precipitation of DNA 
RE-digested DNA was precipitated prior to ligation, using the following procedure: 
To a 1.5 ml microcentrifuge tube containing both double-digested plasmid and double-
digested PCR fragment DNA in solution, 0.1 volumes of sodium acetate (3 M; pH 5.2) and 
2.5 volumes absolute ethanol were added. The contents were mixed by vortexing and kept 
at -20°C for one hour. DNA was precipitated by centrifuging in a microcentrifuge in the 
cold room for ten minutes at top speed (16,000 x g). The supernatant was aspirated and the 
DNA pellet was washed by adding three volumes (relative to the original volume of DNA) 
of cold 70% ethanol, vortexing, and centrifuging for five minutes, as above. Air-dried 
DNA pellets were used in the subsequent ligation steps. 
3.2.1.4 Ligation of restriction endonuclease digested DNA 
Ligation reactions were set up by adding the following to the pellets comprised of double-
digested DNA: 
dd jH20 16 III 
T4 DNA ligase (1 U/IlI; Roche) 2 III 
lOx ligase buffer containing ATP 2 III 
The contents were mixed by vortexing to reconstitute the DNA in the ligation mix. This 
was left to incubate overnight at 4°C. 
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3.2.1.5 Boiling method for direct colony PCR 
The following procedure was employed to obtain small amounts of plasmid DNA from 
transformed E. coli colonies, to test if they contained desired inserts: 
Using a 200 JlI pipette tip, individual transformed colonies were picked from 
transformation plates. The pipette tips containing the bacterial cells were touched to 
labelled positions on reference agar plates, and the remaining cells were resuspended in 
1.5 ml micro centrifuge tubes containing 50 JlI ddjH20. The tubes were vortexed, closed 
and placed in a heating block at 100°C for five minutes. They were subsequently placed on 
ice for two minutes to precipitate moisture on the insides of the tubes. Cell debris was 
precipitated by centrifugation in a microcentrifuge at maximum speed for five minutes. Of 
the supernatant, five microlitres were used as template in PCRs. 
3.2.1.6 Mammalian cell tissue culture 
All cell culture experiments were carried out using aseptic techniques in a Class lIB 
biohazard laminar flow cabinet installed with HEP A filters . Human 293T immortalised 
fibroblasts and sheep choroid plexus (CP) cells were incubated under standard cell culture 
conditions comprising 5% CO2 in a 100% humidified, water-jacketed incubator adjusted to 
37°C. Cells were grown in 10 cm tissue culture dishes using Dulbecco's modification of 
Eagle's medium (DMEM; Cellgro) containing 45 gil glucose and L-glutamine. DMEM 
was supplemented with 10% foetal bovine serum (FBS; Gibco BRL). Bacterial 
contamination was prevented by the addition of 1,000 iUlml penicillin to a final 
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concentration of 100 iU/ml and 1,000 Ilg/ml streptomycin to a final concentration of 
100 Ilg/ml. Cell growth was observed using an inverted light microscope under phase 
contrast. 293T cells were split 1:6 when they reached 80% confluence, using 0.25% trypsin 
to enzymatically facilitate detachment of the cells from the culture dish. CP cells were also 
split at 80% confluence, but only 1 :4. 
3.2.1.7 Transfection of human 293T cells 
293T cells were trypsin neutralised in regular growth media and seeded into either 10 cm 
or 15 cm culture dishes depending on the transfections being performed. The cells were 
transfected at 50% confluence with either 21 Ilg or 28 Ilg plasmid DNA in 10 cm dishes or 
with 58 Ilg DNA in 15-cm dishes using the CalPhos Mammalian Transfection kit 
(Clontech), following the protocol outlined in the manufacturer's handbook. The growth 
medium for each culture dish was replaced 12-16 hours post-transfection with 5 ml fresh 
medium for 10 cm dishes and with 12.5 ml for 15 cm dishes. The medium was then 
harvested and replaced at 24, 48 and 72 hours after the initial medium change. The 24 and 
48 hour culture supernatant fractions were stored at -70°C until the 72 hour fraction was 
collected. 
3.2.1.8 Concentration of viral particles 
Post-transfection culture supernatants from 24, 48 and 72 hours after the initial change of 
medium were pooled and centrifuged using a benchtop centrifuge at 3,000 x g for 10-15 
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minutes at 4°C to remove residual cell debris. The pooled media were filtered using 
0.45 !lm pore size, sterile filters. Viral particles were pelleted by ultracentrifugation in a 
Beckman SW28 rotor over a double glycerol cushion as follows: 
Clear-walled ultracentrifuge tubes received 3 ml each of 50% glycerol, made up in TNE 
buffer [100 mM NaCI, 10 mM Tris, 1 mM EDTA; pH 7.4]. A further 3 ml of25% glycerol 
(made up in TNE) was carefully added drop-wise to complete the double glycerol cushion. 
Clarified medium was gently added to each tube, held at an angle of ~30° so as not to 
disrupt the glycerol cushion. Ultracentrifugation was carried out at 100,000 x g for one 
hour at 4°C. The liquid was decanted from the tubes and the viral pellets were resuspended 
in TNE buffer at 300 or 400-fold higher concentration relative to the initial supernatant and 
stored at -70°C. 
3.2.1.9 Western blotting 
Reagents used: 
• Laemmli electrode buffer (5 litre - a lOx stock of 500 ml was made) 
0.25 M Tris 
1.92 M glycine 
1% (w/v) SDS 
It was a requirement that the pH not be adjusted. 
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• Transfer buffer (2 litres - a lOx stock of 500 ml was made) 
0.02 M Tris, pH 8.3 
0.15 M Glycine 
20% Methanol 
• Blocking buffer (45 ml) 
5% (w/v) non-fat dry milk 2.25 g 
TBS + 0.1 % Tween-20 45 ml 
10 ml blocking buffer was added per blot. 
• lOx Tris-buffered saline (TBS, 1 litre) 
0.2 M Tris 24.2 g 
50 mM NaCI 80.0 g 
Adjusted pH to 7.6 





• 10% resolving gel 
Sucrose 1 g 
40% acrylamide 5 ml 
4x resolving buffer 5 ml 
ddjH20 9ml 
TEMED 20 ~l 
10% (w/v) APS 100 ~l 
The TEMED was added last to the mixture as it serves as the polymerising agent. 
The APS could be stored for a maximum of two weeks at 4°C. 
• 3% Stacking gel 
40% acrylamide 









The gels were poured and left to set for at least one hour before the samples were loaded. 
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Buffers used: 
• 4x resolving buffer 
1.5 M Tris, pH 8.8 
0.4% SDS 
• 2x stacking buffer · 
0.25 M Tris, pH 6.8 
0.2% SDS 
36.34 g 
8 ml (10% SDS stock) 
3.30 g 
2 ml (10% SDS stock) 
The polyacrylamide gel electrophoresis (pAGE) apparatus was assembled as follows: 
Two glass plates were chosen, with the one being smaller than the other. The glass plates 
were cleaned with detergent and subsequently rinsed with 100% ethanol. 
Two spacers (0.75 mm) and clamps were used to hold up the gels. 
A 0.75 mm eight-well comb was used. 
After the apparatus was assembled, the gels were prepared as follows: 
• The resolving gel was mixed. Upon addition of the TEMED, the gel was loaded 
using a needle and syringe to ± 1 cm below the lower edge of where the comb would 
reach. 
• The stacking gel was loaded above the resolving gel and the comb inserted between 
the plates. 
• The gel was left to polymerise for one hoUT. 
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• The gel was transferred to the running tank. The tank was filled with Laemmli 
electrode buffer. The wells of the gel were washed with Laemmli buffer using a 
synnge. 
• A 1 x solution of loading dye was made with Laemmli buffer. A volume of 1-2 I.d 
was added to each well to make them visible for sample loading. 
• The retroviral particles (in TNE buffer) were mixed with loading dye and 
subsequently boiled at 95°C for five minutes. Samples were placed on ice for two 
minutes and briefly centrifuged to collect the contents at the bottom of the tube. 
• A 6 J..lI volume of the broad range protein marker (New England Biolabs) was loaded 
into the first well. 
• A total volume of 20 J..lI (including the loading dye) was loaded into each of the other 
wells. 
• The gel was electrophoresed at 70 V for 30 minutes to allow the sample contents to 
collect at the bottom of the stacking gel. 
• The potential difference was then increased to 100 V and the gel was electrophoresed 
until the tracking dye ran off the gel. 
• After electrophoresis, the gel was transferred to a Hybond nitrocellulose membrane 
using the sandwich cassette system from Amersham Biosciences. 
• The transfer tank was kept cold by inserting the tank into an ice bucket containing 
crushed ice. 
• The Tris-glycine containing transfer buffer was added to the buffer tank and the 
transfer was performed at 100 V for one hour. 
• The sandwich cassette was then dismantled and the nitrocellulose membrane was 
placed in TBS overnight at 4°C. Care was taken not to touch the membrane , 
therefore forceps were used at all times. 
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• Subsequently, the nitrocellulose membrane was blocked for one hour in blocking 
buffer. 
• The membrane was probed using an anti-JSRV gag polyclonal antibody for one hour 
at room temperature. A 1 :500 dilution of the antibody was used in a volume of 8 ml 
wash buffer. 
• Following primary antibody incubation, the membrane was washed three times for 
10 minutes each. 
• The membrane was then placed into a 1 :1000 dilution of goat-anti-rabbit IgG 
(ImmunoPure) secondary antibody labelled with horseradish peroxidase. The 
secondary antibody was diluted in wash buffer. 
• The incubation period of the membrane was one hour at room temperature. 
Prior to detection, the membrane was washed in wash buffer three times for 10 minutes 
each. Detection was performed using the Super Signal West Pico Chemiluminescent kit 
(Pierce) by adding 3 ml Super Signal chemiluminescent substrate stable peroxide solution 
to 3 ml Super Signal chemiluminescent substrate luminal enhancer. The membrane was 
incubated in the solution for 2-5 minutes in the dark. The membrane was transferred to a 
plastic surface and used to expose an X-ray film for a period of 2-4 minutes and 
development was carried out manually by immersion in developing, fixing and washing 
solutions. 
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3.2.1.10 RNA extraction from concentrated retroviral particles 
Particles were resuspended in TNE buffer, so the standard reaction conditions of 
downstream applications had to be adjusted to suit DNase I digestion. A 1 x solution of 
phosphate-buffered saline (PBS) containing 24 mM MgCh was used in the procedure to 
compensate for the ETDA in TNE buffer. This served as a 2x diluent for a final MgCh 
concentration of 12 mM. A 500 III volume of PBS + 24 mM MgCh was made. A 0.5 III 
volume (5 U) of RNase-free DNase I (Roche) was used to make the DNase mix. 
Throughout the procedure, 2 ml screw cap tubes were used. 
• For each sample, 200 III of resuspended viral pellet was added to a 200 III volume of 
DNase mix. 
• The suspension was incubated at 37°C for 30 minutes. 
• To the suspension, three volumes (1.2 ml) TRIzol LS were added. TRIzol LS is a 
noxious chemical therefore all steps involving its use were carried out in a fume 
hood. 
• The tube contents were mixed by vortexing. 
• The homogenised samples were incubated for five minutes at room temperature. 
• Chloroform (without isoamyl alcohol) was added to the tube contents at 0.8 volumes 
of the original sample (320 Ill). 
• The tube was shaken vigorously by hand for 15 seconds and subsequently incubated 
for 10 minutes at room temperature. 
• The tube was centrifuged at ~ 12,000 x g for 15 minutes at 4°C. Samples separated 
into a lower red organic phase, an interphase and an upper colourless aqueous phase. 
The upper aqueous phase constituted 70% of the volume ofTRIzol added (840 I.d). 
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• The aqueous phase was transferred to a new 2.0 ml tube. 
• A 0.5 ~l volume of20 mg/ml glycogen and two volumes of isopropanol relative to 
the original sample of 800 ~l were added to the tube. 
• The mixture was vortexed and left to incubate at room temperature for 10 minutes. 
• After incubation, it was centrifuged at ::; 12,000 x g for 10 minutes at 4°C. 
• The supernatant was removed and the pellet was washed with four volumes (1.6 ml) 
of75% ethanol, which was made up with DEPC-treated ddjH20. 
• The sample was mixed by vortexing, and centrifuged at ::; 7,500 x g for five minutes 
at 4°C. 
• The pellet was air dried for 5-10 minutes. 
• The pellet was resuspended in a 60 ~l volume of DNase reaction mix comprising 1 x 
DNase I buffer (Invitrogen) made up in DEPC-treated ddjH20 and 0.2 U RNase-free 
DNase I (Roche). 
• The mixture was incubated at room temperature for 15 minutes. 
• DNase I was inactivated by the addition of6 ~125 mM EDTA and subsequent 
heating at 65°C for 10 minutes. 
• The RNA was stored at -70°C. 
3.2.1.11 In vitro infection of ovine choroid plexus cells 
Infectivity assays of the three chimeric clones were carried out according to a modification 
of the protocol developed for the in vitro infection of ovine cell lines by the CRIlUCI 
(Palmarini et ai., 1999b). Four infections were carried out, with concentrated viral particles 
derived from pCMV2JS21 (as a positive control) and from the three chimeric clones. Each 
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infection required two 5 cm tissue culture dishes with CP cells at 50% confluence. The 
viral pellets (~450 Ill) were made up to two millilitres with DMEM, supplemented as 
described earlier for tissue culture, as well as with 8 Ilg ofPolybrene per ml. [Polybrene is 
a small cationic polymer that binds to cell surfaces and neutralizes surface charge, thereby 
allowing the viral glycoproteins to bind more efficiently to their receptors, because it 
reduces the repulsion between sialic acid-containing molecules.] The particle suspensions 
were passed through 0.2 11m filters and then divided in half. One halfwas incubated at 
65°C for 15 minutes to inactivate enveloped retroviral particles. Culture media were 
aspirated from the CP cells and replaced with particle suspensions (at this point, 1 ml 
each). The cells were left to incubate for two hours at 37°C, where after 2 ml medium 
containing 8 Ilg/ml ofPolybrene were added to each plate. After 16 hours, the particle-
containing media were aspirated and replaced with 5 ml medium per plate, containing 
Polybrene at a concentration of 2 Ilg/ml. This concentration of Polybrene was subsequently 
maintained as the cells were passaged. 
3.2.1.12 DNA extraction from cultured mammalian cells 
DNA was isolated from sheep choroid plexus cells using the DNeasy Tissue kit (Qiagen). 
The principle ofthis kit is based on selective binding of DNA to a silica-gel-membrane. 
This technologically improved method produces purified DNA in the absence of noxious 
organic chemicals and ethanol precipitation. 
Before the procedure was undertaken, the following instructions as outlined in the 
manufacturer' s handbook were adhered to: 
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Buffer AL was inspected carefully for the presence of a precipitate. If present, the 
precipitate was re-dissolved by incubation at 55°C. 
Buffers AWl and AW2 were diluted in the appropriate amounts of 100% ethanol 
as indicated on the bottles, as they were supplied in a concentrated form. 
A water bath or heating block was set to 70°C before the procedure was carried out. 
Centrifugation steps were performed at room temperature using a speed of 
~6,000 x g. 
The pulse vortexing method comprising 5-10 seconds was used throughout the 
procedure. 
For RNA-free DNA, RNase A was added. 
Sterile, autoc1aved PBS was prepared for use in the procedure. 
Procedure: 
• Choroid plexus cells were removed from the 37°C cell culture incubator and washed 
with PBS to remove any residual debris and dead cells. The PBS was aspirated. A 
volume of 500 !J.I PBS was added to the cell culture dish. A cell scraper was used to 
scrape cells off the surface of the culture plate. The cells, together with the PBS were 
placed into a 1.5 ml microcentrifuge tube. The cells were centrifuged for five 
minutes at 300 x g. The resulting pellet was reconstituted in 200 !J.I PBS. 
• A 4 !J.I volume of RNase A at a concentration of 100 mg/ml was added to the 
resuspended DNA to remove any contaminating RNA from the suspension. The cells 
were incubated in RNase A for two minutes at room temperature. 
• Contaminating protein complexes were degraded by the addition of 20 !J.I proteinase 
K. Thereafter, Buffer AL was added to the cells at a volume of 200 !J.l. The 
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suspension was mixed thoroughly by pulse vortexing to create a homogeneous 
solution. The cells were then incubated at 70°C for 10 minutes . 
• Following incubation, 200 III of 100% ethanol was added to the cell suspension. The 
sample was mixed thoroughly by vortexing. (The addition of ethanol could yield a 
white precipitate, which was added to the spin column as it does not interfere with 
the procedure). 
• The entire cell suspension contents within the microcentrifuge tube were transferred 
to the upper part of the DNeasy spin column, which was housed within a 2 ml 
collection tube. The sample was centrifuged at ~ 6,000 x g (8,000 rpm) in a bench 
top microcentrifuge for one minute. The collection tube containing contaminating 
cell debris was discarded. 
• A new collection tube was used to house the spin column containing the bound 
DNA. The attached DNA was washed by the addition of 500 III Buffer A WI to the 
centre of the membrane. This was followed by centrifugation at ~ 6,000 x g 
(8,000 rpm) for one minute. The collection tube containing the flow-through was 
discarded to prevent any carry-over contamination. 
• The spin column containing the attached DNA was placed into a new collection tube. 
A 500 III volume of Buffer A W2 was added to the DNA bound to the membrane, 
followed by centrifugation for three minutes at maximum speed. This wash buffer 
contains ethanol, therefore the membrane was required to be dried (hence the need 
for the three minute centrifugation at maximum speed). The presence of ethanol 
would have inhibited downstream reactions such as PCR procedures, thus all 
precautions were taken to prevent carryover of ethanol into the subsequent elution 
step. Following centrifugation, the flow though was discarded and the collection tube 
was re-inserted into the spin column. 
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• As an amendment to the procedure in the manufacturer's handbook, a further one 
minute centrifugation step at maximum speed was included in the absence of liquid 
in the collection tube. The handbook suggested this additional centrifugation only if 
the spin column made contact with the flow-through. However, on account ofthe 
author's previous experience with spin column procedures, this step was 
incorporated into the procedure. The author has noted from other such spin column 
procedures that discarding the flow-through from the initial centrifugation step 
facilitated the removal of additional ethanol and in so doing pure, ethanol free DNA 
was obtained. 
• A sterile 1.5 ml microcentrifuge tube was used to house the spin column. A 200 ~l 
volume of Buffer AE was carefully added to the centre of the DNeasy membrane. 
Care was taken to ensure that droplets of elution buffer did not touch the sides of the 
tube as this would prevent optimal elution of the bound DNA. The spin column was 
incubated at room temperature for one minute and subsequently centrifuged for one 
minute at ~ 6,000 x g (8,000 rpm) to effect elution. 
• The elution step was repeated by placing the spin column into a new, sterile 
microcentrifuge tube. A further 200 ~l elution Buffer AE was placed into the centre 
of the membrane. The DNA containing spin column was incubated for one minute at 
room temperature as above. After incubation, the DNA was eluted by a one minute 
centrifugation at ~ 6,000 x g (8,000 rpm). The 200 ~l elution volume was optimal for 
the procedure since an increase in the volume would have resulted in the spin column 
making contact with the eluate owing to the funnel-shaped nature of the 
microcentrifuge tube. 
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3.2.2 Substitution of VRI and VR2 
The creation of chimeric constructs based on pCMV2JS21 containing the endogenous 
(penJS56Al-derived) forms ofVRl and VR2 in place of their exogenous counterparts, 
either individually or in combination, was a multi-step process based on the principle of 
overlap extension PCR (Higuchi et al., 1988; Ho et al., 1989). The basic experimental 
steps involved were as follows: 
• Creation of PCR products that, when combined as templates in further PCRs, would 
yield pCMV2JS21 -based amplicons with penJS56Al-derived VRI or VR2. 
• Restriction of the PCR amplicons and the target pCMV2JS21 backbone with REs on 
either side of the substituted regions. 
• Ligation of the fragments containing the penJS56Al-derived variable regions into 
the pCMV2JS21 backbone. 
• Transformation of competent E. coli with the resulting chimeric plasmid. 
• PCR-screening of the transformed bacterial colonies and selection of those 
containing correctly sized inserts. 
• Culture amplification of the relevant clones and confirmation by DNA sequencing. 
3.2.2.1 Building the method 
The author began by developing a conceptual framework of how the penJS56Al-derived 
VRI could be precisely substituted into the pCMV2JS21 backbone. A model of how a PCR 
amplicon based on pCMV2JS21 , but containing the VRI ofpenJS56Al, could theoretically 
be created, was developed and is graphically represented in Figure 3.1. This model draws 
- III -
VR1 
, =~~~ __ ~pe~n~J~S~5~6~A~1 __ ~J[~==:J-.~~1 ~R~~~====~~~~~3' 5~ outerF - I ] 5' 
3:'" ____ ~ _____ --
5' -. 2R 1 F 
3:-' -----_-_-__ ~_=_=_::;_~~I-_-_-__ -_IJF::::;.~======_5' -------------pCMV2JS21 2 F 
:::~~~:56A! 1 F+outerR using pCMV2JS21 
-~-- L _____ I _____ _ ------- ---------------
product (i) -.---
L _._._._ - - - - - - - - - - -
outer F + outer R 1 
using products (i) + (ii) 
- L 1 ---------------------- -----
outerF+2R 
using pCMV2JS21 





-.---_____ I ______ L ___________________ _ 
product (v) 
1 
outer F + outer R 
using products (iv) + (v) 
_____________________ I ______ L ___________________ _ 
product (vi) 
Figure 3.1 Conceptual framework showing how the sequential use of semi-overlapping 
PCR products could theoretically be employed to create an amplicon consisting of 
pCMV2JS21 -derived sequences (green) flanking the penJS56A1 (red) VR1. The position of 
VR1 is indicated at the top of the schematic. Forward and reverse sequences and primers are 
indicated by solid and dashed lines and arrows, respectively. The green colour of the arrows 
indicates that the primers are based on the sequence of pCMV2JS21 . They would be expected 
to amplify enJS56A1 sequences owing to the high degree of sequence homology of exogenous 
and endogenous JSRVs outside of the variable regions. 
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on the high degree of sequence homology between the endogenous and exogenous JSRVs, 
and all PCR primers are based on the sequence ofpCMV2JS21. Product (i), for instance, 
would be generated using pCMV2JS21-based primers, and penJS56Al as a template. This 
PCR amplicon would be primarily penJS56Al-derived, but with pCMV2JS21-derived tails 
corresponding to the primers used. Product (ii) would be entirely pCMV2JS21-based and its 
sequence would partially overlap with that of product (i) immediately 3' ofVRl. 
A combination of products (i) and (ii) in a PCR would lead to the extension of each of 
these products (they would each act initially as both primer and template), forming a new 
chimeric amplicon, product (iii). In the same PCR, product (iii) would be amplified with 
the primers indicated in Figure 3.1. Product (iv) would be another entirely pCMV2JS21-
based amplicon terminating at the 5' junction ofVRl. Eventually, continuing to use the 
primer-based tails as perfectly homologous overlaps between the combined templates, a 
chimeric product (vi) could be generated that would be pCMV2JS21-based, with the 
exception of the precise substitution of the penJS56A I-derived VRI. 
Having developed this basic framework that could theoretically be implemented, it was 
reasoned that if two semi-overlapping PCR products could be used to produce and 
subsequently amplify a self-generating (by means of sequence extension by Taq DNA 
polymerase [Taq]) combined template, it should also be possible to use three, albeit at the 
possible forfeiture of some degree of efficiency. The model was therefore revised so as to 
reduce the number of steps and intermediate products involved. At the same time, 
candidate primers from existing stocks, as well as potential RE enzymes for use in 
subsequent steps, were identified (Fig. 3.2). The changes made to the strategy principally 
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Figure 3.2. Schematic showing the entire strategy that could be implemented for the 
substitution of the penJS56A1-derived VR1 or VR2 into pCMV2JS21 • Three semi-overlapping 
PCR products (A, Band C pertaining to VR 1, shown in maroon, or E, F and G pertaining to VR2, 
shown in blue) would be generated and used, in combination, as a single template. The positions 
of primers 124F and 1396R (common to the substitution of either VR1 or VR2) are indicated using 
the nucleotide sequence numbering of pCMV2JS21 • The primers 1 F, 1 R, 2 F and 2 R had not 
been designed at this stage, and would be specific for either VR 1 or VR2. Dotted lines indicate 
Taq-mediated primer extension. Extension-competent annealing intermediates are shown with ticks 
to their right; annealing intermediates incapable of extension are indicated by crosses. The 
positions of the recognition sequences of the REs (common to the substitution of either VR1 or 
VR2) that were to be used to digest both pCMV2JS21 and product D or H, are indicated. 
precisely flanking the VR1 , yielding product C. Products A and B would be pCMV2JS21-
derived, with product A terminating at the 5' VR1 junction, and products B starting at the 
3' VR1 junction. 
Based on the design of the primers, the sequences of these three products would partially 
overlap in the upstream and downstream regions flanking VR1. The combining of the three 
products in the context of a PCR would lead to priming of the overlapping parts of the 
sequences, followed by Taq-mediated extension. In the first round ofPCR two extension 
intermediates would be generated from productive base-pairing. There would also be two 
non-productively annealing intermediates that would not be extended by Taq, since Taq 
synthesises in the 5' to 3' direction (Fig. 3.2). In the next round ofPCR, the four strands 
comprising the two extension intermediates (one forward and one reverse strand each) 
would anneal in their overlapping regions, giving rise to an extension-competent and an 
extension-incapable intermediate. The primers included in the reaction would then permit 
the amplification of the former in subsequent rounds ofPCR, giving rise to product D, 
which had a predicted length of 1285 bp. 
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A list of unique RE recognition sites pertaining to the sequence of JSRV21 was generated 
using BioEdit (Table 3.1). Enzymes that cut two times or more would not be suitable for 
the subsequent steps. A further requirement was that they should not cut the vector 
backbone ofpCMV2JS21 , as this would also create more than one RE product. Out of this 
list, PacI and HpaI were initially chosen for the upstream and downstream restrictions, 
respectively. Only once these had been selected, the outer primers 124F and 1396R were 
Table 3.1 List of unique restriction endonuclease recognition sites in JSRV21. 
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chosen, since they were positioned on the outsides of the RE recognition sequences, but 
within reasonably close proximity compared to other available primers, thereby 
minimising the length of product D, and the likelihood of introducing PCR-generated 
sequence errors. 
The next step in this substitution strategy was the restriction of both product D and 
pCMV2JS21 with Pad and HpaI, followed by agarose gel excision of the relevant 
fragments (the restricted product D, and the pCMV2JS21 backbone minus the fragment 
between the Pad and HpaI sites). This was to be followed by T4 DNA ligase-mediated 
ligation of the two fragments, and transformation of competent E. coli cells using the 
ligation product. Screening of transformed colonies was to be performed by direct colony 
PCR, using primers 2F and 1R (Fig. 3.2) (since enJS56A1 VR1 is 12 bp longer than 
JSRV21 VR1 these could be distinguished on the basis of size) as well as 124F and 1396R 
(to ensure that the substituted fragment was not trurIcated). Colonies containing correctly 
sized inserts would then be further screened by sequencing (after plasmid preparation) to 
verify that no PCR-generated sequence errors had been introduced. 
The same principles from this method would be used to substitute VR2 to create 
pJS21/56AI VR2 (Fig. 3.2). Furthermore, using pJS21/56AI VRI as starting material, the 
substitution of VR2 could be repeated to generate a chimeric construct containing both the 
enJS56AI-derived variable regions, which would be named pJS21/56A1 VRI VR2. 
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3.2.2.2 Implementing the method 
PCR primers for the substitution of VR 1 and VR2 were designed precisely at the borders 
ofthese variable regions, as shown in Figure 3.3. The general format for the setup ofPCRs 
was followed, as outlined in 2.2.6. The specific conditions employed in this part of the 
study are summarised in Table 3.2. 
I ~ 568F ~ I 
JSRV21 TGATGAATTGAAACGTTTAGGAAATTTATTAAAGCAGGAAGAAGATCCTCTTCATACT 5 99 
I till 596R till I .f'. 
JSRV21 CCCGATTCGGGACCTAGTTATGATCCTCCTCCTCCTCCTCCCCCATCTCTGAAAATGC 657 
I ~ 660F • I 
JSRV21 ACCCTTCAGACAATGATGATTTACTTTCTTCCACAGACGAGGCAGAACTGGACGAGGA 715 
~------~tiII 688R till I 
I ~ 810F ~ I 
JSRV21 TGAGTTGGTTGAATGTTTTAAAAATCTTACTATTGCTTTACAAAATGCAGGAATTTCG 84 2 
L-..--------"'IIItiII 8 3 8 R .tiII---------l 
JSRV21 CTTCCTCATAATAATACCTTTCCCTCTG//TGATCCCCCGCCCGGGTTTCCTCCACCG 944 
I ~ 954F • I 
JSRV21 TCTAAACATATGTCTCCCCTACAAAGGGCCTTAAGACAGGCACAGCGACTTGGTGAAG :100 2 
I till 976R till I 
Figure 3.3 Sequences in JSRV21 flanking VR1 and VR2 used to design primers. The positions 
of forward primers are shown in blue; those for reverse primers in red. The sequences of VR1 and 
VR2 are indicated in green italics. Forty-six residues of VR2 have been omitted in this illustration, 
indicated by the double stroke. Note that priming begins and ends precisely at the borders of VR 1 
and VR2. 
Products A, B and C were created by PCR as shown in Figure 3.2 and Table 3.2. These 
were mixed 1 III A + 1 III B + 2 III C + 196 III ddjH20 to make a template mix for the PCR 
generation of product D for the substitution ofVRI. Products E, F, G and H were similarly 
derived for the substitution ofVR2 (Fig 3.2 and Table 3.2). 
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Products D and H, as well as pCMV2JS21 (approximately 100 ng each) were double-
digested with Pac! and SexAI. RE digestion reactions were subsequently combined {D + 
pCMV2JS21} or {H + pCMV2JS21} and precipitated with sodium acetate and ethanol, 
before being reconstituted in the context of T 4 DNA ligase reactions. The ligation products 
were used to transform competent E. coli 1M105 cells. 
Table 3.2 Details of peR conditions employed in the creation of VRl- and VR2-
substituted constructs. 
When used for screening 
(2) Enzyme inc\ud.ed. in the One-Step RT-PCR kit (Qiagen) for amplification, subsequent to cDNA synthesis 
by reverse transcrIptIOn. 
For the substitution ofVR1, transformants were screened in two stages of direct colony 
PCR. The first stage employed primers 568F + 688R. Colonies supporting the 
amplification ofa longer product (endogenous VR1 is 12 bp longer than exogenous VR1) 
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were further screened for full-length inserts using primers 124F + 1396R. For the 
substitution ofVR2, colonies were first screened for full-length inserts by direct colony 
PCR, using primers 124F + 1396R. Correctly sized PCR products were purified using the 
High Pure PCR Product Purification Kit (Roche) and RE digested with SmaI, since JSRV21 
VR2 contains a SmaI site, whereas enJS56A 1 VR2 does not. 
Colonies identified as putatively containing constructs with the desired substitutions were 
expanded in broth culture and their plasmid DNA isolated by MiniPrep. The entire regions 
substituted by digestion with Pac! and SexAI were sequenced using primers 124F, 1396R, 
and other primers internal to these, to select clones that did not contain any PCR -generated 
mutations. 
The construction of the double recombinant pJS21 /56A1 VR1 VR2 constituted an exact 
repetition of the steps involved in substituting enJS56A1 VR2 into the 
pCMV2JS21backbone, except that pJS21/56A1VR1 was used as the backbone into which 
the substitution of VR2 was made. The screening of transformed colonies was also the 
same as for the VR2 substitution described above. 
3.2.3 In vitro characterisation of chimeric clones 
3.2.3.1 Particle formation assays 
The ability of the chimeric clones to support particle formation was assessed in vitro. 
Human 293T cells were transfected at 50% confluence with each of the chimeric clones, as 
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well as pCMV2JS21 as a positive control, using the CalPhos Mammalian Transfection Kit 
(Clontech). After the initial change of culture medium (16 hours post-transfection), three 
sets of culture medium were collected from each transfection at 24 hour intervals, and 
pooled. Viral particles were pelleted by ultracentrifugation over a double glycerol cushion. 
Pellets of viral particles were reconstituted in TNE buffer and used as samples in Western 
blots. Particle formation was assayed by the detection of JSRV p26 capsid protein. 
3.2.3.2 Confirmation of particle formation specificity 
In order to confirm that the retroviral particles detected by Western blotting had originated 
specifically from the respective chimeric constructs used to transfect 293T cells, RNA was 
extracted from concentrated retroviral particles (see 3.2.1.10). The RNA (6 J.lI of66 J.ll) 
was used as a template in a One Step RT-PCR (Qiagen) amplification according to the 
manufacturer' s instructions, employing a JSRV21 sequence-specific downstream primer 
1 038R for cDNA synthesis, and the same primer in combination with an upstream primer 
481F (see Appendix II for primer sequences and Appendix III for primer annealing 
positions) for PCR amplification ofa region spanning both VRI and VR2. The final 
concentration of each primer was 0.6 J.lM. The reactions were carried out in a Biometra 
TGRADIENT thermocycler using the following cycling conditions: 50°C for 30 min; 950C 
for 15 min; 35 cycles of 94°C for 35 s, 53.4°C for 1 min, and 72°C for 1 min; 720C 
extension for 5 min. For negative (no reverse transcription) controls, HotStarTaq (Qiagen) 
was used in the absence of the reverse transcriptases Omniscript and Sensiscript contained 
in the One Step RT-PCR Kit. The resulting RT-PCR products were purified from an 
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agarose gel using a QIAquick Spin Gel Extraction Kit (Qiagen) and subsequently 
sequenced using the same primers (481F and 1038R). 
3.2.3.3 Infectivity assays 
Sheep choroid plexus cells were infected with chimeric retroviral particles as described in 
Section 3.2.1.11. Infected cells were maintained in culture in the presence ofPolybrene. At 
various passages post-infection, genomic DNA was isolated from infected cells using a 
DNeasy Tissue Kit for Cultured Cells (Qiagen). The presence of integrated JSRV provirus 
was determined by use of an exogenous-specific JSRV U3 PCR (palmarini et al., 1996b), 
utilising primers P-I and P-III (see Appendix III for primer annealing positions in proviral 
JSRV), adapted by using HotStarTaq DNA polymerase (Qiagen). 
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3.3 RESULTS 
3.3.1 Substitution of VRI and VR2 
A complex strategy was designed that facilitated the precise substitution of the enJS56Al-
derived VRI and VR2 (both individually and in combination) into the infectious molecular 
clone pCMV2JS21. The precision of this novel method is emphasised because an 
alternative and more conventional approach to make these substitutions would have been 
to identify RE sites on either side ofVRl (and separately, VR2) that are shared by 
enJS56Al and JSRV21 . If no shared RE sites could be identified, they could have been 
created by site-directed mutagenesis in such a way that the amino acid sequence of the 
resulting constructs would remain unchanged (i.e. silent mutations). Clones of both these 
sequences (penJS56Al and pCMV2JS21) could then have been digested with the two REs, 
and the fragment containing enJS56Al VRI could have been ligated into the backbone of 
pCMV2JS21. The problem with this approach would have been that any single-nucleotide 
differences between enJS56AI and pCMV2JS21 located in close proximity ofVRl would 
also have been substituted, thereby confounding any findings down the line. If functional 
differences are identified between VRI of enJS56Al and JSRV2h could they be 
categorically attributed to VRI ifthere are other (apparently minor) differences outside 
VRI in the substituted region? 
In this study, three chimeric constructs were created, each based on the backbone of 
pCMV2JS21, but containing the VRl, VR2 and both VRI and VR2 of enJS56AI. The 
substitutions were made exactly at the boundaries of the variable regions, and the strategy 
was published (Hall wirth et al., 2005) in its final form (Fig. 3.4). 
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Figure 3.4 Schematic for the substitution of enJS56A1 VR1 into wild-type JSRV Gag. (I) The 
two starting plasm ids pCMV2JS21 and penJS56A1 are shown. The small vertical rectangles at each 
side indicate the continuation of the plasmid DNA sequences. The numbering of PCR primers is 
based on the sequence of JSRV21 , with arrows indicating the direction of priming. (II) PCR products 
(A, B and C) resulting from amplification of the three primer pairs in I are shown. The PCR primers 
used to amplify these three products into a single PCR product (124F and 1608R) are also shown. 
(III) The resulting PCR product (D) is shown, along with the restriction endonuclease sites (and 
their positions in JSRV21 ) used for directional cloning into pCMV2JS21 backbone. (IV) The resulting 
chimeric plasmid pJS21/56A1VR1 is shown. (Adapted from Hallwirth et al. (2005).)(Hallwirth et al., 
2005) 
3.3.1.1 Creation of relevant PCR products 
Products A and C were generated with the primers indicated in Figures 3.2 and 3.3. 
Product B was initially generated using the primer pair 660F (as shown) and 1396R. At a 
later point, the reverse primer 1396R was replaced with 1608R, as indicated in Figure 3.4. 
All three reactions yielded products of the expected sizes (Fig. 3.5, left panel). The balance 
of the products was run on another agarose gel for excision and gel-purification of the 
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Figure 3.5 Agarose gels of products A, Band C used in the substitution of VR1. Left panel: 
PCR products; right panel: PCR products from left panel, after agarose gel extraction. 
bands, using a QIAquick Spin Gel Extraction Kit (Qiagen). Aliquots (10% by volume) of 
the purified eluates were visualized on a further agarose gel (Fig. 3.5, right panel) to ensure 
that the extractions had been successful. 
For the generation of product D, gel-purified products A, Band C were included in the 
PCR as a combined template, which was amplified initially using primers 124F and 1396R 
(Fig. 3.2), and later with 124F and 1608R (Fig. 3.4). pCMV2JS21 and penJS56A1 were 
used as positive control templates. The generation of product D was successful on the first 
attempt, and the balance of the product was resolved on another gel for excision and 
- 125 -
purification. The gel purification was of greater importance at this stage than it had been 
for products A, Band e, since shorter amplification products had also been generated in 
the peR (Fig. 3.6, left panel). An aliquot (2% by volume) of the gel extraction eluate was 
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Figure 3.6 Agarose gels showing the VR1-substituted product D that was generated from a 
combined template of products A, Band C. Left panel: PCR product D, and two positive 
controls where exogenous and endogenous JSRV plasm ids had been used to compare the size of 
product D. Right panel: Gel-extracted product D and PCR product generated with the same primers 
from penJS56A 1. 
Essentially the same approach was followed for the peR-based steps of the substitution of 
enJS56Al VR2 into peMV2JS21 • Primer pair 124F and 838R was used to generate the 
JSRV21 -based product E, terminating at the 5' junction ofVR2. Primers 954F and 1608R 
(initially 1396R) were used to generate the JSRV21 -based product F, beginning at the 3' 
junction ofVR2. Product G was an enJS56Al-based product flanked by JSRV21 
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sequences, 29 bp on the 5' end and 23 bp on the 3' end, corresponding to the lengths of the 
JSRV21-based primers used, viz. 810F and 976R (Fig 3.3). The semi-overlapping products 
E, F and G were mixed to form a combined template, and amplified using primers 124F 
and 1608R (initially 1396R). This yielded a JSRV21-based product H wherein the VR2 was 
derived from enJS56Al (data not shown). 
3.3.1.2 Endonuclease restrictions and ligations to reconstitute chimeric constructs 
In order to bring product D, containing the enJS56Al-derived VRl , into the pCMV2JS21 
backbone to create the chimeric construct pJS21/56Al VRl , both product D and 
pCMV2JS21 needed to be digested with unique RE that cut pCMV2JS21 only in one 
position each. The initial choice for these restrictions was PacI (New England Biolabs) on 
the 5' side and HpaI (Roche) on the 3' side (Figures 3.2 and 3.7). 
Upon repeated failure of subsequent ligation and I or cloning steps, the 3' ligations were 
carried out with SexAI (New England Biolabs) in place of HpaI, hoping that the sticky 
ends generated by SexAI would be more amenable to ligation than the blunt ends generated 
by Hpal. At the same time, primer 1396R was replaced in all reactions with 1608R. This 
was done for two reasons: Our laboratory stocks of 1396R (which had been brought from 
CRIlUCI) had been all but depleted, and it was preferable to be able to visualise the 
"dropped ends" generated by double digestions of products D and H, as seen in Figure 3.7. 
This was not conveniently possible on the gels being used to visualise the success of the 
double digestions when product D, generated using the downstream primer 1396R, was 
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Figure 3.7 Agarose gel showing the RE digestion products of pCMV2JS21 and product D. 
DNA was double-digested with Hpal (UH") and Pacl (UP") . The fainter bands in the double-digested 
product D lane represent partial digestion products, and sequences cleaved off either end of 
product D. The band that was of the same size as the fragment dropped from the double digestion 
of the vector was gel excised, as was the vector backbone (upper band in the far right lane). 
The RE activity of SexAI is blocked by dcm methylation. Consequently, the use of SexAI 
required unmethylated pCMV2JS21 DNA. This was obtained by making E. coli K12 
GM2163 cells (New England Biolabs), a Dam- and Dcm - strain, competent by the calcium 
chloride method, and transforming them with pCMV2JS21• 
When attempts at ligating and cloning gel-excised fragments failed, using either 124F and 
1396R-generated product D digested on the 3' end by BpaI, or 124F and 1608R-generated 
product D digested on the 3' end by SexAI, a "dirty ligation" strategy was adopted. In 
place of excising the specific DNA bands of interest after RE digestion with P ael and 
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SexAI prior to ligation, the DNA of each of the double digestion products was precipitated 
with sodium acetate and ethanol and reconstituted in ddjH20. A large molar excess of the 
product D double digestion relative to the pCMV2JS21 double digestion was included in 
the subsequent ligation step. This approach had an obvious drawback in that it was 
expected to result in some degree of reconstitution of pCMV2JS21 , since the fragment 
dropped by Pac! and SexAI digestion of the plasmid would still be included in the ligation 
mix. Also, if the RE digestion of the plasmid had not gone to completion in the first place, 
there would still be intact pCMV2JS21 left. It was therefore anticipated that a large number 
of transformed colonies would need to be screened in order to identify those containing the 
substituted VR1. 
3.3.1.3 Screening of transformants 
Figure 3.8 First stage of screening VR1-substituted transformant colonies. Agarose gel 
showing the results of direct colony PCRs of E. coli colonies generated by transformation with the 
ligation products of double-digested pCMV2JS21 and product D. Endogenous VR1 is 12 bp longer 
than its exogenous counterpart, so the lanes with larger fragments (2, 3,4,5,7,9 and 10) 
represent putative VR1-substituted colonies. 
- 129 -
Screening of the putative VRI-substituted transformants was performed in two rounds of 
direct colony PCR. The first used the primer pair 568F and 688R that had been employed 
to amplify VRI to discern the 12 bp size difference between the endogenous and 
exogenous VRI (Fig. 3.8). Colonies containing the longer fragment were further screened 
with primers 124F and 1396R to eliminate truncated products that also arise from the 
substitution strategy employed (Fig. 3.4). Colony #1 was included in the experiment shown 
in Figure 3.9 as a control because it was expected to be JSRV21-derived, based on the 
results shown in Figure 3.8, and thus full-length. 
M VI -ve 1 2 3 4 5 7 9 
Figure 3.9 Second stage of screening VR1-substituted transformant colonies. DNA from 
colonies that yielded larger fragments in the first round of screening was used in a second round of 
direct colony PCR to identify colonies containing full-length inserts for the substituted fragment. 
Based on the previous round of screening, colony #1 was assumed to be of exogenous origin, and 
therefore full-length (since the fragment inserted into the vector backbone would not have been 
derived from the mixed template comprising products A, B and C). It was included as a positive 
size control in this experiment. Only colony #7 conformed to this size out of the colonies shown in 
this agarose gel. 
Colony #7 was the only one in Figure 3.9 that yielded a full-length product. This, together 
with colonies #13, #15 and #16 (which yielded the same results to this stage; data not 
shown) were expanded and their plasmid DNAs extracted by MiniPrep for the purpose of 
sequencing the entire region substituted during the ligation step, using primers 124F, 542F, 
976R and 1396R. 
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The sequenced regions of clones # 15 & # 16 were identical, containing the same two errors 
relative to the predicted sequence - one transition (A to 0) and one transversion (A to T). 
Clone #13 had four transitions (0 to A; C to T; T to C and A to 0). Clone #7 had only a 
single transition (A to 0; Fig. 3.l0), which was later corrected (see Section 3.3.1.4) . 
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Figure 3.10 Single point mutation in VR1-substituted clone #7. The transition mutation is 
indicated in the top panel by a light blue arrow. The wild-type equivalent is shown in the bottom 
panel. The sequences shown are reverse sequences, thus the transition that appears as T to C in 
this figure represents an A to G transition in the forward direction. 
VR2s derived from enJS56Al and JSRV21 differ in length by only three base pairs. This 
difference could not be resolved electrophoretic ally (data not shown), so a different 
screening strategy was employed. For the VR2 substitution, colonies were first screened 
for full-length inserts by direct colony PCR using primers 124F and 1396R, as in the 
second step of screening above. Correctly sized PCR products were then digested with RE 
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SmaI (Roche Applied Science) to distinguish the endogenous from the exogenous VR2, 
since JSRV21 VR2 contains a SmaI site, whereas enJS56A1 VR2 does not (Fig. 3.11). 
MVI 
2176 










1 2 6 8 9 10 
Figure 3.11 Second stage of screening VR2-substituted transformant colonies. The first 
stage of screening was conducted in the same manner as the second stage of screening VR 1-
substituted transformants. The peR products derived from amplification with primers124F and 
1396R were RE digested with Smal to distinguish endogenous from exogenous VR2. enJS56A1 
lacks a Smal recognition site, whereas JSRV21 VR2 contains one. This agarose gel identified 
colonies 1, 6, 8 and 9 as putatively containing the correct VR2 substitution. 
Plasmid DNA was prepared from colonies #1 , #6, #8 and #9 by MiniPrep, and the region 
of interest sequenced in clones #1 and #8 as for the VR1-substituted clones. Whereas clone 
#8 contained one transition and one transversion point mutation, the sequence of clone # 1 
matched that of a predicted VR2-substituted fragment in all positions, and no further 
screening was required. The first chimeric clone to have been successfully generated was 
therefore pJS21/56A 1 VR2. 
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3.3.1.4 Correcting the mutation in pJS21/56AIVRl 
In place of correcting the point mutation in the VRI-substituted clone #7, one could have 
continued to screen more transformed colonies. Since all 20 available colonies had already 
been screened, this could only have been done by repeating the steps employed in the 
generation of these clones. Regrettably, the box containing the concentrated stocks of the 
four PCR primers specific to the generation of the VRI substitution had been rendered 
untraceable pursuant to a laboratory freezer failure and the temporary relocation of the 
freezer's contents to other freezers. The aliquots of working dilutions of the primers would 
have sufficed to generate products A, Band C, but no subsequent screening of clones (as 
shown in Fig. 3.8) would have been possible. Before ordering more primers, the author 
decided to attempt a different approach to correct the point mutation. Since it was 
positioned downstream of the HpaI site, this RE could be used in combination with another 
RE that only cuts once in pCMV2JS2h downstream of the mutation, to yield a JSRV21 -
derived product without any mutations. XbaI, which had been used to digest sheep 
genomic DNA during the isolation of the integrated JSRV21 locus (Palmarini et al. , 1999a), 
was chosen as the second RE to use. Resulting from the CMV promoter insertion during 
the construction ofpCMV2JS21 , the 5' XbaI site was removed, leaving a single 3' XbaI 
site. 
XbaI is inhibited by dam methylation, so unmethylated clone #7 DNA was obtained by 
transformation of competent E. coli GM2163 cells. Double digestion with HpaI and XbaI 
produced two bands, the sizes of which approximated the predicted fragment sizes of 








Figure 3.12 Double digestion of VR1-substituted clone #7 and pCMV2JS21 (indicated as 
JS21 ) with Hpal and Xbal. The predicted sizes of cleavage products are indicated on the right, 
based on the sequence of pCMV2JS21 . 
The bands were initially gel-purified, and the larger (6681 bp) band derived from 
pCMV2JS21 was ligated to the smaller band (4856 bp, containing enJS56A1 VRl) derived 
from clone #7. This approach, once again, yielded no transformants, so the two restriction 
reactions were included in a ligation reaction, and this was used to transform competent E. 
coli JM105. Colonies were tested in duplicate with the exogenous VR1-specific primers 
632F and 613F, and 976R as a reverse primer. Those colonies that displayed an absence of 
exogenous VR1 putatively contained the enJS56A1-derived VR1, and were further 
screened with primers 124F and 1396R to confirm they contained full-length inserts. 
Of the colonies that were confirmed, to this stage, to contain the enJS56A1-derived VR1, 
four were expanded for MiniPrep plasmid isolation. The next step of screening entailed 
sequencing with primer 1396R only to identify those clones not containing the point 
mutation that this strategy had sought to eliminate. Clone #6 was the single one not to 
contain the mutation. The balance of the region substituted by restriction and ligation 
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during the construction of clone #7 was sequenced in clone #6 DNA using primers 124F, 
542F and 976R, and shown to be correct. The second chimeric clone to be obtained was 
therefore pJS21/56Al VRI. 
3.3.1.5 Construction of the double-substituted chimera 
Having made both pJS21/56Al VRI and pJS21/56Al VR2, either of them could have been 
used as a starting template to additionally substitute the other VR, i.e. enJS56Al VR2 
could have been introduced into pJS21/56AIVR1, or enJS56Al VR1 into pJS21/56A1 VR2. 
The loss, mentioned above, of the VRI substitution primers however, dictated that the 
former approach was pursued. The substitution of enJS56Al VR2 into pJS21/56A1 VRI 
utilised the same steps as the generation OfpJS21/56Al VR2. Briefly, product E' 
(equivalent of product E, last paragraph, Section 3.3 .1.1) was created using 
pJS21/56Al VRI as a PCR template. Products F and G did not need to be created again, and 
were mixed with product E' to generate product H'. This was digested with Pad and 
SexAI. The resulting RE digestion products were combined with Pad- and SexAI-digested 
pCMV2JS21 (still available from earlier experiments) in a ligation reaction. This was used 
to transform competent E. coli JMI05, and twelve colonies were screened for full-length 
inserts by direct colony PCR using primers 124F and 1396R. Of the twelve, nine yielded 
the correctly sized PCR products, which were digested with SmaI. Four of those were 
resistant to SmaI digestion, and the corresponding colonies were expanded for plasmid 
MiniPrep and DNA sequencing. Of the first two clones to be screened by sequencing, one 
contained only a silent mutation (i.e. no change in the predicted amino acid sequence), but 
it was decided to finish screening the other two available clones. One of them contained no 
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point mutations. The corresponding colony was expanded, and plasmid DNA prepared by 
MaxiPrep, to yield pJS21/56A 1 VRI VR2. All three VR-substituted clones had, at this stage, 
been generated. 
3.3.2 Particle formation assays 
The ability of the JSRV21-based chimeric constructs to produce retroviral particles was a 
requirement for the in vivo assays envisaged further down the line, even though such 
assays were beyond the scope of this particular study. Previous results generated in 
collaboration with our group (palmarini et al., 2000b) had localised the defect rendering 
pCMV2enJS56Al incapable of releasing particles into the culture supernatant of 
transiently transfected human 293T cells to the first two thirds of gag. In view of the 
presence of both VRI and VR2 in this part of the JSRV genome, it was expected that either 
of these variable regions, or their combined presence, would be responsible for the particle 
release defect in enJS56Al. The ability of the constructs pJS21/56AIVRl , 
pJS21156A 1 VR2 and pJS21156Al VRI VR2 to release particles into the supernatant of 
transiently transfected 293T cells was therefore assayed according to the method of in vitro 
production of JSRV21 particles devised by the CRIlUCI (palmarini et al., 1999a). 
The experiment was carried out in triplicate, using plasmid MaxiPrep DNA preparations 
from three different E. coli host strains for each of the constructs, including pCMV2JS21 as 
a positive control: GM2163 (New England Biolabs), JM105 (Amersham Pharmacia 
Biotech) and DH5a (Invitrogen). Surprisingly, all three chimeric constructs were able to 
release viral particles into the culture supernatants (Fig. 3.13), and the two constructs 
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Figure 3.13 Virus production by VR1 and VR2 chimeras. Human 293T cells were transiently 
transfected with pCMV2JS21 (lane 1), pJS21 /56A1VR1 (lane 2), pJS21 /56A1VR2 (lane 3) and 
pJS21 /56A 1 VR 1 VR2 (lane 4) derived from transformation of E. coli host strains GM2163 (top 
panel), JM105 (middle panel} and DH5a (bottom panel) . The asterisk in the middle panel indicates 
a mock transfection with pcDNA3.1 (-) vector. The 26 kDa JSRV CA antigen was detected using a 
rabbit polyclonal antibody in a Western blot. All four constructs released virus particles, with those 
two harbouring the enJS56A1-derived VR2 giving stronger signals. The difference of signal 
intensity between the three panels relates to the time of exposure of the film to the 
chemiluminescently labelled membrane. 
containing the enJS56A I-derived VR2 consistently gave stronger signals than those 
expressing the JSRV 21-derived VR2. Since the ability of all three chimeric constructs to 
form viral particles was an unexpected result, the initial experiment (palmarini et al., 
2000b) that had led to the anticipation that either VRI or VR2 (or their combined effect) 
was responsible for the inability ofpCMV2enJS56AI to support particle release had to be 
repeated. These results were confirmed by the author to have been correct (Fig. 3.14), in 
that pCMV2enJS56A 1 and pGePEx did not support particle formation, whereas the 
reciprocal construct of the latter, pGxPEe, did. 
The author was made aware of results presented at a conference by another group working 
on JSRV, which showed that co-transfection of293T cells with pCMV2JS21 and 
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Figure 3.14 Particle formation assays pertaining to various chimeras of pCMV2JS21 and 
enJS56A1. The previously published lack of particle release by construct pGePEx containing the 
first two thirds of enJS56A 1-derived gag was confirmed by Western blotting. 
encouraged to reproduce these results. In addition to that, the author considered it a 
reasonable assumption that the reported dominant-negative block of JSRV21 particle 
release would be encoded by the first two thirds of enJS56Al gag, since this region also 
prevents the release of enJS56Al particles. Furthermore, since the VRl- and VR2-
substituted chimeric clones all supported particle release, they could provide the tools to 
determine whether the dominant-negative block of particle release by enJS56Al acted 
specifically on pCMV2JS21 VRI or VR2. Finally, co-transfections were carried out using a 
3:1 ratio ofpCMV2JS21 to either pCMV2enJS56Al or pGePEx, to determine if the 
blocking effect was strictly stoichiometric (Fig. 3.15). 
The results of the co-transfection experiments showed that the dominant negative blocking 
effect of particle release was encoded by and confined to some element in the first two 
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Figure 3.15 Co-transfection experiments used to narrow down the dominant negative block 
exerted by enJS56A1 on pCMV2JS21 -encoded particle release. JS21 = pCMV2JS21 ; 56A1 = 
pCMV2enJS56A 1. All co-transfections of pCMV2JS21 - with constructs containing at least the first 
two thirds of enJS56A 1 gag led to a block of particle release, even when pCMV2JS21 - was used in 
three-fold molar excess. Particle release of the VR 1- and VR2- substituted clones was equally 
blocked. 
pCMV2enJS56Al was. The blocking effect could not be overcome by transfecting with a 
three-fold excess ofpCMV2JS21 relative to either pGePEx or pCMV2enJS56Al. Finally, 
pGePEx exerted the blocking effect on the three VR -substituted chimeras in the same 
manner as it did on pCMV2JS2h demonstrating that the presence of enJS56AI-derived 
VRI and/or VR2 did not confer any resistance to the blocking mechanism. 
3.3.3 Proof of particle production specificity 
The author maintained that the particles produced from transfection with the chimeric 
clones ought to be shown to be specifically derived from these constructs, to rule out, for 
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instance, the remote possibility that the 293T cells had inadvertently been transfected with 
pCMV2JS21. To this end, a method was devised to isolate the genomic RNA of the purified 
retroviral particles derived from each of the transfections with pCMV2JS21, 
pJS21/56A1 VR1 , pJS21/56A1 VR2 and pJS21 /56A1 VR1 VR2, since no standard protocol or 
kit was available for this particular application. A primer pair (JS21_ 481F and 
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Figure 3.16 Supernatants from transiently transfected 293T cells were tested for viral RNA 
by concentration and extraction and RT -peR for JSRV RNA. -, no template; +, 5 pg 
pCMV2JS21 DNA (558 bp); 1, pCMV2JS21 RNA (558 bp); 2, pJS21 /56A1VR1 RNA (570 bp); 3, 
pJS21 /56A1VR2 RNA (561 bp); 4, pJS21 /56A1VR1VR2 RNA (573 bp). The size differences of the 
RT-PCR products arise from the endogenous VR1 and VR2 being 12 and 3 bp longer, respectively, 
than their exogenous counterparts. 
PCR amplification of a part of the JSRV gag gene containing both VRI and VR2. The RT-
PCR products (Fig. 3.16) were sequenced, and each of them was found to correspond 
precisely to the constructs that had been used in the transfections. This constituted 
definitive proof of the particles ' specificity of origin. 
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3.3.4 Chimeric particles are infectious 
While the experiments so far showed and independently confirmed the production of virus 
particles by the chimeric constructs as measured by the release of processed CA antigen, 
they did not address whether the released virus particles were infectious. To test this, sheep 
choroid plexus cells were infected with concentrated supernatants from 293T cells 
transiently transfected with each of the constructs according to a method published by our 
collaborators at CRiIUCI (Palmarini et ai. , 1999b). Control infections were carried out 
with concentrated supernatants that had been incubated at 65°C for 10 min, thereby 







Figure 3.17 Infectivity assays to determine in vitro infectivity of VR1 and VR2 chimeric 
retroviral particles. Choroid plexus cell (CP) in vitro infectivity assays on supernatants from 
transiently transfected cells were carried out as described in Section 3.2.3.3. Infected CP cells 
were tested for the presence of JSRV DNA by JSRV speCific PCR followed by agarose gel 
electrophoresis. Left pane, CP cells at passage 2 post-infection. Right pane, CP cells at passage 5 
post-infection. M, 100 bp ladder (Invitrogen); +, 500 ng JS7 DNA; genomic DNA from CP cells 
infected with particles derived from 1, pCMV2JS21 ; 2, pJS21/56A1VR1; 3, pJS21/56A1VR2; 4, 
pJS21/56A1VR1VR2; H = heat-inactivated control; -, no template. All constructs produced 
infectious virus. 
carry-over. Genomic DNA was extracted at various passages post-infection. Using an 
exogenous-specific JSRV U3 PCR (palmarini et ai. , 1996b), it was found that all the 
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particles were infectious as measured by the presence of exogenous viral DNA. DNA from 
the JS7lung tumour cell line (Bai et ai., 1996; DeMartini et ai., 2001), which contains one 
copy of exogenous JSRV -JS 7 per genome, was used as a positive peR control. As of the 
fifth passage post-infection, carry-over plasmid DNA was no longer detectable (Fig. 3.17). 
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3.4 DISCUSSION 
3.4.1 Substitution of VRI and VR2 
3.4.1.1 Creation ofVR1 and VR2 substitution chimeras 
A conventional RE-based substitution approach was initially recommended to create the 
VRl- and VR2-substituted chimeras, but the author remained adamant that this would 
introduce enJS56A1 gag point mutations outside of the exact delineation of the variable 
regions into the chimeras, thereby confounding findings further down the line. Owing to 
the conceptual complexity of the substitution strategy as it was originally envisaged (Fig. 
3.1), its proposed implementation was received with some reservation on the part of the 
author's peers. The revised strategy admittedly challenged the limits ofPCR versatility in 
that the reaction was expected to create a template from three semi-overlapping PCR 
products (a function for which PCR is not intended), and amplify this template. This added 
further to concerns that the approach might not be successful. It was not based on any 
previously proven methodology that the author or his peers were aware of, but since no 
other alternative for the precise substitution ofVR1 and VR2 had been proposed, it was 
attempted. 
The amplification of products A, Band C comprised standard PCRs, and did not 
necessitate optimisation. The generation of product D, using products A, B and C as a 
template mixture, was successful on the first attempt, thereby indicating that the steps 
comprising the substitution strategy to this point were feasible and translated functionally 
from theory to practice. The most persistent problems were encountered at the steps where 
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they were least expected, viz. at the stage ofligating the Pad and HpaI (later, Pad and 
SexAI) double-digested product D into the similarly double-digested backbone of 
pCMV2JS21. Numerous product specialists from different suppliers were consulted on this 
matter, which led to the attempted use of three different agarose gel extraction kits, 
different ligase enzymes, and various permutations of reaction conditions. None ofthese 
were successful in generating even a single transformant that could be confirmed to 
contain an insert of the correct size. 
The "dirty ligation" approach (see 3.3.1.2), which omitted the gel-purification step after 
double RE digestion of the vector backbone and the PCR product, was successful on the 
first attempt, as far as the ligation step was concerned. However, this approach necessitated 
the design and inclusion of several screening steps that would not have been required if the 
ligation reaction had comprised only double-digested product D and vector backbone. 
Nonetheless, the methodology produced the desired clones, which were further verified by 
DNA sequencing. 
3.4.1.2 Broader applications of substitution strategy 
Once the problematic aspects had been eliminated from the VRI substitution strategy, it 
was relatively simple to re-implement it for the substitution ofVR2, and for the 
introduction of enJS56Al VR2 into pJS21 /56Al VRI. The context wherein the strategy was 
applied relied on the high degree of homology between endogenous and exogenous JSRVs 
outside of the variable regions that were discovered and defmed earlier in this study. 
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Figure 3.18 Schematic outlining the application of the substitution strategy developed in 
this study, adapted to substitute target regions between non-homologous sequences. The 
region of interest is amplified from clone A, using A-based primers with tails homologous to the 
sequences flanking the region to be replaced in clone B, creating product iii. PCR products i and ii 
also flank the region to be replaced in clone B. Mixing products i, ii and iii in a PCR in the presence 
of the outer clone B-based primers yields a chimeric product iv. Clone B and product iv can be 
double-digested with relevant REs, and the restriction products of each ligated to reconstitute clone 
B, containing the region of interest derived from clone A. 
However, the methodology developed here could be applied just as easily to completely 
unrelated sequences, with suitably designed peR primers containing "tails", in much the 
same way that traditional overlap extension peR is amenable to versatile adaptation 
[reviewed by Pogulis et al. (1996) and Aiyar et al. (1996)]. This is demonstrated in Figure 
3.18. Note that the size of the substituted regions does not have to be similar; the only 
requirement is that the tails of the primers used to amplify the region of interest are 
homologous to the sequences flanking the region to be replaced. This methodology could 
be applied to introduce PeR-amplifiable genes or genetic elements into any cloned 
construct. 
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3.4.1.3 Particle fonnation from chimeric constructs 
The particle release defect of enJS56A I had previously been localised to the first two 
thirds of gag (Palmarini et at., 2000b), where the major differences between endogenous 
and exogenous JSRV sequences are constituted by VRI and VR2. It was anticipated that 
the substitution of the variable regions in gag would render one or more of the resulting 
constructs incapable of releasing viral particles into the supernatant of trans fee ted 293T 
cells. Upon finding, and independently verifying, that all three chimeric constructs 
supported particle release, it was concluded that, while the detenninants of the particle 
release defect in enJS56A 1 are located in the first two thirds of gag, at least some of them 
(though more likely all) lie outside ofVRI and VR2, despite the high degree of homology 
between endogenous and exogenous JSRV isolates in these regions. 
The two constructs containing the enJS56A I-derived VR2 consistently released more 
particles into the supernatant of the transfected cells, as measured by Western blot 
targeting the p26 CA antigen, than did those expressing the JSRV21 -derived VR2 (Fig 
3.13). This interesting observation could not be followed up on by the author, both for lack 
of financial resources and the limited time period spent at the CRIlUCI. However, given 
the location ofVR2 inside the coding region of gag (as opposed to upstream of gag), it is 
not likely that the increase in particle release results from an increase in either transcription 
or translation. Rather, enJS56AI VR2-containing particles might be assembled or 
transported to the cell surface more efficiently, or have an advantage in tenns of budding 
compared to particles containing JSRV21-derived VR2. 
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The unexpected finding that all the VR 1- and VR2-substituted chimeras supported particle 
release into the culture supernatant of transiently transfected 293T cells was presented at 
one of the Cold Spring Harbor Laboratories' "Retroviruses" meetings, where it stood in 
contradiction of the results presented by another group. Although the investigators had not 
focussed on VR2, they had substituted enJS56A1-derived VR1 into the backbone of 
pCMV2JS21, and reported that this construct did not support particle release upon transient 
transfection of 293T cells. They concluded that VR1 was responsible for the particle 
other GTG GAA ACT TTA TCC TTT TGG ACA TTA ATT CGT GAT TGC CTG GAC 270 
V E T L S F W T L I R 0 C L 0 90 
56A1VR1 GTG GAA ACT TTA TCC TTT TGG ACA TTA ATT CGT GAT TGC TTG GAT 2 70 
V E T L S F W T L I R 0 C L 0 90 
other TTT GAT AAT GAT GAA TTA AAA TGT TTA GGA AAT GTA TTA AAA CAG 315 
F 0 N 0 E L K C L G N V L K Q 105 
56A1VR1 TTT GAT AAT GAT GAA TTG AAA CGT TTA GGA AAT TTA TTA AAG CAG 315 
F 0 N 0 E L K R L G N L L K Q 105 
other GAA GAA GAT CCT CTC CAT GTT CCT GAT TCG GAA CCC AGA TAT GCT 360 
E E 0 P L H V P 0 S E PRY A 120 
56A1VR1 GAA GAA GAT CCT CTT CAT GTT CCT GAT TCG GAA CCC AGA TAT GCT 360 
E E 0 P L H V P 0 S E PRY A 120 
VR1 
Figure 3.19 Alignment of nucleotide and amino acid sequences of two VR1-substituted 
constructs in the part of gag upstream of VR1 . 56A1VR1 denotes the construct pJS21 /56A1VR1 
made in this study. The other sequence was theoretically derived from the mention of unpublished 
results in a review (Palmarini et al., 2004), wherein the substitution ofVR1 was from amino acid 
position 89 to 142 in Gag. enJS56A1-derived sequences are in blue. The seven single nucleotide 
differences between the two constructs are underlined , and the two resulting amino acid 
differences are indicated in bold as well. The beginning of VR1 is shown. 
release defect of enJS56AI and probably of enJSRVs in general, since the endogenous 
form ofVRI was strongly conserved amongst the known enJSRVs. In view of the particle 
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formation results shown in this thesis (and at the conference), and their independent 
verification by means of sequencing the VRl- and VR2-containing region of the packaged 
retroviral RNA, these conclusions were clearly inaccurate. The author attributed the 
discrepancy of results to the possible use of a different and less precise substitution 
strategy employed by the other group, but the investigators were not prepared to divulge 
experimental details of how they had substituted VR 1. This was unfortunate, since a 
comparison of their construct with pJS21 /56AIVRl would have revealed subtle 
differences, and those differences could have been implicated in the particle release defect. 
In a subsequent review, Palmarini et al. (2004) mention unpublished studies in which they 
also substituted the enJS56Al-derived VRI region (amino acids 89-142 of Gag) into the 
same infectious molecular JSRV clone used in this study, viz. JSRV21 • This chimera did 
not support particle release into the transfection supernatant. In contrast, the precise VRI 
substitution (amino acids 112-132) in pJS21/56Al VRI produced virus particles as shown. 
Alignment of the deduced amino acid sequences of the two chimeras (Fig. 3.19) indicates 
that the 89-142 chimera would differ from the 112-132 chimera by only two additional 
enJS56Al-derived amino acids at positions 98 (Cys/Arg) and 102 (VallLeu). These are 
highlighted in Figure 3.19. This suggested that either Cys98 or Vall 02 (or both in 
combination) are involved in the particle release defect of enJS56A 1, potentially along 
with VRI sequences. It was noteworthy, however, that all other known enJSRV Gag 
sequences resemble the exogenous isolates in these positions, i. e. they have Arg98 and 
Leu102. If the Cys98 and/or Vall 02 were indeed involved in the enJS56AI particle release 
defect, this implied that the defect is not a general one for enJSRV s. These conclusions 
were published along with the substitution strategy and the particle formation results 
(Hallwirth et al., 2005). After this work was accepted for pUblication, Mura et al. (2004) 
- 148 -
reported that the combined mutation of R98C and L 1 02V indeed led to loss of particle 
production for wild-type JSRV, and that the other endogenous Gag proteins do not show 
the particle production defect of enJS56A 1, thereby providing experimental evidence to 
support the above conclusions and strongly suggesting VRI 's lack of specific involvement 
in the particle release defect. 
3.4.1.4 Investigation of the enJS56Al dominant negative block of particle release 
This study extended the findings reported at a conference, which showed that enJS56Al 
inhibits the release of exogenous JSRV particles, by narrowing the region responsible 
down to the first two thirds of enJS56Al gag. Furthermore, it was demonstrated that the 
addition of a three-fold excess of pCMV2JS21 relative to a chimeric construct containing 
the first two thirds of enJS56Al gag did not rescue the ability of the exogenous construct 
to release particles. The first two thirds of enJS56Al gag also inhibited particle release by 
the chimeric constructs containing the enJS56Al-derived VRI and/or VR2. 
A possible explanation was put forward by the author (Hall wirth et al., 2005): The 
enJS56Al Gag protein might have a defective interaction with a component of the cell 
sorting machinery that is responsible for transport and budding of retroviral proteins 
(Bouamr et al., 2003; von Schwedler et al., 2003). If, therefore, enJS56Al Gag protein 
were trapped in an intracellular compartment and unable to undergo normal transport to the 
cell surface, then it would likely inhibit wild-type exogenous JSRV particle release if they 
are both expressed in the same cell, through Gag-Gag protein interactions. These Gag-Gag 
interactions typically are in the nucleocapsid portion of Gag (Swanstrom and Wills, 1997), 
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which is highly conserved between endogenous and exogenous JSRVs. As a result, it was 
not surprising that enJS56Al Gag also inhibited the release of the VRI and VR2 chimeras. 
This hypothesis has very recently been experimentally addressed by another group of 
investigators and found to be accurate (Murcia et ai., 2007). They determined that the 
entire enJS56Al Gag is required to prevent exogenous JSRV particle release and that 
JSRV Gag normally accumulates pericentrosomally. They observed co-localisation of 
enJS56A 1 and exogenous JSRV Gag and conclude that the blocking effect exerted by 
enJS56Al Gag on JSRV is based on Gag-Gag interactions that result in abnormal cellular 
localisation of the latter. 
3.4.1.5 VRl- and VR2-substituted chimeric particles are infectious 
The primary goal of this aspect of the study was to create relevant molecular tools that 
could be used to elucidate the biological significance ofVRl and VR2. These tools 
constituted the VRl- and VR2-substituted chimeric constructs that have been described. In 
order to be used for in vivo studies, these chimeric constructs (or at least one of the three) 
was required to form intact retroviral particles. This turned out to be the case for all three 
of them. However, the final requirement for these particles was that they needed to be able 
to infect host cells, meaning they had to be able to interact with the relevant cell surface 
receptor(s) to enter the cells, reverse transcribe their genomic RNA and integrate that into 
the DNA of the host. This was assayed in vitro by infection of sheep choroid plexus cells, 
and the particles were found to be infectious, since their integrated DNA could be detected 
in the genomic DNA of the infected host cells several passages post-infection. Appropriate 
controls had been included in the design of the experiment to exclude the possibility that 
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the results were an artefact of plasmid carry-over. The chimeric particles are therefore 
suitable for in vivo infection studies, and since all three constructs gave rise to infectious 
particles, the effects and significance of both VRI and VR2, as well as any possible 
combined effects of the two, can be tested. 
3.4.2 Critical appraisal of JSRV Env in vitro transformation studies 
The subject of JSRV transformation will be elaborated upon in detail, owing not only to its 
important contribution to cancer research, but also to the fact that our collaborators' 
pioneering research of JSRV transformation followed directly from our group' s discovery 
of the JSRV variable region 3. For this reason, our group has always followed these 
developments very closely, the author having even been present at the CRIlUCI in 2000 
when the first in vitro JSRV transformation assays were carried out. He was also there 
again in 2003, and party to all the work performed there that was subsequently published. 
We have also maintained close ties with other groups working on various aspects of JSRV 
transformation, to the degree where many results were made available to us at the pre-
publication stage. Most importantly, detailed insight into the current understanding of 
JSRV transformation was required ofthe author to maintain a scope of his work in the 
context of the direction in which the field of JSRV research is moving. 
The future continuation of the author' s work described thus far is intricately linked with 
the developments pertaining to JSRV oncogenesis research in vivo. The study that 
comprises the author' s work was designed not just as a terminal project for the sake of 
generating relevant and publishable data that can form the experimental core of a thesis. It 
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was designed in a broader context, to be continued (either by the author at postdoctoral 
level, or by other researchers) and to provide the tools, knowledge and insight required for 
this continuation. The broader project aims were to render it directly compatible with in 
vivo pathogenesis studies, once the tools for this had been developed. Since the 
pathogenesis of jaagsiekte manifests as a neoplasm, the author was required to keep abreast 
of the developments pertaining to JSRV transformation. This task thus constituted an 
integral theoretical (as opposed to laboratory-based) aspect of his research, on which he 
was required to deliver regular presentations to his peers, as developments in JSRV 
transformation research took place. In this chapter, the recent progress that has been made 
in elucidating the putative steps involved in JSRV transformation will be critically 
appraised in chronological order, covering the time span during which the author's 
practical work was ongoing. Not all JSRV Env transformation work involves VR3 directly, 
but those studies that do cannot be described in isolation while still providing a coherent 
overall context of the research. Some of the most recent developments pertaining to JSRV 
transformation will be discussed separately from the critical appraisal of the initial ground-
breaking in vitro transformation work, since the author was no longer involved in this 
latest work in the way he had been during the initial studies. 
3.4.2.1 JSRV Env can transform immortalised rodent fibroblasts 
As described in Chapter 1, conclusive evidence of JSRV being the sole agent of 
transformation in OP A was first published by the CRIlUCI, in collaboration with two other 
international laboratories (palmarini et ai., 1999a). However, this study could not yet 
address by what possible mechanism(s) JSRV might lead to cellular transformation. In 
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2000, the CRIlUCI was the flrst group to embark on in vitro transformation studies using 
JSRV expression constructs, and their landmark results were published the next year 
(Maeda et al. , 2001). In this study, Maeda et al. transfected mouse NIH 3T3 cells with 
plasmid constructs pJSRV21 and pCMV2JS21 (palmarini et al. , 1999a). The pcDNA3.1(-) 
vector was used as a negative control because it contains the same CMV immediate early 
promoter as pCMV2JS21 , but lacks JSRV sequences. Transfected cells were maintained in 
culture for four to flve weeks. Two weeks after transfection with pCMV2JS21, foci of 
transformed cells became visible. The transformed cells were recognised by their fusiform 
shape and loss of contact inhibition, causing cells to pile on top of each other. Foci were 
counted 28 days after transfection, and it was noted that the transformation efflciency of 
pJSRV21 was much lower than that of pCMV2JS21 , owing to the fact that the JSRV LTR is 
a poor promoter / enhancer in NIH 3T3 cells. Transformed cells were also shown to exhibit 
anchorage independence. Furthermore, these results were confirmed by transforming Rat6 
cells in culture, though at much lower efflciency than NIH 3T3 cells. 
Maeda et al. (2001) established transformed cells lines, from which they were able to 
isolate JSRV plasmid DNA, as well as JSRV RNA. Together, the above results indicated 
that some partes) of the JSRV genome is (are) able to transform NIH 3T3 cells in culture. 
To address which gene(s) might be involved, two stop codons were introduced into the orf-
x gene without affecting the overlapping pol amino acid sequence. The resulting construct, 
pCMV2JS21~Orf-X, transformed NIH 3T3 cells with the same efficiency as pCMV2JS21 , 
from which the investigators concluded that the orf-x gene product is not directly involved 
in cell transformation. They proceeded to make expression constructs for each of the 
coding genes of JSRV and tested them for their ability to transform NIH 3T3 cells (R. Fan, 
personal communication). Only the Env-expressing construct transformed cells. In Maeda 
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et al. (2001), this construct is called pCMV3JS2Jl~GP, because it is lacking gag and ]201, 
and it is shown to induce cellular transfonnation at efficiency comparable to a plasmid 
expressing the activated c-ras proto-oncogene from human T24 bladder carcinoma cells 
driven by a murine leukaemia virus L TR. 
The investigators further point out that the transfonnation efficiency of pCMV3JS21~GP 
(i.e. Env expressed by itself) is higher than that of the full-length clone pCMV2JS21. This 
is true when looking at their table of results, in that the fonner induced an average of 20 
and the latter an average of 16.3 foci under the same experimental conditions. However, 
what the investigators appear to have disregarded is the fact that they used the same 
amount of DNA (28 /lg) in every transfection, but that the ~GP plasmid is only 
approximately half the size of the full-length construct. This means that the transfection 
dose of 28 /lg of the ~GP construct contains double the number of plasmid copies, and 
would thus be expected to produce about twice the number of foci , which is certainly not 
the case. One could consider this to indicate that some genetic elements missing from the 
~GP construct, but contained in the full-length pCMV2JS21 construct, significantly 
enhance the transfonning activity of the JSRV env gene product. 
Using northern blotting, Maeda et al. (2001) found that two fonns of JSRV env are 
expressed in transfected (as well as transfonned) cells, viz. a full-length 2.5 kb transcript, 
as well as a prematurely polyadenylated, and therefore truncated, 1.2 kb transcript referred 
to as tr-env. When expressed by itself, tr-env (which essentially encodes only the SU 
protein and is missing TM, including VR3) was incapable oftransfonning NIH 3T3 cells. 
Since rodent cells lack a functional JSRV receptor (Rai et al. , 2000), the observed 
transfonnation associated with full-length Env could not have been as a result of cell-to-
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cell spread of infectious virus, so the investigators concluded that JSRV Env, either by 
itself or in combination with the tr-env product, is able to transform NIH 3T3 cells. This 
constituted the only other report in addition to a group working with vascular endothelial 
tumours and avian haemangioma virus (AHan et ai., 2000), that a normally functional 
retroviral structural protein could have direct oncogenic potential. 
3.4.2.2 Hyal2 is the cellular receptor for JSRV 
Appearing at the same time as the study of Maeda et al. (2001) was a report that identified 
the product of a candidate lung and breast cancer tumour suppressor gene, human Hyal2, 
as the cellular receptor of JSRV in cell culture (Rai et ai. , 2001). Other animals, including 
sheep, have closely related orthologues of human Hyal2. It was shown that Hyal2 is a 
glycosylphosphatidyl-inositol (GPI)-anchored cell-surface protein. Since some other GPI-
anchored proteins mediate mitogenic responses, the investigators speculated that an 
interaction of JSRV Env with Hyal2 might be involved in JSRV transformation. They also 
used an existing JSRV Env expression construct, called pSX2.Jenv (Rai et ai., 2000), to 
successfully transform 208F rat embryo fibroblasts in vitro, thereby confirming the results 
of Maeda et al. (2001). This construct is driven by a murine leukaemia virus (ML V) L TR, 
with the env gene being derived from the infectious molecular clone JSRVJS7 (DeMartini et 
ai., 2001). Even though Rai et al. (2001) showed that the rodent orthologues ofHyal2 do 
not efficiently mediate JSRV entry, they point out that this does not preclude the 
possibility of some other productive interaction between the Hyal2 orthologue in rodent 
fibroblasts used in the transformation assays, and the JSRV Env protein. 
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Taken together, the results of Maeda et al. (2001) and Rai et al. (2001) prompted the 
suggestion of two possible models of transformation involving Hyal2 and JSRV Env 
(Maeda et al., 2001; Rosenberg, 2001). The first was that the binding of En v to the putative 
tumour suppressor Hyal2 would interfere with its normal negative growth regulatory 
activity. Secondly, binding of En v to Hyal2 could result in positive growth stimuli. 
Another possibility was that JSRV Env interacts with another intracellular or surface cell 
protein to induce transformation. 
3.4.2.3 A PI3K binding motif in the cytoplasmic tail of JSRV Env seems essential 
for transformation 
The finding of Maeda et al. (2001) that JSRV Env can transform NIH 3T3 cells were 
elaborated upon by the same group of investigators via the construction of various 
envelope chimeras, using sequences derived from JSRV21 and enJSRV loci enJS56A1 and 
enJS5F16 (Palmarini et al. , 2001b). Their construct pSUxTMen (Fig. 3.20), consisting of 
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Figure 3.20 Schematic representation of chimeric constructs using JSRV
21 
and endogenous 
JSRV sequences. Adapted from Palmarini et al. (2001b). 
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the exogenous surface and endogenous transmembrane domain, was unable to transform 
NIH 3T3 cells, indicating that parts of TM are needed for transformation. Progressively 
smaller substitutions indicated a need for VR3, and within VR3, for the carboxy-terminal 
36 amino acids downstream of an NruI site in VR3, the corresponding construct being 
r---- ER SRP ----
10 20 30 40 50 60 70 
JSRV21 MPKRRAGFRKGWYARQRNSLTHQMQRMTLSEPTSELPTQRQIEALMRYAWNEAHVQPPVTPTNILIMLLLLLQRV 75 
ENTV ... H . ... . . . . . . .. ..... Y ... . .. . N.T.NG ...... V . . . . . H .......... A .. IK . . . .. . . .... I 75 
JSRV21 
ENTV 
80 90 100 110 120 130 140 150 
QNGAAAAFWAYIPDPPMIQSLGWDREIVPVYVNDTSLLGGKSDIHISPQQANISFYGLTTQYPMCFSYQSQHPHC 
160 170 180 190 200 210 220 
150 
150 
JSRV21 IQVSADISYPRVTISGIDEKTGKKSYGNGSGPLDIPFCDKHLSIGIGIDTPWTLCRARVASVYNINNANATFLWD 225 
ENTV .. ... . . . .. . . . .......... R .. R .. T . .. . .... . . N . . . S ... .. ..... .. . I . .. .. .. . .. T.L ... 225 
r putative PRR 1 
230 240 250 260 270 280 290 300 
JSRV21 WAPGGTPDFPEYRGQHPPIFSVNTAPIYQTELWKLLAAFGHGNSLYLQPNISGSKYGDVGVTGFLYPRACVPYPF 300 
ENTV . . .. . ... . . .. . ... ... L ....... F ... . .... ... . . . . . .... ......... . .. .. . .. . . ....... . 300 
310 320 330 340 350 360 370 
JSRV21 : MLIQGHMEITLSLNIYHLNCSNCILTNCIRGVAKGEQVIIVKQPAFVMLPVEIAEAWYDETALELLQRINTALSR 
ENTV . ...... .. . . ....... . .. . ... . . .. . . . . ..... . ..... . ...... . . T.E ....... . ...... . . . . . 
s urface ., ~ transmembrane (TM) 
(SU ) 380 390 400 410 420 430 440 450 
JSRV21 PKRGLSLIILGIVSLITLIATAVTASVSLAQSIQAAHTVDSLSYNVTKVMGTQEDIDKKIEDRLSALYDVVRVLG 
EN TV 





JSRV21 EQVQSINFRMKIQCHANYKWICVTKKPYNTSDFPWDKVKKHLQGIWFNTNLSLDLLQLHNEILDIENSPKATLNI 525 
EN TV . .. . ...... .. ........ . ... ... ... . . Y . .. . . E ......... .. V . . . ... ...... . .......... . 525 
"-1 --- MSD - - ---.,1 ~ CT 
530 540 550 560 570 580 590 
JSRV21 ADTVDNFLQNLFSNFPS LHSLWKTL IGVGILVFII IVVILI 
EN TV . ... N . ... .. ... ... .. . .. QS1. VIA.!. . . V . .... LV . . . T .. LIK ... Q . . 1. L1. . . 
600 
600 
. .Y.K .. 600 
1 VR3 _____ _ 
610 
JSRV21 ELLKNKERGDAGDDP-- 615 
EN TV DFV . KR.GSCG.QPAEG 617 
1 
Figure 3.21 Amino acid alignment of the JSRV21 and ENTV envelope protein sequences. 
Annotations (Chow et al., 2003; Dirks et al., 2002; Hofacre & Fan, 2004; York et al., 1992) indicate 
the positions of regions within Env. Env is primarily divided into the surface (SU) and 
transmembrane (TM) proteins. The 5' endpoint of the endoplasmic reticulum signal recognition 
peptide (ER SRP) has not been assigned with certainty. PRR, proline rich region ; MSD, membrane 
spanning domain; CT, cytoplasmic tail; VR3, variable region 3. A putative PI3K binding domain, 
YXXM, is highlighted. 
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named pSUxTMxNruIen (Fig. 3.20). It was noted that the reciprocal chimera pSUenTMx 
also did not transform NIH 3T3 cells, possibly indicating a further transformation 
requirement within SU. The other postulated explanation for this observation was that all 
the chimeras containing endogenous SU sequences are expressed at far lower levels than 
those containing exogenous SU sequences. This work was referred to in Palmarini et al. 
(2001 b), and separately published later (palmarini et al. , 2002). 
Having narrowed the critical determinants oftransformation in NIH 3T3 cells down to the 
carboxy-terminal 36 amino acids of the exogenous VR3 (essentially the membrane-
spanning domain and cytoplasmic tail of the transmembrane protein; Fig. 3.21), Palmarini 
et al. (2001b) compared all known JSRV sequences (both endogenous and exogenous) 
corresponding to this region. They found that all exogenous JSRV s (including ENTV) 
contain a YXXM motif, starting at position 590 in JSRV21, that is missing from enJSRVs 















550 560 570 580 590 600 610 
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Figure 3.22 Amino acid alignment of JSRV VR3, highlighting the y590_X_X_M593 motif in 
JSRV2h as well as its corresponding residues in other JSRV and JSRV-reJated sequences. 
position. The investigators do not mention that JSRV sequences of African origin (JSRV-
SA and 92K3) and ENTV lack this motif (Fig. 3.22). YXXM is a potential binding site for 
the regulatory alpha subunit (P85) of phosphatidylinositol 3-kinase (PI3K), while YXN 
motifs bind the growth factor receptor binding protein 2 (Grb-2). Since both these proteins 
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can be involved in cellular transformation processes, Palmarini et al. (2001 b) mutated both 
the motifs to determine if such mutations would abolish transformation. Mutation of y590 
did (whereas mutation of other tyrosine residues in VR3 either had no effect, or just 
reduced transformation efficiency), as did mutation ofM593. Mutation ofN592 did not; in 
fact, when this residue was mutated to threonine, transformation was markedly enhanced. 
(Once again, the investigators did not point out that exogenous JSRV sequences of African 
origin naturally have threonine in position 592 - see Figure 3.22.) 
Palmarini et al. (2001 b) concluded that PI3K binding to YXXM is essential for 
transformation of NIH 3T3 cells, whereas Grb-2 binding and subsequent signalling through 
the RaslRaf/mitogen-activated protein kinase (MAPK) pathway, is not. They did not, 
however, exclude the possibility of the MAPK pathway being activated differently as part 
of JSRV transformation. To further support the involvement ofPI3K in JSRV 
transformation, Palmarini et al. (2001 b) showed that transformed NIH 3T3 cells contain 
phosphorylated Akt, a protein kinase that is activated via another intermediate by PI3K, 
whereas parental NIH 3T3 cells contained only the non-activated I non-phosphorylated 
form of Akt. They also call attention to the fact that the activation of the PI3K1 Akt 
pathway might only be one of several steps required for transformation in vivo. 
3.4.2.4 ENTV Env has the same transforming potential as JSRV Env 
Not surprisingly, ENTV Env was shown to transform NIH 3T3 cells as well (Dirks et al. , 
2002); in fact, it does so at the same efficiency as JSRV Env. Dirks et al. (2002) further 
report that JSRV and ENTV both use ovine Hya12 as receptor, and argue against a 
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receptor-mediated transformation mechanism in JSRV and ENTV on the basis that Hyal2 
is ubiquitously expressed in many tissues, and that JSRV even integrates into several 
different cell types (Holland et ai., 1999; Palmarini et ai., 1996b; Palmarini et ai. , 1999b). 
Yet, it is only oncogenic in the epithelial cells ofthe lower airways. Dirks et ai. (2002) 
speculate that the differences in U3 between JSRV and ENTV lead to different tissue-
specific expression patterns, and that JSRV and ENTV Env-mediated transformation is 
dependent upon active expression, rather than the binding of Env to the JSRV / ENTV 
receptor. 
The results of Dirks et ai. (2002) and Palmarini et ai. (2001b) were extended by a report 
that ENTV Env can transform rat 208F cells (in addition to mouse Nlli 3T3 cells); that the 
tyrosine residue in the YXXM motif of ENTV Env (equivalent to JSRV Env y590) is 
equally indispensable to transformation; and that ENTV Env-transformed rodent (NIH 3T3 
and rat 208F) cells are characterised by phosphorylated Akt (Alberti et ai., 2002). The 
latter observation addressed the concern that Akt activation might be specific either to 
JSRV transformation, or to transformation of NIH 3T3 cells only. 
Whereas previous studies had not determined if Akt phosphorylation was indeed PBK-
dependent, Alberti et al. (2002) demonstrate a dose-dependent inhibition of Akt 
phosphorylation by a PBK-specific inhibitor (L Y294002). The investigators also 
established NIH 3T3 cell lines constitutively expressing either JSRV Env, or JSRV Env 
. h y590 WIt mutated, and found the former to be characterised by phosphorylated Akt 
whereas the latter contained only unphosphorylated Akt, thereby further linking JSRV Env 
y590 to rodent cell transformation and PBKI Akt phosphorylation in vitro. Furthermore, 
they detected phosphorylated Akt in the JS-8 cell line, which is derived from the tumour of 
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a sheep with naturally occurring OP A; even this phosphorylation could be inhibited by 
L Y294002. One matter that the investigators did not address (and it becomes a point of 
note at a later stage) is that rat 208F cells transfected with an ENTV Env y590 mutant 
exhibit a very limited degree of transformation - approximately 1 % compared with wild-
type ENTV Env. Although 1 % efficiency of transformation might be considered negligible 
in certain contexts, it certainly is not when viewed in light ofthe suggestion that JSRV 
might be suitable as a gene transfer vector for differentiated epithelial cells of the lung and 
that the mutation of En v y590 would uncouple its unwanted transforming potential from its 
ability to mediate viral entry (Palmarini et ai., 200 1 b). Even a 99% reduction of 
transforming potential would still render Env y590-mutated JSRV an unsuitable, high-risk 
gene transfer vector. 
3.4.2.5 JSRV Env can transform immortalised chicken fibroblasts 
JSRV Env can also transform the DF-l immortalised chicken fibroblast cell line (Allen et 
ai., 2002). Here, the investigators used avian sarcoma-leukaemia virus (ASL V)-derived 
vectors to express different genomic components of JSRVJS7 upon transfection ofDF-l 
cells. They found that neither the orf-x gene product nor SU by itself could transform DF-l 
cells, whereas Env did. Supernatants of cells transfected with the JSRV Env-expressing 
vector were also used to infect DF-l cells, with the same results. Furthermore, transfected 
cells were inoculated subcutaneously into nude mice, which led to tumour formation. 
Deletion of the 33 carboxy-terminal amino acids of En v abolished transformation ofDF-l 
cells (Allen et ai., 2002), which indicated that this region either contains elements required 
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for transfonnation, or that it is merely needed for the functionally correct confonnation of 
Env. Expression of this truncated fonn of En v was not inhibited relative to full-length Env, 
eliminating this as a possible explanation. The carboxy-tenninal 33 amino acids of JSRVJS7 
contain the YXXM motif that was shown to be essential for transfonnation of rodent 
fibroblasts by both JSRV and ENTV Env (Alberti et ai., 2002; Palmarini et ai., 2001b). 
Allen et ai. (2002) mutated both the tyrosine and methionine residues in their Env 
expression construct and found, surprisingly, that neither of these mutations significantly 
reduced the transfonnation efficiency compared to the wild-type Env. The investigators 
discuss this apparent contradiction with the results of the previously published reports by 
suggesting that PI3K might be activated in both rodent and avian cells transfonned by 
JSRV Env, but that PI3K does not interact directly with the Env protein. It is worth noting, 
even if the possible significance of these comparisons cannot be evaluated here, that Allen 
et ai. (2002) used JSRVJs7 in avian DF-l cells, and that they mutated the tyrosine residue 
of YXXM to either alanine or serine and the methionine to either valine or leucine. 
Palmarini et ai. (2001 b) and Alberti et ai. (2002) collectively used JSRV 21 and ENTV in 
rodent fibroblasts, and they mutated the tyrosine of YXXM to aspartic acid or 
phenylalanine and the methionine to threonine. The use of JSRV21 vs. JSRVJS7 per se is not 
likely to explain any differences between studies relating to JSRV Env transfonnation, as 
the amino acids sequences of these two isolates are identical. 
3.4.2.6 Role ofHyal2 in JSRV Env transfonnation 
IfHyal2 is indeed a tumour suppressor gene, then the binding of JSRV Env to Hyal2 might 
inhibit Hyal2 and thus lead to oncogenic transformation (Liu et ai., 2003a). In support of 
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their hypothesis, Liu et al. (2003a) began by demonstrating physical binding of JSRV SU 
to Ryal2 orthologues and that Ryal2 does mediate JSRV entry into cells. Previously, this 
had only been inferred from genetic studies. They developed NIR 3T3 and 208F cell lines 
that express human Ryal2, and showed that these cell lines are considerably less sensitive 
to JSRV Env transformation than parental NIR 3T3 and 208F cells that do not over express 
human Ryal2. When Liu et al. (2003a) transduced JSRV Env-transformed NIR3T3 cell 
lines with vectors expressing human Ryal2, 80% of the cells reverted to their normal non-
transformed phenotype. 
Liu et al. (2003a) added a FLAG tag (DYKDDDDK) to the 3' end of the Env coding 
region in their JSRV Env expression construct. Using an anti-FLAG antibody, this allowed 
them to monitor the levels of En v protein in transfected NIR 3T3 cells. They found a 
significant reduction in JSRV Env levels in those cells expressing human or rat Ryal2, 
more so for human than for rat Ryal2. Mouse Ryal2 did not reduce levels of JSRV Env, 
even when over expressed. Similarly, the above results, viz. binding ofRyal2 to SU, 
suppression of Env transformation by Ryal2 and the reversal of transformed phenotype all 
pertained most strongly to human Ryal2, followed by rat Ryal2, and did not apply to 
mouse Ryal2. This means that JSRV Env transforms mouse NIH 3T3 fibroblasts without 
any discernible interaction with Ryal2 in these cells, making it very unlikely that mouse 
Ryal2 is involved in JSRV Env transformation ofNiR 3T3 cells (Liu et ai., 2003a). The 
reduction of JSRV Env levels in cells expressing human or rat Ryal2 does not support the 
notion ofa specific tumour suppressor activity of En v transformation by Ryal2. Rather, it 
would seem that a more generalised effect ofRyal2-mediated degradation of En v is 
responsible for the reduction of transformation in those cells expressing human or rat 
Ryal2. In the discussion of their results, the investigators did not mention the possibility of 
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interaction between Hyal2 and the extracellular domain of JSRV TM. In view of all the 
findings to this point, such an interaction could still allow for a role of Hyal2 in JSRV Env-
mediated transformation, even of NIH 3T3 cells. 
All JSRV Env in vitro transformation studies thus far had used immortalised fibroblast cell 
lines, owing to their ease of transfection and the ability to employ established 
transformation assay protocols. However, the target cells of JSRV transformation in vivo 
are epithelial cells, so Danilkovitch-Miagkova et ai. (2003) investigated JSRV Env 
transformation in vitro using an immortalised non-transformed human bronchial epithelial 
cell line, BEAS-2B. They found that transfection with a plasmid encoding an influenza 
haemagglutinin (HA) tag and JSRV Env led to stable expression of JSRV Env in these 
cells and to formation of transformed foci after six weeks. 
In BEAS-2B control cells, Hyal2 is associated with an inactive / dormant form of the 
receptor tyrosine kinase RON, as shown by coimmunoprecipitation and western blotting 
(Danilkovitch-Miagkova et ai., 2003). In BEAS-2B cells that had been transformed by 
JSRV Env, however, RON was no longer associated with Hyal2, and it was activated. The 
investigators speculate that this activation of RON occurs by means of 
autophosphorylation. They show that the activation of RON in Env-transformed cells is 
associated with constitutive activation of Akt and mitogen-activated protein kinase 
(MAPK), so that activation of the Akt and MAPK pathways would drive proliferation and 
transformation, and maintain the transformed phenotype ofBEAS-2B cells. The 
investigators point out that both Akt and MAPK had previously been shown to be activated 
directly by kinase-active RON. The ectopic over expression of "kinase-dead" RON 
(kdRON), however, could reverse Env-mediated transformation (Danilkovitch-Miagkova 
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et al., 2003), presumably because it abrogates activation of the Akt and MAPK pathways. 
Over expression ofHyal2 was also able to reverse transformation in this system. Taken 
together, the above results meant that RON activation is essential for transformation and its 
maintenance in BEAS-2B cells, and the investigators concluded that Hyal2 negatively 
regulates the function of RON receptor tyrosine kinase in bronchial epithelial cells. 
BEAS-2B cells are difficult to transfect, so Danilkovitch-Miagkova et al. (2003) continued 
their studies in human embryonic kidney and canine kidney cells. In these cell lines, they 
confirmed that JSRV Env induced ligand-independent RON and MAPK activation and that 
both are reduced by co-expression ofHyal2. In both cell lines, Env was NOT tyrosine-
phosphorylated. Such tyrosine phosphorylation would be required by the model of rodent 
fibroblasts transformation proposed by Palmarini et al. (2001 b) and Alberti et al. (2002), 
involving Env activation ofthe PI3KJAkt pathway. Danilkovitch-Miagkova et al. (2003) 





Intracellu lar Cell 
degradaUon transformation 
Figure 3.23 Model of JSRV Env-mediated transformation of RON-expressing cells. A) Hyal2 
negatively regulates the activity of RON kinase dimmers. 8) JSRV Env competitively binds Hyal2, 
removing it from its association with RON. RON autophosphorylates and activates MAPK and Akt , 
leading to cellular transformation. (Danilkovitch-Miagkova et al., 2003) 
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expression and that Env competes with RON for binding Hyal2. Also, the complex formed 
by Hyal2 and Env is degraded intracellularly. The scenario they propose for epithelial cells 
is that RON is expressed on the cell surface as an inactive dimer, the activation of which is 
prevented by its association with Hyal2 (Fig 3.23A). Competitive binding ofHyal2 by 
JSRV Env mediates viral entry, and subsequently expressed Env sequesters Hyal2. The 
Env/Hyal2 complex is degraded via a cellular proteasomal mechanism. The removal of 
Hyal2 from its association with RON renders the latter active, which induces activation of 
oncogenic pathways involving Akt and MAPK (Fig 3.23B). The activation of both these 
kinases was shown to be Env-dependent in this study. 
In further support of their proposed mechanism, Danilkovitch-Miagkova et al. (2003) 
showed that RON is activated in some human BAC cell lines and in one lung 
adenocarcinoma. They also point out that the over expression of RON in the distal lung 
epithelial cells of transgenic mice can induce peripheral adenocarcinomas (Chen et al., 
2002), thereby providing more substantiation for a role of RON in lung cancer. They agree 
that their model cannot apply to NIH 3 T3 cells transformed by JSRV Env, because mouse 
Hyal2 does not interact with JSRV Env, and NIH 3T3 cells do not even express Stk (the 
mouse orthologue of RON). 
3.4.2.7 JSRV Env transformation of rodent fibroblasts does not require the SU 
domain 
In rat 208F cells, the involvement ofHyal2 was all but excluded by the finding that these 
cells could be transformed by JSRV Env in the absence of its putative receptor binding 
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domain (RBD) (Chow et ai., 2003). The investigators had first created viral particles based 
on MMuLV, pseudotyped with JSRVlMMuLV or JSRVIMMTV chimeric Env genes. 
Some of these were able to induce morphological changes in 208F cells, but the only 
chimeric Env gene that supported transformation contained the leader peptide, RBD and 
proline-rich region from MMuL V, while retaining the remainder of SU and the whole of 
TM from JSRV (Fig 3.24A). Hyal2 was unable to mediate viral entry of these particles, 
indicating that the receptor binding domain pertaining to Hyal2 had been successfully 
replaced. Chow et al. (2003) then showed that a JSRV Env expression construct from 
which the putative RBD had been deleted (JSE~rbd; Fig. 3.24B) pseudotyped particles that 
were incapable of infecting cells expressing Hyal2, indicating that they cannot interact 
with Hyal2. The same construct, when used to transfect 208F cells, was able to transform 
them at about one third the efficiency of wild-type JSRV Env, demonstrating that Hyal2 is 
not required for JSRV Env transformation of rodent fibroblasts . 
su TM 
A , v , LP RBD PRR CT B su TM 
)( .:t~ II ~( I JSRV , v \ LP RBD PRR CT 
MMuLV )f .. ~ ............ ~ ( )( 
MMuLVprr-.,lSE 
JSEarbd 
Figure 3.24 Env expression constructs used by Chow et al. (2003) to determine lack of 
involvement of Hyal2 in transformation of rodent fibroblasts (adapted from Chow et al., 2003) . 
A) Parent sequences for derivation of chimeric construct capable of 208F cell transformation, and 
structure of resulting construct. 8) JSRV Env expression construct lacking the receptor binding 
domain. 
From the results of the MMuLV/JSRV Env chimeras and the deletion of the JSRV RBD 
the elements responsible for JSRV transformation could be localised to the carboxy-
terminal third of SU, or TM. Chow et ai. (2003) narrowed this down further by creating 
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, 
progressive amino-terminal deletion constructs of TM, linked to a myristoylation signal 
(Myr) at the amino terminus so that the gene products would be localised to the cell 
membrane. The JSRV Env cytoplasmic tail (without which transformation does not occur) 
by itself was not able to transform 208F cells (Fig. 3.25, pMyr-JSE7061), nor were several 
progressively larger TM constructs. The smallest construct that did support transformation 
expressed the carboxy-terminal 141 amino acids of JSRV Env (Fig. 3.25, pMyr-JSE6770). 
The transformation efficiency was one to two thirds that of wild-type JSRV Env, and 
transformed cells were shown to contain activated Akt. Furthermore, when the 
myristoylation signal was omitted (Fig. 3.25, p~Myr-JSE6770), transformation was 
abrogated, indicating a need for membrane localisation. The transmembrane domain of 
JSRV Env is therefore a major determinant of transformation, and 208F cells were 
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Figure 3.25 Myristoylated JSRV TM expression constructs used by Chow et al. (2003) to 
narrow down the JSRV Env transformation requirements to the carboxy-terminal 141 amino 
acids ofTM. 
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3.4.2.8 PI3K binding domain in CT of JSRV Env is not required for transformation 
of rodent fibroblasts 
The replacement of the JSRV Env cytoplasmic tail (CT) with the cytoplasmic domain of 
either ML V or HIV -1 abrogates transformation of 208F cells (Liu et al., 2003b), 
confirming earlier findings that CT is indispensable to JSRV Env transformation. In 
contrast with the finding by Palmarini et al. (200 1 b) that the tyrosine and methionine 
residues in the YXXM motif of JSRV Env are essential for transformation of NIH 3T3 
cells, Liu et al. (2003b) reported that both these residues can be mutated in JSRV and 
ENTV and still transform 208F as well as NIH 3T3 cells, albeit at reduced efficiency and 
sometimes only after transfected cells were left to grow for longer periods of time. As 
mentioned earlier in this chapter, Alberti et al. (2002) had already shown low levels of 
208F transformation by an ENTV Env y590 mutant in one of their tables of results, but had 
failed to take this into account in the discussion of their results. These findings by Liu et al. 
(2003b) correlate with those of Allen et al. (2002), who had shown that, in the 
transformation of the chicken fibroblast cell line DF-1 , both the tyrosine and methionine 
residues of YXXM are entirely dispensable. 
Liu et al. (2003b) confirmed that Akt is phosphorylated in JSRV- and ENTV-transformed 
208F cells, and showed that it is also kinase-active. They found that this activity was 
completely inhibited by the PI3K-specific inhibitor L Y294002, thereby confirming the 
results of Alberti et al. (2002) that had shown Akt activation in transformed cells to be 
PI3K dependent. However, in contrast to Alberti et al. (2002) who had linked this 
activation of the PI3K1Akt pathway directly to y 590, Liu et al. (2003b) showed that cells 
transformed (at lower efficiency) by the various constructs mutated in the YXXM motif 
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are still characterised by Akt phosphorylation and Akt activity, which was inhibited by 
L Y294002. L Y294002 could also reverse the transformed phenotype of En v-transformed 
rodent fibroblasts, regardless of whether the constructs used for transformation contained 
the YXXM motif or not. 
Liu et al. (2003b) were unable to detect phosphorylated tyrosine in the Env proteins 
expressed by JSRV- and ENTV-transformed 208F cell lines. Such tyrosine 
phosphorylation would be required at YXXM if it were to bind and activate PI3K. They 
also did not detect any binding association between JSRV Env and p85, the regulatory 
subunit ofPI3K. Taken together, this means that Akt activation in transformed rodent 
fibroblasts is PI3K dependent, but that the PI3KJAkt pathway is activated indirectly, i.e. 
not via activation ofPI3K by JSRV or ENTV Env. 
In contrast with their JSRV transformation studies on epithelial cells, where they showed 
MAPK to be activated (Danilkovitch-Miagkova et al., 2003), Liu et al. (2003b) did not 
detect activated / phosphorylated MAPK in transformed rodent fibroblasts. They conclude 
that MAPK is probably not involved in the transformation of rodent fibroblasts, despite the 
fact that the MAPK pathway can playa role in tumourigenesis, either by itself or in 
combination with the PI3K1Akt pathway. They also found no association of JSRV Env 
with Grb2, despite the presence of the potential binding motifYXN. As pointed out earlier 
in this chapter, however, the involvement of Grb2 seemed somewhat unlikely in any event, 
since the YXN motif is found in only some exogenous pathogenic JSRV isolates. 
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3.4.2.9 Primary chicken fibroblasts can be transformed by JSRV Env 
So far, the cytoplasmic tail of JSRV Env had been shown to be essential for JSRV 
transformation of both NIH 3T3 and 208F cell lines (Chow et ai., 2003; Liu et ai. , 2003b; 
Palmarini et ai. , 2001 b). Despite several other differences pertaining to rodent vs. chicken 
fibroblasts, this absolute requirement of CT was shown to hold true in DF -1 cells, using a 
replication-competent avian retroviral vector expressing wild-type and mutated forms of 
JSRV21 Env (Zavala et ai., 2003). This study also confirmed the results of Allen et ai. 
(2002), which had demonstrated that the YXXM motif in the cytoplasmic tail of JSRV Env 
is dispensable to transformation ofDF-l cells, although Zavala et ai. (2003) mutated the 
tyrosine to different residues compared with Allen et ai. (2002). Zavala et ai. (2003) 
extended previous findings by reporting that JSRV Env-transformed DF-l cells contain 
phosphorylated Akt; this property is therefore shared by JSRV-transformed rodent, DF-l 
and BEAS-2B cells (Danilkovitch-Miagkova et ai. , 2003), as well as JS-8 cells (Alberti et 
ai. , 2002). However, Zavala et ai. (2003) did not find phosphorylated Akt in those DF-l 
cells transformed by y590 mutants, which contrasts with the results ofLiu et ai. (2003b) 
using 208F cells. 
All in vitro JSRV transformation assays to this point had used immortalised (yet non-
transformed) cell lines, which had undergone genetic changes that would render them more 
susceptible to transformation compared to primary cells. Zavala et al. (2003) were the first 
to demonstrate JSRV transformation of primary cells, using primary chicken embryo 
fibroblasts (CEFs). In contrast with DF-l cells, they found that Env y590 mutations reduce 
the degree to which CEFs are transformed (in terms of phenotypic changes), and the 
degree of reduction varies depending on which amino acid residue the tyrosine is mutated 
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to. Furthermore, Akt phosphorylation was only found in fully transformed CEFs, i.e. those 
that had been transformed by non-mutated JSRV Env. This indicates a role in efficient 
~ . . I' Akt . . ~ y590 translormatIOn, mvo vmg actIvatIOn, lor . 
Like Liu et ai. (2003b), Zavala et ai. (2003) showed that phosphorylated Akt in JSRV-
transformed 208F cells is indeed kinase-active. They also extended their earlier results of 
dose-dependent inhibition of JSRV Env transformation by the PI3K-specific inhibitor 
L Y294002 in NIH 3T3 cells (Alberti et ai., 2002) to include 208F cells. However, using 
various concentrations of the inhibitor, Zavala et ai. (2003) found evidence of possible 
generalised toxicity of L Y294002 in their experiments, and could therefore not rule out 
that the observed inhibition of transformation by L Y294002 relates to this, rather than to 
the inhibition of the PI3K1Akt pathway. Finally, they tested ten OPA tumours from sheep 
and ten ENT (five from sheep and five from goats) tumours for Akt phosphorylation. All 
OP A tumours were negative, as were four of the ENT tumours. From all their results, 
Zavala et ai. (2003) conclude that activation of the PI3K1Akt pathway plays an important 
role in JSRV transformation, but that it is not likely to be the pivotal event in this process. 
3.4.2.10 Evidence that indicates JSRV transformation of rodent fibroblasts does not 
involve PI3K 
Maeda et al. (2003) used four different experimental approaches to show that JSRV 
transformation of rodent fibroblasts does not involve PI3K. The first two made use of 
dominant negative forms of the PI3K regulatory subunit (~p85), which would still be able 
to bind phosphorylated YXXM motifs, but not be able to form dimers with the catalytic 
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subunit ofPI3K. Transformation efficiency of NIH 3T3 cells was unchanged, and the 
transformed cells still contained phosphorylated Akt, indicating that Akt had been 
activated independently ofPI3K (Maeda et al., 2003). The next experiment involved the 
use fibroblasts derived from mice in which the genes encoding the p85a. and p85~ isoforms 
of the regulatory subunit of PI3K had been knocked out. These cells were also efficiently 
transformed by JSRV Env (Maeda et al., 2003). 
Finally, Maeda et al. (2003) found that, even though the PI3K-specific inhibitor LY294002 
was able to inhibit JSRV Env transformation in NIH 3T3 cells, it inhibited transformation 
by v-mos (a PI3K-independent oncogene) to the same degree, indicating that the inhibition 
of transformation by L Y294002 is likely to be a non-specific effect. Furthermore, 
L Y294002 was unable to reverse the transformed phenotype of NIH 3T3 or Rat 6 cells 
transformed by JSRV Env (Maeda et al., 2003). Both these observations stand in direct 
conflict with those ofLiu et al. (2003b) who had shown that JSRV transformation of208F 
cells could be reversed by L Y294002, and that Fos-induced transformation of208F cells 
(also PI3K-independent, like v-mos) was only very weakly reduced by L Y294002. Liu et 
al. (2003b) had attributed this weak reduction to toxic effects of L Y294002. A further 
contrast with the findings ofLiu et al. (2003b) is that Maeda et al. (2003) still report the 
YXXM motif in the cytoplasmic tail of JSRV Env to be necessary for transformation of 
NIH 3T3 cells. 
It might be worth noting at this point that there is a potentially important difference 
between the constructs used in the work by Liu et al. (2003b) and JSRV Env expression 
constructs from Hung Fan's and Massimo Palmarini's laboratories. Whereas the latter are 
driven by a human cytomegalovirus promoter / enhancer, the former are driven by a 
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murine leukaemia virus L TR, which is likely to be more efficient in mouse and other 
rodent cells. None of the publications pointed out this difference, even when commenting 
on and discussing the contrasting results that the different groups were reporting. 
Owing to their continued finding that YXXM is necessary for transformation of rodent 
fibroblasts, Maeda et al. (2003) restored this motif in pCMV3~GP(NruIend), a construct 
that expresses JSRV Env, but with an endogenously derived cytoplasmic tail downstream 
of the NruI site. Prior to restoration ofYXXM, this construct did not transform NIH 3T3 
cells. This was expected, as it is essentially the same as pSUxTMxNruIen described by 
Palmarini et al. (2001 b) (Fig. 3.20). By replacing His586 with Tyr, Maeda et al. (2003) 
restored the YXXM motif in this construct, but this did not rescue its ability to transform 
NIH 3T3 cells, meaning that residues other than the PI3K docking motif in the cytoplasmic 
tail of JSRV Env are required for transformation. Although the investigators do not point 
this out, it might turn out to be important that all exogenous JSRV s have an arginine 
residue after the tyrosine in YXXM, i.e. YRXM (Fig. 3.22). The mutated form of 
pCMV3~GP(NruIend) would have a sequence ofYKXM, and this might account for the 
finding of Maeda et al. (2003). It would have been interesting to see if a different result 
could have been achieved if the motif had been changed to YRTM, corresponding to JSRV 
isolates of African origin. This is not likely though, in view of the reports that the YXXM 
is dispensable to JSRV Env transformation in DF -1 cells (Allen et al., 2002) as well as 
rodent fibroblasts under the correct conditions (Liu et al. , 2003b). 
To confirm that their findings pertaining to the lack of involvement ofPI3K in JSRV 
transformation of NIH 3T3 cells was not due to lack of expression of their constructs in 
cells expressing ~p85 , or to altered subcellular localisation, Maeda et al. (2003) HA-
- 174 -
tagged their constructs to make their Env products immunologically detectable. They 
found that all their constructs were expressed at similar efficiency, and that subcellular 
localisation was the same for wild-type and YXXM-mutated constructs. Maeda et al. 
(2003) further refer to results not shown in the publication. Firstly, no tyrosine 
phosphorylation of the JSRV Env protein could be detected [consistent with Liu et al. 
(2003b)]. Secondly, no binding interaction between JSRV Env and the p85 subunit of 
PI3K was detected. The investigators discuss the possibility that PI3K-independent 
activation of Akt could be mediated by pathways involving either the cytoplasmic tail of 
TM or other envelope protein domains including SU, despite the earlier report by Chow et 
al. (2003) that showed JSRV transformation not to require the surface domain. As an 
example of other motifs important to JSRV Env transformation, Maeda et al. (2003) refer 
to unpublished data of theirs - if a valine residue in the cytoplasmic tail near the 
membrane-spanning domain is mutated, transformation is abrogated. They do not identify 
the position of this residue, nor whether or not it is shared by enJSRVs. 
3.4.2.11 Hyal2 does not directly modulate RON activity in rodent fibroblasts 
In an effort to further characterise the involvement of RON and Hyal2 in the JSRV Env 
mediated transformation of epithelial cells (Danilkovitch-Miagkova et al., 2003), this 
group attempted to investigate these interactions in rodent fibroblasts (Miller et al., 2004). 
They had encountered difficulties in reliably transfecting the BEAS-2B cells used in their 
previous study, and found the reproducibility of their transformation assays to be poor. 
Rodent fibroblasts are the most commonly used cell lines for transformation assays, and 
other reports had indicated that they can be transformed by Stk, the mouse orthologue of 
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RON. Danilkovitch-Miagkova et ai. (2003) had concluded that Hyal2 down-regulates 
RON/Stk activity and that this down-regulation is inhibited by JSRV Env binding to 
Hyal2. Miller et ai. (2004) reasoned that they should therefore be able to suppress 
transformation mediated via the RON/Stk pathway by overexpressing Hyal2. 
Miller et ai. (2004) transfected NIH 3T3 cells with plasmids expressing either RON or Stk 
(the human and rodent orthologues, respectively). As mentioned before, these cells do not 
naturally express this receptor. They found no transformation of NIH 3T3 cells as a result 
of RON or Stk expression. When repeating these experiments using rat 208F cells 
however, they did find extremely low levels of transformation (less than 1 % of the 
transformation activity observed for JSRV Env). They established stably transformed cell 
lines from the transformants and treated them with human macrophage stimulating protein 
(MSP), the natural ligand ofRON/Stk. As expected, they observed that the transformed 
phenotype of RON/Stk-transformed 208F cells was enhanced by treatment with MSP. 
Surprisingly, the transduction of the RON/Stk transformed cell lines (whether they 
expressed MSP or not) with human or rodent Hyal2 had no effect on their morphologies 
and phenotype. This shows that, contrary to the conclusions of their earlier study 
(Danilkovitch-Miagkova et ai., 2003), Hyal2 does not directly modulate the activity of 
RON/Stk, at least in this system that uses 208F cells. It therefore seems likely that 
additional factors are present in BEAS-2B cells that are required for Hyal2 regulation of 
RON activity. The investigators maintain that the RON pathway might be more important 
in JSRV oncogenesis in vivo than the alternative pathway(s) suggested for rodent 
fibroblasts, since the natural targets for JSRV transformation are lung epithelial cells. 
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3.4.2.12 Evidence for SU requirement in JSRV Env transformation 
Despite the report by Chow et al. (2003) that the surface (SU) protein of JSRV Env is 
dispensable to JSRV transformation of rodent fibroblasts, Hofacre & Fan (2004) presented 
evidence that it is required. They created three sets of constructs mutated in SUo The first 
set had increasingly larger SU deletions, all starting downstream from the endoplasmic 
reticulum (ER) signal recognition peptide (SRP) so as not to affect trafficking to the cell 
membrane. Dirks et al. (2002) had suggested that the JSRV Env ER SRP lies upstream of 
residue 77, so all deletions had their 5' endpoint at residue 102, where a Pst! linker had 
been inserted for cloning purposes (Hofacre & Fan, 2004). None of these deletion 
constructs induced transformation of either NIH 3T3 or 208F cells, even the one with the 
smallest deletion of about 50 amino acids. 
The second set of constructs tested by Hofacre & Fan (2004) for SU involvement in JSRV 
Env transformation had nested 50-amino acids deletions throughout SU (Fig. 3.26). None 
~I 50 I 
CMV 
l'l P ER 
c:::;o----o SRP I 'OTI l'lGP SUl'l14-52 
~ 'OTI l'lGP SUl'l53-1 02 
~ IDIJ l'lGP SUl'l103-152 
~ lITO l'lGP SUl'l153-202 
~ lITO l'lGP SUl'l203-252 
~ IDIJ l'lGP SUl'l253-302 
~- IDIJ l'lGP SUl'l353-402 
Figure 3.26 JSRV Env expression constructs with nested 50-amino acid deletions 
throughout SUo Adapted from Hofacre & Fan (2004) . 
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of these transformed NIH 3T3 cells either. One of the constructs, however, was able to 
transform 208F cells. This construct (~GP SU~14-52) had its deletion upstream of the ER 
SRP. The third set of mutants comprised a set of minimal insertions of two amino acids at 
various points throughout SUo Once again, none of these minimal insertion mutants 
transformed NIH 3T3 cells, whereas one transformed 208F cells. This construct also had 
its two amino acid insertion upstream of the ER SRP, and the investigators presume that 
the reason the two constructs that are mutated upstream of the ER SRP are able to 
transform 208F cells is because this region would be cleaved off as part of the removal of 
the signal peptide in ER, thus forming wild-type SUo The investigators do not offer a 
suggestion as to why these two constructs do not transform NIH 3T3 cells if they transform 
208F cells. 
The above results indicate a need for the SU protein in JSRV transformation of rodent 
fibroblasts. Hofacre & Fan (2004) addressed possible alternative explanations of their 
results, firstly by verifying the reading frames of all their constructs and secondly, by 
showing that the mRNA expression of deletion constructs is not reduced relative to that of 
the full-length Env expression construct. Thirdly, they also HA-tagged several of their 
constructs to enable antibody detection of the products. This allowed them to demonstrate 
that the products derived from the deletion and minimal insertion products were equally 
stable as the wild-type JSRV Env, and that they were also correctly localised to the cell 
membrane. 
Hofacre & Fan (2004) proposed that the JSRV Env SU and TM domains act independently 
to facilitate transformation. In support of this hypothesis, they conducted various co-
transfections of208F cells with pairwise combinations ofSU- and TM-mutated constructs 
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that were each not able to induce transformation by themselves. These experiments were, 
of necessity, preceded by the identification of non-transforming TM mutants. Consistent 
with Liu et ai. (2003b), they found that an Env expression construct with the methionine 
residue of the "critical" YXXM motif (Fig. 3.21 and 3.22) mutated, was able to induce 
transformation of208F cells at decreased efficiency. Contrary to the findings ofLiu et ai. 
(2003b) however, in the hands ofHofacre & Fan (2004), mutation of the tyrosine residue 
(in a construct they call 8GP Y590F) abolished transformation of208F cells. They 
therefore used 8GP Y590F (which would encode a functional SU) in co-transfections with 
three different SU-altered non-transforming constructs (which would each encode 
functional TM). In each of these co-transfection studies, the SU encoded by 8GP Y590F 
complemented the TM encoded by the SU mutants to result in efficient transformation of 
208F cells. 
In the discussion oftheir results, Hofacre & Fan (2004) refer to the apparent inconsistency 
of their findings with those of Chow et al. (2003), who had shown SU to be dispensable to 
JSRV Env transformation. Hofacre & Fan (2004) argue that the deletion of the putative 
receptor binding domain of JSRV by Chow et ai. (2003) left the carboxy-terminal portion 
of SU intact (Fig. 3.24B), and propose that this region might be important for 
transformation, in combination with the PI3K-independent activation of Akt, mediated by 
JSRV TM. They refer to unpublished data of theirs that indicate JSRV Env binding to Toll-
like receptor 4 (TLR-4), and cite personal communication with another researcher who has 
found TLR-4 to bind to the carboxy-terminal portion of mouse mammary tumour virus SUo 
However, Hofacre & Fan (2004) apparently disregard two facts: Firstly, most of their SU 
deletion constructs also left the carboxy-terminal portion of SU intact (Fig 3.26), raising 
the question of why these were not sufficient to induce transformation; secondly, Chowet 
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al. (2003) also achieved efficient transformation of 208F cells with a construct that only 
expressed the carboxy-terminal 141 amino acids of JSRV Env (Fig. 3.25, pMyr-JSE6770). 
This construct would be missing all ofSU, as well as the amino-terminal portion ofTM. 
Both studies demonstrated correct localisation of their Env constructs to the cell 
membrane, so the fact that Chow et al. (2003) used a myristoylation signal and Hofacre & 
Fan (2004) relied on the ER SRP native to JSRV SU should make no difference. 
3.4.2.13 JSRV Env transformation of canine kidney epithelial cells 
Up until this point, it appeared as though JSRV Env transformation in vitro operates via 
two entirely distinct mechanisms for fibroblasts and for epithelial cells (Liu & Miller, 
2005). Since most studies had focussed on rodent fibroblasts, yet the natural targets for 
JSRV oncogenesis are epithelial cells, Liu & Miller (2005) once again used an epithelial 
cell system to study JSRV Env transformation. Owing to various difficulties experienced 
with the BEAS-2B cell line used in their earlier study involving epithelial cells 
(Danilkovitch-Miagkova et al. , 2003), they now turned to the Madin-Darby canine kidney 
(MDCK) epithelial cell line. Their expression constructs were once again based on 
pSX2neo, driven by an ML V promoter. Using these, they showed that JSRV and ENTV 
Env can transform MDCK cells, and that their respective cytoplasmic tails are essential for 
MDCK transformation. In agreement with their findings in 208F cells (Liu et ai., 2003b), 
the y590_X_X_M593 motif is not required for transformation ofMDCK cells, either by JSRV 
or by ENTV Env. In fact, in MDCK cells the transformation efficiencies for all mutations 
of the Tyr or Met residues were in excess of20% compared to the wild-type Env-
expressing constructs - a lot higher than in 208F cells. 
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Next, Liu & Miller (2005) showed that Akt was phosphorylated in all the Env-transfonned 
MDCK cells (including those transfonned by YXXM mutants), and that this Akt 
phosphorylation could be completely inhibited by L Y294002. L Y294002 treatment also 
partially reverted the morphology of transfonned MDCK cells back to their non-
transfonned state. These results indicated a requirement for PI3K activation in Env 
transfonnation ofthese cells. However, Liu & Miller (2005) detected neither Env 
phosphorylation (Tyr phosphorylation in YXXM would be necessary for binding PI3K) 
nor coimmunoprecipitation of En v with the p85 regulatory subunit ofPI3K, implying that 
JSRV and ENTV Env proteins activate PI3K1Akt through one or more unidentified adaptor 
molecules, as already suggested by Allan et al. (2002), working on chicken DF -1 cells. The 
same would then be true for 208F cells (Liu & Miller, 2005). 
To complete the comparison of JSRV and ENTV Env transfonnation in BEAS-2B and 
MDCK cells, Liu & Miller (2005) showed that, in contrast with BEAS-2B cells, neither 
RON nor Hyal2 played a role in transfonnation ofMDCK cells. (Interestingly, they 
observed that canine Hyal2 can function as a receptor for JSRV, but not for ENTV.) The 
investigators therefore conclude that the transfonnation mechanism operative in MDCK 
cells is likely to be the same as in 208F rat fibroblasts. In the discussion of their results , 
they mention that they were not able to transfonn MDCK cells with the same construct 
used by Chow et al. (2003) that expresses the carboxy-tenninal141 amino acids of JSRV 
TM (Fig. 3.25, pMyr-JSE7061), and that they only achieved minimal transfonnation of 
208F cells with this construct, as opposed to Chow et al. (2003), in whose hands it 
supported efficient 208F transfonnation. 
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3.4.2.14 Summary and discussion 
In summary, the available experimental evidence at the time when the author concluded his 
practical research work described in this thesis favours the existence of two alternative 
models to explain JSRV Env transformation in vitro. The first has thus far only been 
shown to apply to the immortalised non-transformed human bronchial epithelial cell line 
BEAS-2B (Fig. 3.23). This model proposes that Hyal2, the cellular receptor for JSRV and 
ENTV, normally functions to negatively regulate a receptor tyrosine kinase, RON. 
Infection with JSRV particles would be mediated by binding of the receptor binding 
domain (RBD) within the SU protein to Hyal2. JSRV replication would lead to Env 
expression in the infected cell and Env proteins would be trafficked to the cell membrane 
where they once again bind Hyal2, in competition with RON. The Env/Hyal2 complex is 
internalised and degraded, leaving RON to autophosphorylate and subsequently activate 
oncogenic pathways involving mitogen activated protein kinase (MAPK) and Akt. 
Although the RBD in the SU protein of JSRV Env would obviously be required by this 
model, the involvement of other regions within JSRV Env have not been investigated. 
Evidence for the second model of JSRV Env transformation has been gathered from 
transformation studies in immortalised rodent and chicken fibroblasts, as well as primary 
(non-immortalised) chicken embryo fibroblasts and canine kidney epithelial cells. Taking 
into account the data inconsistencies arising from the use of various JSRV Env expression 
constructs and mutants, for the transformation of different cell lines, this model currently 
proposes the following: Regions within the cytoplasmic tail of JSRV Env (part ofVR3), 
possibly in combination with other elements contained in the TM protein, indirectly 
activate the PI3K1Akt pathway, leading to oncogenesis. Although one study indicates that 
- 182 -
PI3K is not involved in this process, all other available evidence indicates that it is. The 
one requirement of JSRV transformation that all studies contributing to this model agree 
on is that of the cytoplasmic tail in VR3, and the common signature of both models (and all 
studies, in all cell lines ) is the activation of Akt kinase. 
The ideal in vitro system for JSRV transformation studies would obviously be sheep type 
II pneumocytes with indefinite growth potential. Unfortunately, type II pneumocytes from 
any animal have proven very difficult to maintain in culture for any length of time, and 
they tend to lose their state of differentiation quickly (various personal communications). 
In fact, at the CRIlUCI the author was witness to numerous unsuccessful attempts at 
culturing these cells from rats, and establishing stable cell lines. However, the published 
abstract of a conference presentation (DeMartini et ai., 2004) reports the establishment of a 
primary sheep alveolar type II cell line that was successfully maintained in culture for 
seven to fourteen days and productively infected with JSRV. It will be most interesting to 
follow the outcomes of studies conducted with these cells. Further encouragement in this 
regard has been presented by the results of a recently published study (Archer et ai., 2007), 
where alveolar type II cells from OP A tumours were successfully established as cell lines. 
Two proliferative cell subpopulations were identified: The first expressed JSRV, but could 
not be maintained for more than seven passages. The second was a transformed, yet JSRV-
negative population that displayed long-term maintenance in vitro. The investigators 
propose that the latter subpopulation is acutely transformed by JSRV Env in the absence of 
integrated JSRV, and express their intention of determining whether JSRV is detrimental 
to those cells that it infects. 
Finally, whereas in vitro studies are of the utmost importance in helping to dissect the 
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potential mechanisms of transformation in a disease such as OP A, the aim is ultimately to 
determine each of the steps leading to the disease in sheep infected with JSRV. In vivo 
infection studies by different groups, using numerous mutated JSRV forms (e.g. I!!.orfx, 
Env Y590F, etc.) are currently underway (various personal communications), and it is very 
likely that differences between the in vitro models and the in vivo effects will be noted. 
These will then need to be investigated and explained using in vitro studies once again. 
Already at this point, it is not certain that the in vitro signature of JSRV transformation-
Akt activation - is applicable to the disease situation, when considering that OP A tumours 
were not found to contain phosphorylated Akt. It is to be expected that the naturally 
occurring, as well as experimentally induced, disease progression will be far more complex 
than any simple model based purely on in vitro studies is likely to be able to explain. 
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CHAPTER 4 
GENERAL DISCUSSION AND CONCLUSIONS 
Ovine pulmonary adenocarcinoma (OP A) serves as a valuable, naturally occurring outbred 
animal model for peripheral human lung carcinomas, and to epithelial cancers generally, 
since most other animal models of retrovirally induced cancer pertain to the 
haematopoietic system. This study has significantly advanced the specificity and 
underlying comprehension pertaining to this model. This chapter summarises and discusses 
the major findings of the three aspects of the study described in this thesis. The first phase 
comprised the cloning and sequence determination of three full-length endogenous JSRV 
loci from sheep. Comparison with exogenous JSRV sequences led to the discovery of three 
variable regions in JSRV that consistently distinguish exogenous pathogenic from 
endogenous non-pathogenic JSRV isolates. These were termed the variable regions of 
JSRV: VRI and VR2 are found in gag, whereas VR3 is located at the carboxy-terminus of 
env, comprising the 3' end of the transmembrane region and encompassing the cytoplasmic 
tail. The second phase of the study consisted of the author's pursuit of creating relevant 
biological constructs for the future study of the significance ofVRl and VR2. 
Concurrently, his international colleagues focussed their attention on VR3, and linked it to 
transformation in vitro. While the author did not have the opportunity of contributing any 
laboratory work to this third aspect of the study, he was intricately involved in its 
progressive development. Finally, this chapter will present overall conclusions and 
directions for the continuation of this work. 
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4.1 DISCOVERY OF VARIABLE REGIONS IN JSRV 
The determination of the sequence of JSRV (York et ai., 1991; York et ai., 1992) was 
arguably the single greatest advancement in JSRV molecular biology research at the time 
of its publication, and saw in a new era in this field. The work has been cited 126 times in 
subsequent publications. Having the complete nucleotide sequence of JSRV at their 
disposal, however, appeared to bring researchers in the field no closer to identifying 
genetic elements or regions within the JSRV genome to implicate in its pathogenic role in 
OP A. In fact, until the results of this study were published, no further discoveries 
pertaining to JSRV -encoded pathogenesis were made. Given this long passage of time 
since the elucidation of the genomic sequence of JSRV, it was decided to resolve this 
impasse by conducting a detailed comparison of the sequences of exogenous pathogenic 
JSRV isolates with non-pathogenic endogenous ones. It was hypothesised that such a 
comparison would identify some elements or regions that consistently distinguish JSRV 
from enJSRVs. Such regions could then become the focus of further investigation. 
A comprehensive comparison necessitates the use of several sequences in order to 
differentiate between mutations in enJSRVs accumulated since their integration into the 
sheep germ line and those differences with regard to JSRV that are common to enJSRVs in 
general. An initial approach to this was the peR amplification of two sub-genomic 
enJSRV fragments that, taken together, would reconstitute almost an entire enJSRV locus. 
Given the multiplicity of enJSRVs in the sheep genome, however, there was no indication 
that the two sub-genomic fragments were from the same locus. A different approach was 
adopted, whereby a sheep genomic library was screened for full-length enJSRV loci. Three 
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of these were successfully sub-cloned and their full proviral sequences were determined. 
These constituted the first-ever full-length enJSRV genomes to be sequenced. 
Analysis of the three full-length enJSRV sequences identified several characteristics that 
were unique to individual loci, as well as yielding novel insights into the evolution of 
phylogenetics of enJSRVs. More importantly, however, it led to the accomplishment of the 
goals that had been envisaged for this aspect of the study, viz. the discovery that JSRVs 
and enJSRVs are consistently distinguished from one another in three short regions within 
their coding genes. This was precisely the type of finding that the author and his 
colleagues, both locally and abroad, had envisaged in the design of the study. These three 
regions were named the variable regions of ovine betaretroviruses, and comprised VRI and 
VR2 in the first two thirds of gag, and VR3 at the 3' terminus of env. The remainder of 
enJSRV genomes were found to be remarkably similar and homologous to JSRV isolates. 
Given their specialised facilities and extensive expertise, the author's international 
colleagues at the CRlIUCI embarked on the investigation ofVR3's role in transformation 
in vitro. This work was, from the outset, an integral, albeit non-laboratory based part of the 
author's own study. Concurrently, the author accepted the challenge of developing 
molecular biological tools that could be used, down the line, to discern the significance of 
VRI and VR2. 
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4.2 VR3 AND JSRV ENVELOPE TRANSFORMATION 
The author did not have the opportunity to conduct laboratory-based research into the role 
ofVR3 in JSRV pathogenesis, since our laboratory did not have the relevant facilities for 
the associated studies. It was anticipated that any involvement ofVR3 in transformation 
could be more readily detected in vitro than the effects ofVRl and VR2, since the 
envelope protein interacts with cell surface receptors and has more opportunity of altering 
cellular functions, the resulting phenotype whereof can be observed in tissue culture. In an 
effort to maintain an overall perspective of the progress made in JSRV pathogenesis 
research, the author was required to keep abreast of the work being undertaken in this field, 
both by our collaborators and by other investigators. This was done by corresponding with 
various laboratories involved in JSRV transformation research, and by critically appraising 
the work being published, and by providing feedback to our colleagues. The in vitro 
transformation studies produced a tremendous amount of data during the time that the 
author was conducting his laboratory-based research involving VRI and VR2, and it is to 
be borne in mind that the development of this entire field was based on the earlier findings 
of this study, as already discussed. 
The fact that human cells express the JSRV receptor HYAL2 and are transduced by JSRV 
(Rai et al., 2000), taken together with the finding that 30% of human bronchioloalveolar 
carcinoma and pulmonary adenocarcinoma samples, but not adenocarcinomas from other 
organs, are immunopositive using antibodies against the JSRV capsid protein (De las 
Heras et al., 2000), raises justified concerns that JSRV or a related virus might be 
carcinogenic in humans. Such fears were allayed to some degree by a report that showed 
immunodeficient mice to be susceptible to the development of JSRV Env-induced 
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bronchioloalveolar tumours upon infection with an adeno-associated virus vector 
expressing JSRV Env (Wootton et aZ. , 2005), while immunocompetent mice were resistant 
to tumour development. Since mice do not express Hyal2 that is functional as a JSRV 
receptor, tumourigenesis occurred in the absence of Hyal2-mediated cell entry. The 
investigators conclude that sheep are likely to be susceptible to JSRV transformation 
owing to the expression of enJSRVs and resultant immunotolerance towards JSRV. Since 
enJSRVs are absent in other species, their immune recognition of JSRV Env is expected to 
protect against JSRV tumourigenesis (Wootton et aZ. , 2005). 
In drawing their conclusions, (Wootton et aZ. , 2005) appear to be unaware of an earlier 
study that describes the finding of JSRV orfx sequences in 19 of 64 and gag-pro 
sequences in 4 of38 samples, mainly from individuals from Cameroon and Nigeria 
(Morozov et aZ. , 2004). The investigators excluded the possibility that the JSRV sequences 
they detected in these samples were food-derived by demonstrating an absence of sheep- or 
goat-specific mitochondrial DNA. They did not establish a link with lung cancer (this had 
been the objective of their study), but they noted that they detected JSRV sequences more 
frequently in HIV-patients than in healthy blood donors. They suggest that a JSRV-like 
virus might circulate among people from some parts of Africa, and that AIDS predisposes 
to infection with this virus. However, the fact that JSRV sequences were detected in 
healthy controls implies that they were infected with a JSRV-like virus. This does not 
contradict the immune protection afforded against JSRV -induced tumourigenesis 
suggested by (Wootton et at. , 2005). Considering the high prevalence of HI V and 
associated immunodeficiency, the possibility of human infection with JSRV, and 
subsequent tumourigenesis remains a concern in the author' s opinion. 
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The use of JSRV Env to pseudotype feline immunodeficiency (FIV)-based lentiviral 
vectors constructed for the transduction of airway epithelia has recently been reported 
(Sinn et ai. , 2005b). This study followed an earlier report that the inclusion of JSRV 
proviral sequences (env and some of its flanking regions) in these lentiviral vectors led to a 
10,000-fold increase in titre (Sinn et ai., 2005a). In their discussion, (Sinn et ai., 2005b) 
refer to unpublished results that show a Y590D mutation of JSRV Env to lead to a 
dramatic drop in FlV pseudotyping efficiency. The mutation had been introduced to 
address concerns regarding JSRV Env' s oncogenic potential, which would constitute a 
problem if JSRV Env were to be considered as a pseudotyping candidate for gene transfer. 
The investigators express hope that the presentation of JSRV Env in the context of a 
replication incompetent retroviral vector might not have any harmful effects. The creation 
of a JSRV -based replication-defective virus expressing JSRV env under the control of its 
own L TR has recently been described (Caporale et ai., 2006), and was shown to induce 
OPA in newborn lambs. The implication of these findings is that JSRV viral spread after 
infection is not required to induce OP A. 
A recent study was successful in developing mouse monoclonal antibodies that very 
specifically recognise JSRV Env in the tumours of naturally OPA-affected sheep from 
Europe, USA and Africa, as well as in JSRV Env-induced tumours in mice (Wootton et ai. , 
2006). These antibodies could be used in the context of a highly specific diagnostic test for 
OP A, and possibly for ENTV. Other observations in this study were that Env expression is 
limited to tumours, and the investigators propose that JSRV Env might be toxic to the 
majority of differentiated lung cell types in sheep, accounting for the relative lack of 
observed metastasis. The final conclusion of this study is that the primary effect of JSRV 
infection is to drive localised proliferation of lung epithelial cells, which contrasts with the 
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findings of (Caporale et al., 2005), namely that infection of lung epithelial cells and 
induction of OPA is not the most common outcome of JSRV infection. 
It is evident from the above selection of recent studies on JSRV transformation and Env 
that this is an emerging field, attracting ever-increasing numbers of investigators. It 
presents an array of interesting challenges that, if met, will provide profound insights into 
an oncogenic retrovirus that is gradually becoming more understood. 
4.3 FUNCTIONAL ANALYSIS OF VRl- AND VR2-SUBSTITUTED 
CONSTRUCTS 
Some might be tempted to argue that the involvement ofthe JSRV envelope protein in 
transformation, in the absence of gag, diminishes the importance of investigating VRI and 
VR2 in any great detail. However, there are compelling scientific reasons to investigate the 
two variable regions in gag. They, together with only one other conserved variable region, 
clearly distinguish an exogenous retrovirus that causes an infectious ovine lung cancer 
from 15 to 20 very closely related endogenous proviral loci that reside benignly in the 
genetic makeup of sheep. It is expected that the effects ofVRl and VR2 will be subtle and 
that the biological significance of these variable regions will most likely only be 
discernible in vivo. Such tests will form the basis of another study. It was the aim of this 
study to develop the molecular tools that would, in future, be used to test the functions of 
VRI and VR2, and to characterise these tools in vitro to establish their suitability for 
further in vivo studies. 
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This final objective of the study described in this thesis was met by precisely substituting 
VRI and VR2, individually and in combination, into the exogenous infectious molecular 
clone pCMV2JS21. The strategy developed for this precise substitution was novel, and in 
spite of its conceptual complexity, was shown to be implemented with relative ease once 
the experimental pitfalls had been identified. The method was superior in its specificity 
compared to more conventional approaches, as was demonstrated by the fact that a parallel 
experiment carried out by another group culminated in the presentation of inaccurate 
conclusions regarding the involvement ofVRl in the lack of enJSRV particle formation. 
Furthermore, it was shown that this substitution strategy is readily adaptable to the 
substitution of any PCR-amplifiable region, even between entirely unrelated DNA 
sequences. It is therefore a highly versatile tool with broad applications in molecular 
biology. 
The objectives of this last aspect of the study were met, in that the tools were developed 
that could be used to test the biological significance ofVRl and VR2. These tools 
comprise the three chimeric constructs pJS21 /56AIVR1, pJS21/56AIVR2 and 
pJS21 /56A 1 VRI VR2. A prerequisite for the progression to in vivo testing of these 
constructs was that at least some of them support retroviral particle formation, as this is the 
form in which they will need to be administered. It was shown that all three chimeric 
constructs supported abundant particle formation in vitro, with levels comparable to the 
non-substituted wild-type pCMV2JS21 in the case of pJS21 /56A 1 VR1, and exceeding it in 
the case of pJS21 /56A 1 VR2 and pJS21 /56Al VRIVR2. A further condition for the use of the 
chimeric retroviral particles in vivo is that they be able to infect targetlhost cells and 
integrate their genomes into those of the infected cells. This was shown to be the case by 
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use of in vitro infectivity assays, thereby rendering the chimeric constructs fully qualified 
for in vivo tests to ascertain the significance ofVRl and VR2. 
4.4 CONCLUDING REMARKS AND FUTURE PERSPECTIVES 
In conclusion, all aims and objectives set out at the beginning of the various stages of this 
project were met. The first three (and so far only) full-length enJSRV proviral sequences 
were determined. These were comprehensively analysed, and three variable regions were 
identified that consistently differentiate exogenous pathogenic from endogenous non-
pathogenic JSRV isolates. One of these variable regions has already been successfully 
linked to JSRV-induced transformation, both in vitro and in vivo. Finally, the molecular 
tools were generated that will be used to elucidate the more subtle biological effects of the 
other two variable regions, and the suitability of these tools for future studies has been 
validated. 
This work has already had a broad impact in the field of JSRV research, with the earliest 
publication arising from it having been cited 38 times so far in other lSI-recognised 
journals. The identification of variable regions specific to exogenous JSRVs has led to the 
design of new diagnostic tests that exceed the specificity of previously used tests 
(padayachi, 2005). However, this work did not have a veterinary focus, and these benefits 
are secondary. More importantly, the work has led to profound progress in furthering the 
understanding of OPA as a uniquely useful model of human disease. 
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Future directions leading on directly from this work will include the in vivo testing of the 
particles derived from the three chimeric constructs developed in this study. It will be most 
interesting to observe the effects of endogenous VRI and VR2 in the context of the 
exogenous JSRV. Also, reciprocal constructs will be created using the novel substitution 
strategy developed in this study, based on a combination of the sequences of the three 
endogenous proviruses. The point mutations that have been identified as being inhibitory 
to particle release in enJS56Al will either be avoided by using gag from one of the other 
enJSRVs, or corrected by site-directed mutagenesis. Exogenous VRI and VR2 will be 
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APPENDIX I 
GenBank accession numbers of sequences arising from, referred to in, or pertinent to, this 
thesis: 
enJS56Al AF153615 ESRVLTRL5 X95449 
enJS5F16 AF136224 ESRVLTRLI X95445 
enJS59Al AF136225 ESRVLTRL4 X95448 
ENTV Y16627 ESRVLTRL3 X95447 
ENTV-2 AY197548 enJRVLTR2 Z66532 
JSRV-SA M80216 enJRVLTRl Z66531 
JSRV21 AFI05220 809T Y18302 
JSRVJS7 AF357971 84R528 Y18304 
caenENTV gag AY372190 83R528 Y18303 
ESRVLTRL2 X95446 enJRVLTR3 Z66533 
caERV2U3 AY196353 exLTR UK Z71304 
caERVU3 AY196352 exLTRt2 X95452 
TNC196eL AY196356 exLTRtl X95451 
TNC396eL AY196355 EN54 Y18307 
TNC294eL AY196354 Y16 Y18306 
TN035eL AY196359 enJRVGAG2 X92180 
oENTVenvPrec AF401741 enJRVGAGl Z49800 
TN028eL AY196357 OPVCAPD L29127 
TN02geL AY196358 enJRVGAG4 X92182 
ESRVLTRL6 X95450 enJRVGAG3 X92181 
92K3 Y18305 oENTVenvU3 AY271312 
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APPENDIX II 
Sequences of DNA oligonucleotide primers designed specifically for use in this study: 
Position in 
JSRV21 
Sequence (5' - 3') 
35R TTGAGAGGATCAGCCCAAAA~ATAC 
124F GCAGGTGGCGCCCAACGT 
481F AAGTTCCTGTGGAAACTITATCC 
533F 
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